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Abstract
RNA editing is an mRNA processing event that involves the insertion,
deletion or substitution of bases in the pre-mRNA molecule and has the
potential to alter the genetic code resulting in a range of proteins with a
different primary sequence than that suggested by the DNA. Its importance
has only been fully realised now that the sequence of the human genome is
being finalised and that the number of genes it contains are much lower than
expected.
The adenosine deaminases acting on RNA or ADAR enzymes convert
adenosine to inosine in dsRNA. They are members of the larger cytidine
deaminase family and consist of a C-terminal catalytic domain and two or
more double-stranded RNA binding motifs (dsRBMs). In Drosophila
melanogaster there is only one adar gene. The Drosophila ADAR (dADAR)
enzyme consists of two dsRBMs and a deaminase domain and is known to
edit a number of transcripts encoding ion channels in the central nervous
system. The generation of 3 different dADAR isoforms at varying stages of
fly development enables enzyme activity to be regulated, with the adult form
being the most active.
The ADAR family of enzymes is thought to have evolved from the ADAT
(adenosine deaminase acting on tRNA) family that convert adenosine to
inosine in tRNA, by adding dsRNA binding motifs to a deaminase domain.
Drosophila ADAT1 is very homologous to the deaminase domain of the
dADAR enzyme, both having 3 distinctive motifs containing residues
thought to chelate zinc. Studies have shown that the deaminase domain of
the ADAR enzymes is responsible for substrate specificity. I have cloned and
purified the Drosophila deaminase domain and assayed its editing activity in
vivo and in vitro on the dADAR self edit site, and on a dsRNA. The results
suggest that the dADAR deaminase domain can edit dsRNA by itself. The
IV
editing pattern on the dsRNA mirrors that seen with the full-length wild-
type ADAR enzyme suggesting that site specificity is indeed conferred by the
deaminase domain.
The absence of an alternatively spliced exon between the two dsRBMs of
dADAR in adult flies results in higher editing activity when compared to the
isoform containing the exon seen at earlier stages of development. A number
of constructs containing the dsRBMs were successfully cloned and purified.
NMR data of RBM1 confirms that the dsRBMs of dADAR are members of the
well characterised family of dsRBMs with a typical a helix, 3 P sheets, a helix
structure and each dsRBM has a distinct affinity for dsRNA substrate
indicating possible different roles. Point mutations within dsRBMl result in
a loss of binding activity.
The self-editing site of dADAR is found within exon 7 of the pre-mRNA, 3' to
the second catalytic motif of the deaminase domain. Editing at this site
results in a serine to glycine change in the translated protein and has been
shown to reduce editing activity in all known substrates. This region of the
protein is highly conserved throughout the ADARs and sequence
comparisons with human ADAR2 at the DNA level show it has the potential
to be edited at the same site as dADAR. When the same serine is mutated to
glycine in human ADAR2 a decrease in activity is again seen suggesting that
this serine residue plays a role in the active site of the enzyme.
My results confirm the hypothesis that the catalytic deaminase domain
acquired dsRBMs, increasing the efficiency of the editing reaction on dsRNA.
The dsRBMs bind non-specifically to dsRNA altering and stabilising the
structure, allowing the catalytic domain easier access to the adenosine
nucleotide to be edited. However, because the deaminase domain has
activity on its own it too must play a role in binding to dsRNA substrates.
The characteristics of a dsRNA substrate do not involve an easily delineated
nucleotide sequence but may instead involve a more complex structural
v
motif. This is not recognized by the dsRBMs but by the deaminase domain
itself, probably in a way similar to how the ADATs recognize the
evolutionary conserved structure of tRNAs.
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RNA editing is a term used to describe the structural alteration, insertion or
deletion of nucleotides in RNA (Grosjean and Benne, 1998). If modification
occurs in the messenger RNA it can result in the translation of a protein with
a different primary sequence than that suggested by the DNA sequence of
the gene. This process plays an important role in creating functional
diversity in the protein products of gene expression.
RNA editing was first discovered in the mitochondria of primitive
eukaryotes where the deletion or insertion of bases created new open reading
frames (Benne et al., 1986). Mammalian editing is in the form of base
alteration where a hydrolytic deamination of a cytidine or adenosine base
results in uridine and inosine, respectively.
1.2 C-to-U editing
C-to-U editing of the apolipoprotein B (apoB) transcript was the first
example of RNA editing identified in mammals (Chen et al., 1987; Powell et
al., 1987). Since this discovery, A-to-I RNA editing as well as C-to-U editing
of DNA have been extensively studied.
1 Introduction
1.2.1 C-to-U editing in RNA
1.2.1.1 The apoB editing machinery
Studies on cDNA clones showed a single C-to-U base change at C6666 of the
apoB-100 mRNA resulted in an in-frame UAA stop codon replacing
glutamate 2153 and resulting in the apoB-48 intestinal transcript (Chen et al.,
1987; Powell et al., 1987) (Figure 1.1). This C-to-U change was later identified
as an RNA editing event catalysed by the APOBEC-1 (apoB mRNA editing
catalytic component 1) enzyme (Driscoll and Zhang, 1994; Lau et al., 1994;
Teng et al., 1993). Further studies indicated that the human APOBEC-1 gene
is located on chromosome 12pl3.1 - pl3.2 and cDNA analysis predicts a 236
amino acid protein of approximately 27 kDa (Lau et al., 1994). The transcript
is only found in the small intestine with the transcribed protein forming
homo dimers but unable to edit the apoB transcript on its own (Lau et al.,
1994; Navaratnam et al., 1993; Teng et al., 1993). Instead, an editing complex
composed of an APOBEC-1 dimer and a 63.4 kDa auxiliary factor known as
APOBEC-1 complementation factor (ACF) is the minimum requirement for
apoB editing (Lellek et al., 2000; Mehta et al., 2000).
The APOBEC-1 protein is similar to the cytidine deaminase family especially
in the region of its active site. Two conserved motifs found in this region,
C/FLAE and PCXXC, are involved in zinc chelation and proton shuttling
during deamination and site-directed mutagenesis at these sites abolishes
catalytic activity (Driscoll and Zhang, 1994; MacGinnitie et al., 1995). The
RNA-binding activity of APOBEC-1 is relatively weak when compared to
other cytidine deaminases and as yet, a distinct RNA binding domain has not
been identified (Anant et al., 1995; Navaratnam et al., 1995).
A 65 kDa apoB editing auxiliary factor was purified and its structural











Figure 1.1 Cytidine deamination of apolipoptotein B.
A schematic of the human apoB gene. Concurrent with splicing
and polyadenylation, C-6666 in the intestinal apoB mRNA
undergoes site-specific deamination resulting in a U at this
position. The proteins translated from the unedited and edited
mRNAs are represented below.
(Taken from RNA Editing, 2000 Ed. B.L. Bass)
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the protein contains three non-identical RNA recognition motifs (RRM) and
is widely expressed in human tissues (Lellek et al., 2000; Mehta et al., 2000).
Along with APOBEC-1, ACF comprises the minimal protein requirements for
apoB editing and is thought to act as the RNA binding subunit of the
editosome (Lellek et al., 2000; Mehta et al., 2000). More recently, ACF has
been shown to be responsible for bringing APOBEC-1 from the cytoplasm
into the nucleus where apoB RNA editing occurs (Blanc et al., 2003).
Other auxiliary factors have been identified and are believed to play a role in
the editosome complex though as demonstrated only ACF and APOBEC-1
appear to be essential (Lellek et al., 2000; Schock et al., 1996).
1.2.1.2 Editing of the apoB transcript
The apoB gene is 43 kb in length and encodes 29 exons. Two forms of this
gene exist, apoBlOO (512 kDa) and apoB48 (241 kDa). ApoBlOO is
synthesised in the liver and is involved in the transport of cholesterol and
triglycerides on very low density lipoproteins (VLDL). ApoB48 is found in
the small intestine and is involved in the synthesis, assembly and secretion of
chylomicrons. This shorter isoform is generated by the C-to-U editing event
at cytidine 6666 (C6666) which converts a glutamine (CAA) codon to a stop
codon (UAA) in exon 26 (Innerarity et al., 1996).
The apoB mRNA sequences around C6666 are highly conserved across many
species. Downstream of the editing site is an 11-nucleotide sequence called
the "mooring" sequence (Shah et al., 1991). Point mutations in this sequence
abolish editing (Driscoll et al., 1993; Shah et al., 1991) and the binding of the
RRMs of ACF to the apoB mRNA are dependent on this sequence being
intact (Mehta et al., 2000). The region between the edited C6666 and the
mooring sequence is also important and is know as the "spacer" element.
The length of this can range between 2 and 8 nucleotides, with the optimal




6609 6628 6653 6661 6671 6681 6717 6747
6666 ^3 5' Distal Efficiency Element
C~*U £3 5' Proximal Efficiency Element
ES 5' Regulator Element
E3 Mooring Sequence
■ 3' Efficiency Element
B S6666
5 1... U A Mooring SequenceC
A ~~G
Human AUUU AUCAGUA-UAn uidii i i i i i i i i i i i ii •
UAAA UAGUUAU AU *
C G U
3'...G U U A
6747^ 3' Efficiency Element
Figure 1.2 The apolipoprotein B substrate
A. Model of apoB mRNA in the region of the editing site showing different
structural elements important for apoB mRNA editing.
B. Proposed secondary structure of human apoB mRNA.
(Taken from RNA Editing, 2000 Ed. B.L. Bass)
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A 5 nucleotide region immediately 5' of the editing site deemed the 5'
regulator element has been shown to play a significant role in editing
efficiency although unlike the mooring sequence it is not essential (Backus
and Smith, 1992). A number of other efficiency elements have been
identified both 5' and 3' to the editing site and mutations in these regions
reduce editing activity in vitro (Backus and Smith, 1991; Driscoll et al., 1993)
(Figure 1.2).
1.2.1.3 Overexpression and deletions of APOBEC
Studies in low density lipoprotein (LDL) receptor deficient mice and rabbits
demonstrated that an increase in apoB editing in the liver lowered LDL and
VLDL levels in plasma (Teng et al., 1997). This suggested that APOBEC-1
may be a good candidate in gene therapy treatments of elevated LDL and
VLDL levels which are often associated with coronary heart disease.
However, overexpression of APOBEC-1 in the livers of mice and rabbits
resulted in hepatocellular carcinomas. This was probably due to the
indiscriminate editing of other transcripts involved in cell growth and
differentiation (Yamanaka et al., 1995). Yamanaka et al. later identified a
novel APOBEC-1 target, NAT1, which is highly conserved among species.
This protein has homology to the carboxy-terminal portion of the eukaryotic
translation initiation factor, eIF4G and is thought to be a translational
repressor. When APOBEC-1 is overexpressed the NAT1 transcript is edited
at several sites. This changes the primary sequence and generates stop
codons resulting in considerably lower levels of NAT1 protein in the livers of
mice overexpressing APOBEC-1 (Yamanaka et al., 1997). This promiscuous
editing of NAT1 is thought to play a role in the oncogenic phenotype of these
transgenic mice.
Hirano et al. and Morrison et al. generated apobec-1 "/" mice by targeted
disruption of the gene (Hirano et al., 1996; Morrison et al., 1996).
Homozygous mice were viable and fertile and displayed no obvious
6
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phenotype other than increased levels of low density lipoprotein and
reduced levels of high density lipoprotein. No apoB48 was detected
indicating that the major role of APOBEC-1 is apo B RNA editing and the
modulation of lipid transport (Hirano et al., 1996; Morrison et al., 1996;
Nakamuta et al., 1996).
1.2.2 C-to-U editing in DNA
1.2.2.1 Antibody diversification
Antibody diversity is generated in the B lymphocytes of the immune system
using recombination, gene rearrangement and mutation. Immature B cells
found in bone marrow assemble immunoglobulin (Ig) genes in a process
called V(D)J recombination catalysed by the complex of rearrangement
activating genes RAG1-RAG2. The exon encoding the antigen-binding
domain is assembled from V (variable), D (diversity) and J (joining) gene
segments and this V(D)J segment is linked to the /z constant region (C/z).
This generates a primary repertoire of the low affinity IgM antibodies.
After antigen contact, B cells expressing an IgM molecule that recognizes the
antigen are induced to proliferate and form germinal centres in secondary
lymphoid organs. The antigen-binding regions undergo further
diversification by somatic hypermutation (SHM). This introduces point
mutations along the variable region allowing generation of antibodies with
improved affinity for the antigen. In addition to this, stretches of nucleotide
sequences are copied from the pseudogene V elements (\p V) into the
functional V(D)J exon further modifying the variable region in a process
called immunoglobulin gene conversion (IGC). Finally, exons encoding the
constant region of the antibody are swapped by recombination events
replacing the C/z constant region of the IgM antibody with the y, s or a
constant regions allowing the production of IgG, IgE and IgA antibodies.




Activation-induced deaminase (AID) was discovered by Muramatsu et al.
using subtractive hybridisation to identify genes in murine B lymphoma cells
whose expression increased in parallel with the induction of class switch
recombination (CSR) (Muramatsu et al., 1999).
Basal expression of AID is low however, upon stimulation by IL-4, TGF-(3
and CD40L, 80% of B cells switch from IgM to IgA and AID expression is up
regulated by 10 fold. This increase in AID mRNA is synchronous with
germinal centre formation after antigen stimulation. Cyclohexamide
treatment reduced this up regulation of AID after stimulation indicating de
novo synthesis of proteins is also required (Doi et al., 2003; Muramatsu et al.,
1999).
One open reading frame was identified encoding a 198 residue protein with
an approximate molecular weight of 24 kDa. The murine AID protein shows
34% identity to APOBEC-1 and contains the well characterised cytidine
deaminase (CDA) motifs and a leucine-rich region at the carboxy terminus.
Like APOBEC-1, AID has also been shown to shuttle between the nucleus
and cytoplasm via a N-terminal nuclear localization signal and a C-terminal
nuclear export signal (Ito et al., 2004).
AID has been demonstrated to have CDA activity on [3H] deoxycytidine.
Tetrahydrouridine, a CDA specific inhibitor, and 10-o-phenanthroline, a zinc
chelator, inhibit this activity indicating that the reaction is zinc dependent
(Muramatsu et al., 1999).
The human AID gene has been mapped to chromosome 12pl3, very close to
the APOBEC-1 locus (12pl3.1 - pl3.2) indicating that the two genes may
originate from a common ancestor that has CDA activity. A 2.9 kb AID
mRNA is expressed in B lymphocytes but not seen in fibroblasts or T cells.
8
1 Introduction
Human AID shows 92% amino acid identity to the mouse protein, especially
at the CDA motifs and C-terminal leucine-rich region (Muto et al., 2000).
1.2.2.3 AID deletions
AID _/" mice and AID v" / RAG-2 _/~ chimera were generated by Muramatsu et
al.. Phenotypically both mice were similar. B, T and other haematopoietic
cells all developed normally. At 10 weeks neither serum IgG3, IgG2b nor
IgA were detected and low levels of IgGl and IgG2a were observed but
found to be maternal in origin. Interestingly, serum IgM levels were found
to be 2-3 fold higher in AID 7 mice than AID +/"mice (Muramatsu et al., 2000).
When exposed to T-dependent antigens, antigen-specific IgM was produced
but no IgGl antibody was seen. This indicates that AID deficiency causes a
complete defect in class switching and the mice show a hyper-IgM
phenotype with enlarged germinal centres containing strongly activated B
cells before and after immunization. In vitro studies in AID "/_ B cells confirm
the phenotype is not due to a defect in B cell activation but that AID is
required for CSR and overexpression of AID in B lymphoma cells results in
an increase of class switching from IgM to IgA without cytokine stimulation.
In addition to this, the VH gene did not accumulate mutations after
immunization signifying a defect in somatic hypermutation (Muramatsu et
al., 2000; Nagaoka et al., 2002). Studies on AID chicken DT40 cells also
indicate a complete block of Ig gene conversion (Arakawa et al., 2002).
The AID mouse phenotype of no class switch recombination, no somatic
hypermutation and lymph node hyperplasia resembles that of the autosomal
recessive Hyper-IgM Syndrome (HIGM2). Linkage analysis maps the
HIGM2 locus to chromosome 12pl3, the same locus as human AID. The AID
gene in a number of HIGM2 patients was sequenced and 10 independent
mutations described. Some mutations are predicted to lead to truncated
proteins, others are missense mutations localised within the putative cytidine
9
1 Introduction
deaminase catalytic region (Revy et al., 2000; Zhu et al., 2003). These studies
suggest class switching, somatic hypermutation and Ig gene conversion all
share a common molecular mechanism involving the AID protein.
1.2.2.4 Mechanism
The mechanism by which AID initiates CSR, SHM and IGC was initially
thought to be through the editing of mRNAs. This hypothesis was given
credence by the striking homology between AID and the RNA editing
enzyme APOBEC-1 and that AID requires de novo protein synthesis to initiate
CSR (Doi et al., 2003; Muramatsu et al., 1999). However, AID showed no
CDA or binding activity on the APOBEC-1 substrate apoB and was unable to
bind to an AU-rich RNA (Muramatsu et al., 1999).
An alternative hypothesis proposed that AID acted on the DNA at the
immunoglobulin gene locus either directly by deamination or indirectly
through one or more auxiliary factors. Indeed, when expressed in E. coli AID
was shown to deaminate dC residues (Petersen-Mahrt et al., 2002) in single
strand DNA (Bransteitter et al., 2003; Chaudhuri et al., 2003; Dickerson et al.,
2003). Futher studies suggest a link between AID-mediated hypermutation
and transcription with transcription targeting AID to dsDNA by generating
secondary structures that provide the necessary ssDNA substrates
(Bransteitter et al., 2003; Chaudhuri et al., 2003).
The model proposed suggests that the recruitment of AID to the Ig locus
results in the localised deamination of dC - to - dU. Repair of this uracil can
occur by a number of methods and the pathway used and location of the






The ADAR1 enzyme was initially purified from bovine liver (Kim et al.,
1994a) and calf thymus (O'Connell and Keller, 1994). The purified proteins
exhibited adenosine-to-inosine editing activity with the 116 kDa
polypeptide (O'Connell and Keller, 1994) showing twice the specific activity
of the smaller 93, 88 and 83 kDa polypeptides (Kim et al., 1994a). The protein
was sensitive to N-ethymaleimide (NEM) and required 1-10 mM DTT for
activity indicating the enzyme may contain essential SH group(s) perhaps
involved in the catalytic mechanism.
Human ADAR1 cDNA was isolated by Kim et al. and O'Connell et al. from a
HeLa cDNA library. The full-length cDNA clone was found to give a single
open reading frame of 1226 amino acids with a predicted molecular weight
of 139 kDa (Kim et al., 1994b; O'Connell et al., 1995). The human ADAR1
gene has been localised to chromosome lq21 and contains 15 exons spanning
30kb (Wang et al., 1995). It appears to be ubiquitously expressed in human
tissue (Wagner et al., 1990) with relatively high levels in the brain (Kim et al.,
1994b).
Analysis of the primary structure indicates the presence of three dsRNA
binding domains and a C-terminal region containing the HAE and PCG
motifs commonly found in the cytidine deaminase family (Kim et al., 1994b;
Liu and Samuel, 1996; O'Connell et al., 1995) (Figure 1.4). Further analysis
identified two putative Z-DNA binding motifs at the amino terminus
(Herbert et al., 1997). The Za motif has been shown to bind Z-DNA in a
conformation-specific manner (Herbert et al., 1998) whilst the Zp does not
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Figure 1.3 Adenosine deamination by hydrolytic deamination.
ADARs catalyse a hydrolytic deamination at C6 of adenosine to inosine.
Inosine structurally resembles guanosine, will form base pairs with
cytosine and is read as guanosine by the translational machinery.
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consists of Za and Z(3 motifs separated by a tandem repeat of a 49 amino acid
linker (Schwartz et al., 1999).
It has been postulated that Z-DNA formation occurs 5' to or behind a moving
RNA polymerase during transcription so recognition of Z-DNA by ADAR1
provides a plausible mechanism by which ADAR1 can be targeted to nascent
RNA so that editing occurs before splicing however, this method of
regulating enzyme activity has yet to be demonstrated.
A screen to isolate interferon-regulated cDNAs identified a 6.7 kb clone
designated K88, whose expression was increased fivefold by interferon
treatment (Liu and Samuel, 1996; Patterson et al., 1995). Immunoblot
analysis using antisera prepared against K88 cDNA products recognized an
interferon-inducible 150 kDa protein associated with both the nucleus and
cytoplasm and a second constitutively expressed primarily nuclear 110 kDa
protein. Western blot analysis and adenosine deaminase activity assays
illustrated that both the pl50 and pllO proteins were dsRNA-specific
adenosine deaminases. However, the full-length pl50, using the translation
start site Ml, was poorly expressed in COS cells when compared to the pllO
isoform using the M296 translation start site (Patterson and Samuel, 1995).
Three promoters have been identified upstream of the ADAR1 gene (George
and Samuel, 1999; George et al., 2005). The interferon inducible promoter, P,,
has been shown to contain elements known to be interferon responsive. This
promoter region generates transcripts incorporating exon 1A that contains
the Ml translation start site. This results in a single open reading frame of
1226 amino acids (iADARl). The constitutively active promoter, Pc, has no
interferon responsive elements and is immediately 5' to exon IB. Transcripts
initiated from this promoter incorporate exon IB structures giving an open
reading frame of 931 amino acids initiating from the alternative start site
M296 found in exon 2 (cADARl). The amino terminal truncated M296
ADAR1 protein contains all three dsRNA binding motifs and the catalytic
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deaminase domain. However, it lacks the Za motif of the Zab domain
though the biological significance of this is unknown (George and Samuel,
1999). A third promoter has recently been identified. Incorporating exon 1C,
this transcript is very scarce and only detected in the brain and heart (George
et al., 2005).
cDNA library screens with ADAR1 cDNA have also identified two
alternative splice sites involving a 78 nucleotide deletion in exon 7 and a 57
nucleotide deletion in exon 6. These splicing events alter the spacing
between the third dsRNA binding motif and the catalytic domain and the
second and third dsRNA binding motifs, respectively. Three ADAR
spliceoforms were found to be differentially expressed in human cells.
ADAR-a containing full-length exons 6 and 7, ADAR-b containing full-length
exon 6 with the exon 7 deletion and ADAR-c containing both deletions. The
fourth possible variant consisting of full-length exon 7 and the exon 6
deletion was not detected in any cDNA library examined but was expressed
in vivo and in vitro alongside the three naturally occurring variants in both
the full-length Ml and the shorter M296 forms. All recombinant variants
possessed comparable dsRNA deaminase activity indicating that the
deletions resulting from alternative splicing in exons 6 and 7 have no
discernible effect on enzyme activity in vitro (Liu et al., 1997).
Deletion analysis and point mutations of the ADAR1 enzyme revealed that
the first and third dsRBMs are important for dsRNA binding with the third
dsRNA binding domain being essential (Lai et al., 1995; Liu and Samuel,
1996). In spliceoforms with the exon 7 deletion the second dsRNA binding
motif was found to be dispensable whilst the presence of both the exon 6 and
exon 7 deletions appears to reduce the functional significance of the first
dsRNA binding motif (Liu et al., 1997). Point mutations within the catalytic
domain demonstrated that the histidine (H910) and cysteine (C966) residues
found within the deaminase CHAE and PCG motifs and another cysteine
(CI036) are essential for activity and probably play a role in the catalytic
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mechanism. A glutamate residue at position 912 was predicted, based on the
three-dimensional structure of E. coli cytidine deaminase, to be involved in
the critical proton transfer function of the enzyme. A substitution at this
position with alanine also abolishes all activity (Lai et al., 1995; Liu and
Samuel, 1996). Any deletion at the carboxy terminus has been shown to
abolish enzyme activity (Lai et al., 1995).
A study by Cho et al. demonstrated that ADAR1 exists predominantly as a
homodimer. Like the E. coli cytidine deaminase and APOBEC-1, the ADAR1
monomers were found to interact over a widespread region of the protein
including the deaminase domain and dsRNA binding domain with the N-
terminus being dispensable (Cho et al., 2003). This region of interaction
differs greatly from that of other dsRNA binding domain-containing proteins
such as PKR and Drosophila ADAR which mediate their dimerisation via N-
terminal regions including their dsRNA binding domains (See section 1.6.2).
ADAR1 did not form heterodimers with either ADAR2 or ADAR3 (See
sections 1.3.3 and 1.3.5) even though previous studies showing the mixing of
ADAR3 with either ADAR1 or ADAR2 resulting in diminished editing
activity suggested this may be a possibility (Chen et al., 2000).
The nuclear localisation signal of the human ADAR1 is not located in the N-
terminus as previously believed but overlaps with the third dsRNA binding
motif. This NLS activity is independent of RNA binding indicating a dual
function for this region of protein. Deletion analysis demonstrated that only
the entire dsRNA-binding motif could exhibit NLS activity (Eckmann et al.,
2001). The nuclear localisation of the human protein appears to be regulated
in a transcription-dependent manner similar to that of the hnRNPs. Cells
treated with actinomycin D showed a reduced concentration of hADARl in
the nucleus and accumulation in the cytoplasm indicating that the protein
15
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Figure 1.4 Domain structure of the Adenosine deaminase family of
proteins. NES, nuclear export signal; Za and Z|3, Z-DNA binding domains;




shuttles between the two compartments and that nuclear localisation is not
solely dependent on the presence of a NLS but requires on-going RNA
polymerase II transcription (Eckmann et ah, 2001).
The nuclear export signal (NES) of iADARl is located in a leucine rich region
of the proteins N-terminus and mutations in these key hydrophobic residues
results in nuclear localisation of ADAR1 (Poulsen et al., 2001). The nuclear
export of iADARl is inhibited by leptomycin B, a drug that covalently binds
the nuclear export receptor CRM-1, impeding its function. This suggests that
iADARl utilises a CRMl-dependent mechanism for nuclear export and this
is further supported by the fact that CRM1 specifically binds to the NES of
iADARl (Poulsen et al., 2001). It should be noted that this NES is not present
in the cADARl isoform perhaps accounting for it nuclear localisation
(Poulsen et al., 2001).
ADAR1 has also been shown to shuttle between the nucleolus and
nucleoplasm with this transient nucleolar sequestration thought to be
mediated by the abundance of dsRNA structures within this compartment
(Desterro et al., 2003). iADARl is located between the cytoplasm and
nucleus with cADARl locating to the nucleus and nucleolus due to its lack of
a nuclear export signal (Poulsen et al., 2001). Rather than editing substrates
being recruited to the nucleolus, expression of an editing substrate was
found to delocalise ADAR1 suggesting this nucleolar localisation is transient
and dynamic (Desterro et al., 2003).
Whilst in the nucleolus, ADAR2 (See section 1.3.3) has been shown to edit
transcripts whereas ADAR1 appears inactive (Vitali et al., 2005). Desterro et
al. recently reported that ADAR1 co-localises with the small ubiquitin
modifier, SUMO-1, in a specific sub-nucleolar region (Desterro et al., 2005).
Analysis of the ADAR1 peptide sequence indicated the presence of 2
potential SUMO-1 consensus motifs at lysines 418 and 899. ADAR1 was
shown to be modified by SUMO-1 at lysine 418 with a K418R point mutation
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abolishing this sumoylation. This modification is not a requirement for
ADAR1 function but instead has been shown to reduce the editing activity of
the enzyme indicating that sumoylation may play a role in ADAR1 enzyme
regulation (Desterro et al., 2005). As ADAR2 is not modified by SUMO-1, the
modification and resulting decrease in activity of ADAR1 could explain the
absence of ADARl-mediated editing within the nucleolus.
Many groups have examined the role of the interferon-inducible promoter
controlling ADAR1 expression. Systemic inflammation has been shown to
increase the number of inosine-containing mRNAs, a direct consequence of
increased ADAR1 expression and subsequent increase in A-to-I editing
(Yang et al., 2003). Studies on lung tissue have demonstrated that ADAR1
expression is upregulated when microvascular injury is induced with
pulmonary expression of ADAR1 localising to inflammatory cells including
neutrophils and monocytes (Rabinovici et al., 2001). Interferon is produced
early on in the inflammation cascade suggesting that the Ml form of ADAR1
plays a role in the inflammatory response perhaps through the modulation of
protein production.
A genome wide search in three families suffering from the autosomal
dominant disorder Dyschromatosis symmetrica hereditaria (DSH) mapped
the disease locus to chromosome lq21.3 and identified 4 mutations within
the ADAR1 gene in affected families (Miyamura et al., 2003); two nonsense
mutations predicted to result in truncated proteins, a leucine to proline
amino acid change in the deaminase domain that probably compromises
enzymatic activity and, a phenylalanine to serine change in exon 15 at the
carboxy terminus. A further seven novel mutations have since been
identified (Zhang et al., 2004). This disorder is characterised by a mixture of
hyperpigmented and hypopigmented macules distributed on the dorsal
aspects of the hands and feet, a phenotype not seen in any adar+/~ or adar'~
mouse models that have been generated. In fact the distinct regions of
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altered pigmentation are difficult to explain pathologically mainly due to the
ubiquitous expression of ADAR1.
A recent study has suggested an involvement with the RNAi pathway (Nie
et al., 2004). The long form of ADAR1 is found in the cytoplasm and has
been show to bind very specifically and strongly to siRNA in a sequence-
independent manner. ADAR2 and the shorter form of ADAR1 have also
been shown to bind to siRNA but with much lower affinities. All the ADARs
bound to siRNA molecules as small as 15 bp but A-to-I editing only occurred
in molecules >30 bp. The efficiency of RNAi silencing was greatly enhanced
in mouse embryonic fibroblasts null for ADAR1 or expressing a mutant
ADAR1 protein not containing the dsRNA binding domains. These results
suggest that the inhibitory effect ADAR1 has on the RNAi pathway is
mediated via its dsRNA binding domains and its ability to sequester rather
than edit siRNA (Zhang et al., 2004). Indeed, a subunit of the RNA-induced
silencing complex (RISC), Tudor staphylococcal nuclease (Tudor-SN), has
been shown to interact with hyper-edited dsRNA substrates promoting their
cleavage (Scadden, 2005). This is the first evidence of a direct interaction
between both pathways.
1.3.2 ADAR 1 deficient mice
Initial attempts by Wang et al. to generate adarT/' transgenic mice by
targeting exons 12 and 13, corresponding to a part of the catalytic domain,
proved impossible. adarT/' chimeric mice did not survive past embryonic
day 14 and displayed defects in the haematopoietic system suggesting the
presence of substrates in the liver that are essential for normal development
(Wang et al., 2000). The likely existence of a dominant-negative truncated
protein inhibiting already reduced levels of wild-type enzyme could explain
the heterozygous-lethal phenotype observed.
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In order to minimize the potential for interfering products, new null alleles
were constructed in which exons 2-13 (Hartner et al., 2004) were replaced
with a pgk-neo gene. These exons encode residues corresponding to all three
dsRNA binding domains, the two putative Z DNA binding domains and
most of the catalytic deaminase domain. adarl+/A2'13 heterozygous mice
appeared normal and intercrosses produced heterozygous and wild-type
pups at normal frequencies but no homozygous pups indicating that
differently constructed adarl null alleles result in embryonic death between
E11.5 and E12.5 in homozygotes. Interestingly, Hartner et al. generated
adarl*'A7~9 mice that appeared normal and went on to produce adarlA7'9,A7~9
embryos that phenotypically resembled the adarlA2~13/A 2-13mice. Indeed, Wang
et al. (2004) have recently successfully generated both adarl*''and adarl''"mice
with exons 12-15 excised via the Cre-LoxP system. Therefore the
haploinsufficiency seen in Wang et al. (2000) seems to have resulted from
insufficient expression of the manipulated adarl allele rather than a
dominant-negative truncated protein.
To determine the effect of ADAR1 deficiency on RNA editing, a number of
editing sites were analysed. No editing of sites A and B of the 5-HT2C
serotonin receptor was detected in adarl'/'mice compared with levels of 80-
90% in wild-type mice (Hartner et al., 2004; Wang et al., 2004). There was
also a reduction in editing of GluR5 Q/R and GluR-B R/G indicating that
they too may be potential targets of ADAR1 (Wang et al., 2004). Editing at
site C of the 5-HT2C receptor and Q/R site of GluR-B remained unchanged
whilst sites D and E of the 5-HT2C receptor showed increased levels of editing
when compared to wild-type (Hartner et al., 2004; Wang et al., 2004). These
results may reflect easier access for ADAR2 to these sites in the absence of
ADAR1 and suggests a site-selective A-to-I editing function for ADAR1
indicating that the ADAR proteins can edit distinct subsets of adenosines
even when they are closely grouped together.
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ADARl-deficient mice die in utero between E11.0 and E12.5 (Hartner et al.,
2004; Wang et al., 2004). They appear grossly normal except for a significant
reduction in foetal liver size and a pale yolk sac and embryo when compared
to wild-type. The vascular architecture of yolk sacs appears normal with
vessels containing nucleated erythrocytes with no morphological
abnormalities.
The first wave of haematopoiesis is extra-embryonic and takes place in the
yolk sac from around E7 to Ell producing nucleated erythrocytes termed
primitive. At around Ell, the foetal liver becomes the major haematopoietic
tissue and gives rise to blood cell lineages (termed definitive) found in the
adult until shortly before birth when haematopoiesis shifts to the spleen and
bone marrow. At E11.5 of adarl'/' embryos cell numbers in embryonic
haematopoietic tissues are significantly reduced in the yolk sac and
peripheral blood when compared to adarl*/ ' and wild-type embryos.
Analysis of E11.5 adarl'/' embryos' yolk sacs, foetal livers and peripheral
blood contain significantly fewer definitive (foetal liver-derived)
haematopoietic progenitor cells when compared with adarl*/' and wild-type
embryos (Hartner et al., 2004). In contrast to this, Wang et al. (2004) found
no significant difference in the number of definitive erythroid and myeloid
progenitor cells in the yolk sacs of adarl'/', adarl*/' and wild-type embryos
at E9.5 (Wang et al., 2004). This also contradicts the near complete block of
definitive erythropoiesis they observed previously (Wang et al., 2000).
Rather than the dramatic increase in erythroid cells seen in wild-type foetal
livers at El 1.25, ADARl-deficient livers contain very few erythroid cells,
most of which are yolk sac derived nucleated erythrocytes (Hartner et al.,
2004). ADARl-deficient livers show a profound scarcity of haematopoietic
cells at El 1.25 onwards, with many cells displaying the characteristic signs of
apoptotic cell death (Hartner et al., 2004). TUNEL assays revealed that these
elevated levels of apoptosis can be seen in many tissues including vertebra
and heart and have been detected as early as E10.5. The highest levels of
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apoptosis were detected within the foetal liver for both hepatocytes as well
as the haematopoietic cell population (Wang et al., 2004). This may explain
the difference in numbers of definitive progenitor cells seen on days E9.5 and
E11.5.
From El 1.5 onwards, there is a significant reduction in cell density of the
liver with blood accumulating in pathologically enlarged spaces perhaps
created by cell death. A reduction in cell proliferation to about 30% of wild-
type as revealed by bromodeoxyuridine incorporation (Hartner et al., 2004)
accompanied by high levels of apoptosis in the hepatocyte population (Wang
et alv 2004) contribute to this breakdown of liver architecture. No
morphological abnormalities were found in other tissues including
neuroepithelium, heart, branchial arches, placenta and yolk sac (Hartner et
al., 2004).
The mechanism by which ADAR1 prevents liver disintegration and
increased apoptosis in wild-type embryos is unclear. Studies in mouse
embryonic fibroblasts indicate that apoptosis seen in adarl null embryos is
stress-induced and similar conditions result in the significantly increased
expression of the ADAR1 pl50 isoform in wild-type MEF cells. Apoptosis
induced in adarl null embryos is independent of the PKR and RNase L
pathways both of which are activated by the presence of dsRNA and can
lead to the induction of apoptosis in cells under stress (Wang et al., 2004).
No haematopoietic or liver transcripts have been identified that need
ADARl-mediated A-to-I editing therefore this anti-apoptotic ADAR1
function may involve a new and novel mechanism.
1.3.3 ADAR 2
In an attempt to find the dsRNA adenosine deaminase activity responsible
for GluR-B Q/R editing, a screen of rat brain cDNA using a probe based on
the predicted catalytic domain of ADAR1 was performed. A number of
22
1 Introduction
clones were identified, one of which was capable of editing both the Q/R site
and R/G sites of GluR-B as well as converting adenosine to inosine on
synthetic dsRNA molecules (Melcher et al., 1996b). Initially named RED1,
this clone shared a 31% overall sequence identity to ADAR1 and consisted of
2 dsRNA binding motifs and a C-terminal catalytic domain where the
cytidine deaminase motifs, CHAE and PCG were present (Melcher et al.,
1996b) (Figure 1.4).
A screen of human libraries isolated a number of different cDNA clones, each
of which was derived from alternative splicing of the same original transcript
(Gerber et al., 1997; Lai et al., 1997) and mapped to the long arm of
chromosome 21, region q22.2-q22.3 (Cheng et al., 1994). All isoforms share
an identical N-terminus, two dsRNA binding motifs and a catalytic domain .
However, two isoforms differ by the presence of an Alu cassette in the
middle of the deaminase domain (Gerber et al., 1997; Lai et al., 1997). The
identification of putative exonic splice sites in this region suggest the Alu
cassette is alternatively spliced and in vitro assays demonstrate that the short
form, the isoform minus the Alu cassette, has a higher catalytic activity than
the long form (Gerber et al., 1997).
A number of other clones differed at the 3'-end with some failing to encode
the C-terminal 29 amino acids (Gerber et al., 1997; Lai et al., 1997) and these
isoforms were found to display no editing activity (Lai et al., 1997) indicating
residues in this region may be involved with protein stability and/or
enzymatic function.
Rat ADAR2 was found to modify its own transcript creating a new AG 3'
splice site (Rueter et al., 1999). This alternative splicing results in the
inclusion of an additional 47 nucleotide region, a frameshift and the
predicted translation of an 88 amino acid polypeptide (Rueter et al., 1999). In
rat brain a high percentage of mRNAs containing this 47 nucleotide region
were detected however, low levels of the truncated protein are seen
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suggesting that much of the edited mRNA is targeted for nonsense mediated
decay (Rueter et al., 1999).
hADAR2, the human 90 kDa protein was originally purified from HeLa
nuclear extract (O'Connell et al., 1997). The enzyme was sensitive to N-ethyl-
maleimide (NEM) and its activity inhibited by o-phenanthroline by 30%
when compared to the 90% inhibition seen with ADAR1. This suggests the
presence of a Zn2+ ion at the active site of both enzymes which is less
accessible in ADAR2 than in ADAR1 (O'Connell et al., 1997).
Kinetic analysis of the ADAR2 editing reaction indicates that the protein
functions as a dimer (Jaikaran et alv 2002). Further studies confirmed this
result stating that like ADAR1, ADAR2 exists predominantly as a
homodimer with the monomers interfacing over both the catalytic and
dsRNA binding domains (Cho et al., 2003) (See section 1.6.2).
ADAR2 was found to accumulate in the nucleolus (Desterro et al., 2003;
Sansam et al., 2003) and required binding to dsRNA for this localisation
(Sansam et al., 2003). FRAP analysis indicates that ADAR2 shuttles between
the nucleolus and nucleoplasm with actinomycin B treatment resulting in a
complete translocation of ADAR2 to the nucleoplasm (Desterro et al., 2003;
Sansam et al., 2003). Deletion analysis indicated the presence of a nucleolus
targeting signal in the N-terminal region of ADAR2 involving residues 75 to
132 that is necessary but not sufficient for nucleolar targeting (Desterro et al.,
2003).
These results suggest the nucleolus is a site of functional sequestration for
ADAR2 activity and limits its nucleoplasm^ activity on endogenous pre-
mRNAs. Expression of an editing substrate was found to delocalise ADAR2
from the nucleolus suggesting the localisation of ADAR2 to this
compartment is transient (Desterro et al., 2003). More recent studies
however, have shown that there is no ADAR1-mediated editing observed
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within the nucleolus but ADAR2 can edit sites in the GluR-B and 5-HT2c
substrates (Vitali et al., 2005). One of these targets is the C-site of the
serotonin receptor and nucleolar editing at this site has been shown to be
specifically inhibited by a C/D small nucleolar RNA, MBII-52. This snoRNA
is believed to target the C-site for 2'-0-methylation and thus, as discussed by
Yi-Brunnozzi et al., decrease the efficiency of editing at this site (Yi-Brunozzi
et al., 1999).
An as yet unexplained reduction in ADAR2-mediated editing of GluR-B has
been implicated in the selective neuronal death seen in sporadic amyotropic
lateral sclerosis or ALS (Kwak and Kawahara, 2005). GluR-B editing remains
normal in other cell types but is markedly reduced to approximately 50%
within the motor neurons of patients with ALS indicating that the resulting
increase in Ca2r permeability may play a role in the selective motor neuron
death seen in these patients (Kawahara et al., 2004; Kwak and Kawahara,
2005).
1.3.4 ADAR 2 deficient mice
adarT/'and adarl/' transgenic mice were generated by the insertion of a pgk-
neo gene in exon 4 that contains the essential deaminase motif (Higuchi et al.,
2000). The adarl* /' mice appeared normal however the homozygotes
suffered seizures and died between 0 and 20 days after birth.
Electrophysiological analysis showed an increase in AMPA receptor
conductance and this appears to be the primary cause of seizures.
Analysis of 25 known editing sites indicated that editing was substantially
reduced at most positions in adarl'/' mice, in particular the GluR-B Q/R site
where editing was reduced 10-fold. The GluR-B primary transcripts were
incompletely processed resulting in nuclear accumulation and a 5-fold
reduction in GluR-B mRNA. This suggests that editing is a prerequisite for
efficient splicing and processing of the GluR-B pre-mRNA.
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GIuR-B+/Aecs transgenic mice were generated by the deletion of the
downstream editing site complementary sequence (ECS) in a GluR-B allele
preventing editing at the Q/R site (Brusa et alv 1995). The absence of editing
at the Q/R site resulted in a shortage of edited GluR-B subunits for assembly
of the heteromeric AMPA receptor, an increase in glutamate-activated Ca2+
permeability and death (Brusa et al., 1995).
The adarZ/" phenotype was rescued by introducing a GluR-BR codon
containing an arginine residue at the Q/R site. Heterozygous adarl'1'/GluR-
B+/R mice showed partial rescue with the phenotype less impaired when
compared to GIuR-B+/Aecs mice (Brusa et al., 1995). This is consistent with the
theory that phenotypic impairment increases with the Q/R ratio of GluR-B.
As one GluR-B allele expresses exclusively the "R" form, the primary
transcripts from the second allele are under edited and mRNA levels are
reduced due to impaired splicing and processing. adar2~'~/GluR-Bm mice
appear normal at all ages (Higuchi et al., 2000). These results identify the
GluR-B Q/R site as the most important target of ADAR2.
It should be noted that GluR-B deficient mice are mostly viable with the
phenotype less severe than that of ADAR2 deficient mice even though the
Ca2+ permeability of the AMPA receptors is greatly increased. This difference
may be due to the possibility that the GluR-B subunit may enhance AMPA
receptor assembly (Feldmeyer et al., 1999). Recent studies have
demonstrated that this is indeed the case and Q/R editing modulates the
assembly of AMPA receptor tetramers with the GluR2 (R) isoform being
retained in the endoplasmic reticulum. Only when assembly is possible with
other subunits does GluR2 (R) exit the ER and proceed to the cell surface





ADAR3 cDNA was first isolated from rat brain total RNA. The full-length
cDNA clone was found to encode a 746 amino acid protein with a predicted
molecular weight of 82 kDa. The human gene was mapped to chromosome
10pl5 (Mittaz et al., 1997) and the human protein was shown to be 72%
similar in sequence to human ADAR2 having a similar domain structure
with 2 dsRNA binding motifs and a catalytic deaminase domain (Chen et al.,
2000) (Figure 1.4). However, unlike ADAR2, ADAR3 contains an N-terminal
54 amino acid region rich in arginine and lysine residues known as the R
domain (Melcher et al., 1996a). ADAR3 transcripts appear to be restricted to
the brain in both humans and rats, with the thalamus and amygdala
containing relatively higher levels (Chen et al., 2000).
Melcher et al. and Chen et al. demonstrated that the purified rat and
recombinant human ADAR3 enzyme have no activity on well characterised
ADAR substrates such as the GluR-B "Q/R" site, "R/G" site, and the
intronic "hot spot" site as well as synthetic dsRNA (Chen et al., 2000;
Melcher et al., 1996a). However, filter binding assays show ADAR3 is
capable of binding both dsRNA and ssRNA, with the former mediated by the
2 dsRNA binding motifs and the latter being mediated by the R domain
(Chen et al., 2000). This RNA binding activity may account for the inhibitory
effect ADAR3 has on ADAR1 and ADAR2 editing activity in vitro (Chen et
al., 2000).
ADAR3 may exhibit no activity in vitro but the fact that it can bind RNA and
has conserved motifs within the catalytic domain, suggests that this is a
functioning enzyme with possible substrates waiting to be discovered. The
likelihood is that ADAR3 acts as a competitive inhibitor suppressing the
activity of the other ADAR enzymes either by competitive substrate binding
or by sequestering the active ADARs in non-functioning heterodimers (Chen




dsRNA adenosine deaminase activity was first identified in Drosophila
extracts by Casey et al. (Casey and Gerin, 1995) and a Drosophila cDNA clone
with homologous to ADAR1 and ADAR2 was first isolated using degenerate
primers based on the highly conserved ADAR catalytic domain (Hanrahan et
al., 1998).
Palladino et al. also identified a PCR product from a Drosophila whole adult
cDNA library with significant homology to the ADAR deaminase domain
and higher homology to ADAR2 than ADAR1. This was identified as the
Drosophila Adar gene and localised to the 2B6-7 region of the X chromosome
(Palladino et al., 2000a).
Sequence analysis of cDNA clones identified a number of start methionines,
the exon -1 and +1 ATG sites being the most frequently used (Palladino et al.,
2000a). Two promoters were identified generating either exon -4a or -4b-
containing transcripts. The -4a promoter was active throughout all stages of
fly development unlike the -4b promoter which appears to be highly
regulated (Palladino et al., 2000a). Alternative splicing was observed at exon
3a between the two dsRNA binding motifs and alters the spacing between
these structural motifs (Palladino et al., 2000a).
Overall, 4 major transcripts were identified, generated by the presence or
absence of exons -la and 3a with the exclusion of all other alternative exons
(Palladino et al., 2000a). cDNA sequence analysis predicted a protein of 670
amino acids and on purification, an 80 kDa band was observed that exhibited
A-to-I editing activity on synthetic dsRNA substrates (Palladino et al., 2000a).
Indeed, four dADAR protein isoforms can be translated starting at the exon -
1 or exon +1 ATG and including or excluding 3a.
The dADAR enzyme was found to edit its own transcript. This editing event
occurs at a site in exon 7 within the catalytic domain six amino acids
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downstream of the second cytidine deaminase motif (PCGD) and results in a
serine to glycine amino acid change (Palladino et alv 2000a). Termed the S/G
site, editing here, as with other Drosophila ADAR substrates (Hanrahan et al.,
2000; Keegan et al., 2005), is highly regulated with low levels seen in the
Drosophila embryo and pupae (Palladino et al., 2000a). Self-editing increases
dramatically upon eclosion with over a 40-fold increase from embryo to
adult. This serine to glycine amino acid change is essential for Drosophila
viability and results in a dADAR isoform less active than the genomically
encoded serine isoform (Keegan et al., 2005). Interestingly, if editing at this
site is prevented in vivo and only genome-encoded ADAR is present,
hyperediting occurs at other physiological targets leading to early death in
the flies (Keegan et al., 2005).
Recent studies have demonstrated that like ADAR1 and 2, dADAR functions
as a dimer (Gallo et al., 2003). Unlike ADAR1, the deaminase domain is not
required, instead in a pattern resembling other dsRBD-containing proteins,
the region of interaction was identified as the N-terminus and first dsRBM
(Gallo et al., 2003). Abolition of RNA binding activity in dADAR by point
mutations within the first dsRBD disrupted dimerisation indicating the
requirement of dsRNA for dimer formation (Gallo et al., 2003). Various
dADAR isoforms were able to interact and generate heterodimers exhibiting
different editing activities suggesting that alongside the alternative splicing
of exon 3a and self-editing, dimer formation is another dADAR regulatory
mechanism (Gallo et al., 2003).
1.3.7 Drosophila ADAR null mutants
Drosophila ADAR null mutant flies have been generated using two different
approaches. Having identified the dADAR enzyme Palladino et al. generated
a deletion mutant by site-selected P element mutagenesis followed by
excisions of the P element (Palladino et al., 2000b). 13 deletions of dAdar
were recovered with one allele, 5G1, completely deleting the dAdar locus
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including all coding sequences. All mutants were conditionally lethal but
under ideal growth conditions developed into morphologically normal
adults displaying significant behavioural deficits. A translocation of a Y
chromosome containing the complete dAdar locus to the tip of the X
chromosome rescued all phenotypes indicating that the mutant phenotypes
observed are the result of null alleles of dAdar (Palladino et al., 2000b). The
5G1 allele produced no detectable dAdar transcripts and crude extract from
dAdar null mutant adults showed no A-to-I conversion activity on synthetic
dsRNA (Palladino et al., 2000b).
Using a forward genetic approach, Ma et al. performed a genetic screen
looking for loss-of-function mutations involved in sensitivity to anoxia (Ma
et al., 2001). Two mutants were identified, hypnos-2L and hypnos-2P, that
mapped to the same locus with hypnos-2P being more sensitive to oxygen
deprivation. Analysis of the hypnos-2P locus identified the deletion to be
within the dAdar gene and to abolish the second dsRBM and part of the
deaminase domain located in exons 5 and 6. hypnos-2P proteins were
detected in the Drosophila embryo and adults but were smaller than those
detected in Canton-S wild-type flies indicating the deletion to be in-frame
(Ma et al., 2001). A transgene encoding wild-type dADAR rescued the
hypnos-2P phenotype indicating that deletion of the second dsRBM and part
of the deaminase domain is sufficient to abolish dADAR editing activity (Ma
et al., 2001).
dAdar null mutant adult flies present severe behavioural deficits involving
slow uncoordinated locomotion, occasional tremors, abnormal body posture,
and excessive grooming (Ma et al., 2001; Palladino et al., 2000b). Adult male
dAdar nullflies display extreme mating difficulties and do not initiate any of
the normal courtship rituals (Palladino et al., 2000b). A number of editing
targets identified in Drosophila including cacophony (Smith et al., 1996),
paralytic (Hanrahan et al., 1998), nap and slowpoke (Hoopengardner et al.,
2003) are involved in the courtship song display (Peixoto and Hall, 1998).
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The absence of editing activity at these substrates may explain the mating
defect seen in male dAdar null mutants.
Under optimal conditions dAdar null mutants have a life span comparable to
wild-type flies but if incubated at 25 °C or in a high-density population they
have a higher mortality rate than wild-type flies (Ma et al., 2001; Palladino et
al., 2000b). The recovery time from anaesthesia or anoxia is longer and they
appear to be extremely sensitive to heat shock, which exacerbates the already
severe locomotion and behavioural defects (Ma et al., 2001; Palladino et al.,
2000b).
All dAdar null mutants display gross anatomical abnormalities within the
brain. From a young age the retina is disorganised with photoreceptors
extending further to reach the laminar layers (Palladino et al., 2000b).
Lesions appear in the central brain, optic lobes and retina in adult flies
increasing in number and size with age (Palladino et al., 2000b). Cortical
neurons within the medulla, lobula complex and lamina also degenerate (Ma
et al., 2001).
Editing activity on the para Na+ channel, DmcalA (cacophony) Ca2+ channel,
DrosGluCl-a glutamate-gated chloride channel (Ma et al., 2001; Palladino et
al., 2000b), Da6 nicotinic acetylcholine receptor subunit (Grauso et al., 2002),
and the Shab K+ channel (Bhalla et al., 2004) transcripts is abolished in dAdar
null mutants indicating that dADAR is the enzyme responsible for site-
specific A-to-I editing in all these substrates. Lack of editing of the para Na+
channel has been shown to significantly lower membrane potential in
cultured neurons demonstrating a functional electrophysiological
consequence of ADAR activity (Ma et al., 2001).
1.3.8 C. elegans ADR
Using a differential display screen, Morse et al. identified 5 new ADAR
substrates in C. elegans, 4 of the transcripts are edited in untranslated regions
31
1 Introduction
(UTRs) whilst the fifth is predicted to be a non-coding RNA (Morse and Bass,
1999). The proteins responsible for this activity were identified from a C.
elegans cDNA library. The two open reading frames were predicted to
encode proteins with C-terminal domains similar to the deaminase domain
of the ADAR proteins (Hough et al., 1999; Morse and Bass, 1999). adr-2 was
found to encode a protein with one dsRNA binding motif and a highly
conserved deaminase domain containing the CDA consensus of HAE(x)41.58
PCG(x)44_154 SCSDK. adr-1 was shown to have two dsRNA binding motifs and
further analysis revealed 5 possible spliceoforms. The deaminase domain of
adr-1 is not as conserved as adr-2 with a consensus sequence of DAI(x)48
PPC(x)42 CTADK. This may account for its apparent lower levels of editing
activity (Tonkin et al., 2002).
adr-1 was found to be highly expressed in the nervous system throughout
worm development and remains present in adult worms. Interestingly, adr-1
expression was also seen in the developing vulva during morphogenesis of
this organ, adr-2 has been found to be expressed ubiquitously in early
embryos (Tonkin et al., 2002).
1.3.9 C. elegans adr-1 and adr-2 null mutants
The 10 known targets in C. elegans for the ADR proteins are all edited in non-
coding regions therefore the physiological function of RNA editing in worms
is unclear. Homozygous deletions of adr-1 and adr-2 and a double mutant
were isolated and editing and behavioural activities were analysed (Tonkin
et al., 2002).
All of the mutant worms appeared normal indicating that adr-1 and adr-2 are
not essential genes in worms unlike in mammals, adr-1 mutant worms
showed a significant decrease in ADAR activity both in vitro and in vivo
however, adr-2 and the adr-1 ;adr-2 double mutant exhibited no detectable
ADAR activity. All of the mutant worms demonstrated defects in
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chemotaxis, a measure of the worms olfactory system, with the adr-1 worms
having a relatively mild phenotype when compared to the adr-2 and the adr-
l;adr-2 mutants. These results suggest that the ADR-2 protein is active on its
own but the ADR-1 protein requires ADR-2 for its activity, perhaps the 2
proteins function as a heterodimer.
In addition to the phenotypes described above, adr-1 mutants and double
mutants had defects in their somatic gonad resembling the protruding-vulva
(Pvl) phenotype. This corresponds with the expression pattern of adr-1 seen
during morphogenesis of the vulva (Tonkin et al., 2002).
Interestingly, even though the ADRs do not antagonise the RNAi pathway in
C. elegans when dsRNA is injected, transgenes expressed in somatic tissues of
wild-type animals are silenced in the adr-1 ;adr-2 mutants with the double
mutant having a stronger effect than either of the single adr mutants. U to C
changes were found in the antisense strand of the transgene in wild-type
worms indicating that when present, the ADR proteins deaminate these
dsRNAs resulting in I-U mismatches and preventing the dsRNA molecules
from initiating the RNAi pathway (Knight and Bass, 2002).
Worms with rde-1 or rde-4 mutations resulting in a defective RNAi pathway,
rescued the chemotaxis phenotype seen in adr mutants (Tonkin and Bass,
2003). This data along with the RNAi phenotype seen in adr null worms
suggests that the ADAR proteins play a role in monitoring which dsRNAs
enter the RNAi pathway.
1.3.10 ADATs
In higher eukaryotes, eight tRNAs (Ala, Leu, lie, Val, Ser, Pro, Thr, Arg) have
been found to carry inosine at the wobble position (position 34) of the
anticodon. Eukaryotic tRNAAa also has inosine at position 37. This is the
result of a zinc-mediated hydrolytic deamination reaction where a water
molecule is activated by zinc and attacks the carbon-6 of the adenine base to
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produce a keto group and the release of ammonia. In the case of tRNA^3,
inosine 37 is then methylated by a S-adenosylmethionine (SAM) to form the
Nbmethylinosine^. In absence of SAM inosine 37 containing tRNA
accumulates indicating that the deamination reaction is first to occur
(Grosjean et al., 1996).
Tadlp (scADATl) was identified in the yeast Saccharomyces cerevisiae as the
enzyme that specifically deaminates A37 of tRNA^3 to inosine. It was
identified because of its homology to the C-terminus of the ADARs and is
not essential for cell viability. Unlike the ADARs, these ADAT enzymes have
no dsRBMs but bind tRNA through an as yet uncharacterised RNA binding
domain. This binding appears to be dependent on the correct folding of the
L-shaped tRNAA)a substrate as well as the local conformation of the anticodon
loop. Mutations affecting the three-dimensional structure of the tRNA
molecule eliminate the deamination of A37. tRNA editing has also been
found to be strictly magnesium dependent (Auxilien et al., 1996). In the
absence of Mg2+ ions no A-to-I conversion can be seen on tRNA. This is
believed to be due to the involvement of Mg2T ions in maintaining the highly
conserved tRNA architecture that is recognised by the ADAT enzyme and
required for activity. Because of this highly specific substrate requirement it
is unlikely that an adenosine in long dsRNAs could be a substrate for Tadlp
(Gerber et al., 1998).
The human and Drosophila version of this enzyme, hADATl and dADATl
have also been cloned (Keegan et al., 2000; Maas et al., 1999). These proteins
have been shown to specifically edit adenosine 37 of tRNAAla to inosine and
are more similar to the ADARs than Tadpl supporting the notion of a
common evolutionary origin for ADARs and ADATs.
In a search of the Saccharomyces cerevisiae genome for open reading frames
encoding putative deaminases Gerber et al. identified the TAD2 gene. Yeast
with one copy of this gene deleted was not viable showing that TAD2 is an
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essential gene. The Tad2p enzyme was found to be involved in the
deamination of of yeast tRNA and was also found to modify the E. coli
tRNA^8. This deaminase was found to be a heterodimer consisting of 2
subunits, Tad2p and Tad3p with Tad2p being the catalytic subunit. Like
TAD2, the TAD3 gene was also found to be essential indicating that the
inosine at the wobble position of tRNAs is a crucial modification in yeast.
Tad2p and Tad3p share the deaminase motifs of the cytidine deaminase
family suggesting that Tad2p/Tad3p are ancestors of the deaminase domain
found in Tadlp and the ADAR family (Gerber and Keller, 1999).
A prokaryotic tRNA that is modified at position 34 has also been identified.
E. coli tRNAArg2 is modified at the wobble position by the tadA homodimer,
converting the A34 to inosine. The tadA gene has been shown to be essential
indicating that modification at the wobble position is essential in prokaryotes
also (Wolf et al., 2002).
1.4 Transcripts edited by ADARs
1.4.1 Structural characteristics of pre-mRNA that undergo
editing
What elements within a specific transcript dictate that a particular adenosine
is edited? Deletion analysis of known pre-mRNA has identified cis elements
involved in the regulation and determination of what adenosines are edited
in a given mRNA sequence.
Studies on the GluR-B Q/R editing site demonstrates that editing occurs
prior to splicing and that intronic sequences are required (Egebjerg et al.,
1994; Higuchi et al., 1993). Deletion analysis identified regions in the
downstream intron necessary for RNA editing (Brusa et al., 1995; Egebjerg et
al., 1994; Higuchi et al., 1993) (Figure 1.5). None of these regions are present
in the intronic sequences of the unedited GluR-A, GluR-C or GluR-D genes
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(Egebjerg et al., 1994). Sequence analysis revealed one region, -310
nucleotides downstream, consisting of 10 nucleotides complementary to the
unedited exonic sequence surrounding the Q/R site (Higuchi et al., 1993).
Base pairing between this exonic complementary sequence or ECS and the
nucleotides around the Q/R site is essential for efficient editing. Substituting
4 of the intron nucleotides to extend the intron-exon duplex and certain
paired complementary exonic and intronic substitutions reduced the extent
of editing at Q/R site suggesting that a duplex region is necessary but certain
nucleotide sequences and structural characteristics are required to ensure
accurate and efficient editing of the mRNA molecule (Higuchi et al., 1993).
Formation of this dsRNA duplex structure required for editing is aided by
the presence of an imperfect inverted repeat sequence in the proximal
portion of the downstream intron (Egebjerg et al., 1994; Higuchi et al., 1993).
This inverted repeat is predicted to fold into two hairpins consisting of 3
helical regions and disruption of this structure can decrease or even
eliminate Q/R editing (Egebjerg et al., 1994) (Figure 1.5).
Analysis of the Q/R editing sites in GluR5 and GluR6 identified an ECS 1900
nucleotides distal to the editing site (Herb et al., 1996) and deletion of the
ECS region of GluR6 in mice resulted in no Q/R site editing (Vissel et al.,
2001) further demonstrating the physiological importance of these non-
coding, and sometimes distant regions.
Sequence analysis of the GluR-B, GluR-C and GluR-D R/G sites in exon 13
and the downstream ECS-containing intron 13 demonstrated that the bases
in paired helical regions of this dsRNA duplex were conserved whereas
nucleotides in non-helical regions varied (Aruscavage and Bass, 2000).
Interestingly, this pattern of conservation was not observed in the GluR-A
gene (Aruscavage and Bass, 2000). This data would suggest an evolutionary
pressure by an ADAR-induced mechanism to retain certain intronic








































Figure 1.5 Predicted secondary structure of the pre-mRNA transcripts
encoding the (from left to right) GluR-B Q/R site, GluR-B R/G site, GluR5
Q/R site, GluR6 Q/R site, 5-HT2cR, and HDV amber/W site.
From Chapter 19, Grosjean and Benne, 1998
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duplex that facilitate editing at the R/G site.
Not all ECS have that have been identified reside in the downstream intron.
Two D. melanogaster substrates, the ADAR self-edit site (Palladino et al.,
2000a) and the FSP site of the para Na+ channel (Hanrahan et al., 2000) have
been shown to have an ECS within the same exon that contains the edited
adenosine. Many targets in D. melanogaster are conserved in other Drosophila
species however, the FSP site is not edited in D. virilis but sequence analysis
would suggest dADAR is edited in D. pseudoobscura. Indeed, structural
analysis of the sytl pre-mRNA substrate in Drosophila indicates a specific
pseudo knot structure conserved through evolution is responsible for driving
editing (Reenan, 2005).
In a perfectly paired dsRNA duplex, ADAR edits multiple adenosines yet in
physiological substrates this activity is highly specific, targeting a limited
number of particular adenosines. This selectivity is determined by the
structural characteristics of the dsRNA substrate. Internal loops act to divide
a substrate into smaller duplexed regions that appear as short dsRNA
substrates and are deaminated more selectively therefore reducing the
number of editing events across the whole molecule (Lehmann and Bass,
1999).
A number of studies have suggested that the efficiency of ADAR editing at a
particular adenosine is influenced by its base pairing/mismatch status.
Biochemical analysis indicates that when there is an A:C mismatch at the
editing site rather than an A:U base pair or A:G/A:A mismatch, ADARs are
enzymatically more efficient (Stephens et al., 2000; Wong et al., 2001).
However, in naturally occurring substrates this can vary. The adenosine at
the Q/R site of GluR-B is base paired yet at the R/G site the adenosine is
mismatched (Lomeli et al., 1994) and the Q/R target sites of GluR5 and
GluR6 are within a bulge due to a 4 bp mismatch between the exon and ECS
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sequences (Herb et al., 1996). It is unclear whether this base pair bias has any
significant influence on the efficiency of the ADARs at these different sites.
1.4.2 Glutamate-gated ion channels
The first examples of A-to-I editing in mammals were observed in mRNA
transcripts encoding glutamate-gated ion channels in the central nervous
system (Sommer et alv 1991). These receptors are involved in fast synaptic
neurotransmission and calcium entry through these channels plays an
important role in development and in forms of synaptic plasticity that may
underlie higher order processes such as learning and memory (Dingledine et
al., 1999).
There are three classes of glutamate receptor channel (GluRs); the NMDA
(N-methyl-D-aspartate) receptors, the AMPA (a-amino-3-hydroxyl-5-
methyl-4-isoxazolepropionic acid) receptors and the kainate receptors
(Dingledine et al., 1999). Only non-NMDA receptor transcripts are substrates
for RNA editing.
The GluRs consist of four different, sequence-related subunits and the
properties of the channel are dependent on which subunits are assembled.
Each subunit has four transmembrane hydrophobic regions, TMI- TMIV with
TMII forming a re-entrant loop resulting in an extracellular N-terminus and
intracellular C-terminus. The large loop between TMIII and TMIV is
exposed to the cell surface and forms part of the ligand binding domain
(Dingledine et al., 1999).
1.4.2.1 AMPA receptors
The AMPA receptors are assembled from a combination of the GluR-A,
GluR-B, GluR-C and GluR-D subunits into homo- or heteromeric channels.
Studies have shown that the GluR-B subunit is dominant in determining the
functional properties of a heteromeric AMPA receptor channel (Jonas and
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Sakmann, 1992). Native AMPA receptor channels are impermeable to
calcium and this impermeability is determined by the GluR-B subunit
(Burnashev et al., 1992). The GluR-B mRNA is edited at a site in the channel-
forming TMII region resulting in a single amino acid change from glutamine
(Q) to arginine (R) (Sommer et al., 1991). The positive charge of arginine at
this Q/R site contributes to low calcium permeability suggesting that this
residue is critical in determining AMPA receptor properties (Burnashev et
al., 1992) (Figure 1.6).
This glutamine to arginine amino acid change is the result of an enzymatic
conversion of the adenosine base in the glutamine CAG codon to inosine
(Rueter et al., 1995). The inosine is translated as though it were guanosine,
resulting in an arginine residue (CGG). This deamination was found to be
mediated by a dsRNA adenosine deaminase activity (Hurst et al., 1995;
Melcher et al., 1995; OGonnell et al., 1997) and the presence of a downstream
intronic sequence, the ECS, was shown to be essential (section 1.5.2) (Brusa et
al., 1995; Egebjerg et al., 1994; Higuchi et al., 1993).
ADAR2 was identified as the enzyme responsible for Q/R editing (Higuchi
et al., 2000; Melcher et al., 1995). ADAR2 null mice were prone to seizures
and died young however, the insertion of the edited allele of GluR-B rescued
this phenotype (section 1.4.2) (Higuchi et al., 2000). Overexpression of the
genomically encoded GluR-B (Q) subunit results in an increase in AMPA
receptor conductance and epileptic seizures and premature death (Brusa et
al., 1995; Feldmeyer et al., 1999) further highlighting the physiological
importance of Q/R editing. Interestingly, it has been shown that the GluR-B
(Q) subunit is not essential for brain development and function (Kask et al.,
1998) though a compensatory mechanism is believed to be involved when
GluR-B is missing.
Greger et al. demonstrated that the GluR-B subunit resides in an intracellular
pool within the endoplasmic reticulum (ER) and that this ER retention is
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controlled by the arginine residue at the Q/R editing site (Greger et al., 2002).
GluR-B (R) subunits are largely dimeric and are retained in the ER unlike
unedited GluR-B (Q) subunits which readily tetramerize and are rapidly
exported from the ER and trafficked to the cell surface (Greger et al., 2003;
Greger et al., 2002). This suggests that the arginine at the Q/R site is a
unique ER retention signal and alters a region of the subunit involved in
receptor assembly thus restricting the incorporation of GluR-B (R) subunits
in AMPA receptor tetramers (Greger et al., 2003; Greger et al., 2002).
These results suggest that in studies where Q/R editing is abolished the
phenotypes seen may not only be due to an increase in calcium permeability
of each individual channel but also changes in AMPA receptor stoichiometry
and number.
Lomeli et al. identified another RNA editing site in exon 13 of GluR-B
resulting in an arginine to glycine codon switch (Lomeli et alv 1994). Termed
the R/G site, this induced amino acid change was found to also occur in the
GluR3 and GluR4 transcripts (Lomeli et al., 1994).
The R/G site is located immediately upstream of the alternatively spliced
flip-flop cassette and the extent of editing at this site varies in a flip-flop
splice-dependent manner (Lomeli et al., 1994). A conserved region critical
for R/G editing was identified in the proximal portion of intron 13 of the
GluR-B, GluR-C and GluR-D genes and this region has been deemed the ECS
(Lomeli et al., 1994). R/G site editing of the GluR subunits results in slower
AMPA receptor desensitization and an increase rate of recovery (Lomeli et
al., 1994). Rapidly recovering receptors are able to respond to repeated







genomic DNA TTG GGT GCC TTT ATG CflG CAG GGA TGC GAT GGA TCC TCA TTA I
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Figure 1.6 Schematic diagram of the heteromeric AMPA receptors
indicating ion-permeation properties of channels containing non-edited
(Q586) or edited (R 586) GluR-B receptor subunits. Nucleotide and
predicted amino acid sequence alignments between GluR-B genomic,
mRNA and cDNA sequences; nucleotide discrepancies and predicted
alterations in amino acid sequence are indicated in inverse and open




Kainate receptors can be generated from the heteromeric assembly of the
subunits GluR.5, GluR6, KA-1 and KA-2 (Dingledine et alv 1999). Like the
AMPA receptor GluR-B subunit, GluR5 and GluR6 transcripts are edited in a
critical position (Q/R site) of the putative channel-forming segment TMII
(Egebjerg and Heinemann, 1993; Kohler et al., 1993). However, in contrast
with AMPA receptor channels, the presence of glutamine at the Q/R site
results in channels with low calcium permeability, whereas an arginine
determines higher calcium permeability (Egebjerg and Heinemann, 1993;
Kohler et al., 1993).
Unlike the AMPA receptors, calcium permeability is not solely controlled by
Q/R editing. Sequence analysis of GluR6 identified two other RNA editing
sites within the TMI region that change an isoleucine residue to valine (I/V
site) and a tyrosine residue to a cysteine (Y/C site). If the TMI sites are
unedited, calcium permeability is less influenced by the presence of either
glutamine or arginine at the Q/R site of TMII thus Q/R editing in kainate
receptors is not the only determinant of calcium permeability (Kohler et al.,
1993).
The GluR5 and GluR6 editing sites are not edited to 100% like the GluR-B
Q/R site but instead different edited variants are co-expressed in a single cell
(Ruano et al., 1995). Kainate Q/R site editing is mediated by a dsRNA
adenosine deaminase activity (Herb et al., 1996) and is developmentally
regulated (Lee et al., 2001). An ECS has been identified in GluR5 and GluR6
located 1900 nucleotides from the Q/R site (Herb et al., 1996) and is essential
for kainate Q/R editing (Vissel et al., 2001). Mice with an ECS deletion in the
GluR6 gene express only the GluR6 (Q) subunit (Vissel et al., 2001).
Phenotypically they display no behavioural deficits but have increased
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seizure vulnerability (Vissel et al., 2001). This suggests that RNA editing at
the Q/R site of the kainate GluR5 and GluR6 subunits may play a role in
seizure susceptibility and perhaps be potential targets for antiepileptic drugs.
1.4.3 Serotonin (5-HT2C) receptor
The 5-HT2C receptor is a seven-transmembrane-spanning G-protein coupled
receptor that undergoes RNA editing at 5 distinct sites located in the coding
region of the second intracellular loop, a region of the protein involved in the
coupling of receptors to G protein-mediated signalling cascades (Burns et al.,
1997; Fitzgerald et al., 1999) (Figure 1.7). Editing patterns at sites A-E occur in
a tissue-specific manner and can result in, amongst others, a VGV or VSV
isoform of the 5-HT2C receptor, both of which exhibit a reduced coupling
ability to the G protein (Burns et al., 1997).
The serotonin receptor has been shown to be constitutively active, that is, it
can couple to the G protein a subunit in the absence of an agonist. The basal
phosphoinositide hydrolysis activity of the rat non-edited 5-HT2C INI isoform
was substantially higher than that of the VGV isoform yet when treated with
serotonin both isoforms have the same magnitude of increase in inositol
phosphate formation. These data indicate that by editing the 5-HT2C
transcript the constitutive activity of the receptors is silenced not its ability to
couple to G proteins (Niswender et al., 1999). Further studies on the human
receptor indicate that changes in agonist high affinity binding are also seen in
edited isoforms and contribute to the overall decrease in downstream effects
(Fitzgerald et al., 1999). This reduction in agonist potency depends on the
intrinsic activity of the ligand with full agonists being most affected by
editing and antagonists showing little effect.
RNA editing occurs specifically in the region of the 5-HT2C receptor that
interacts with the G protein a subunit. Price et al. have demonstrated that the
unedited INI isoform is capable of interacting with the a subunit of both the
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Gq and G13 proteins whereas the edited VGV and VSV isoforms are unable to
activate the G13 protein (Price et alv 2001). This results in a potential change
in 5-HT2C receptor downstream effects as the G13 protein does not interact
with the adenyl cyclase or phospholipase pathways but instead has been
found to alter the actin cytoskeleton arrangement via Pho-dependent
mechanisms (Gohla et al., 1999). Further studies have shown that unlike the
edited VGV isoform, the unedited INI isoform is capable of activating Rho-
GTPases via G13 and the phospholipase D pathway, a pathway implicated in
downstream responses such as actin cytoskeletal rearrangement and
exocytosis (McGrew et al., 2004).
A number of contradictory pathological studies have implicated changes in
the RNA editing patterns of the 5-HT2C receptor in a number of psychiatric
disorders including schizophrenia (Dracheva et al., 2003; Iwamoto and Kato,
2003; Sodhi et al., 2001), depression (Gurevich et al., 2002b; Iwamoto and
Kato, 2003; Iwamoto et al., 2005; Yang et al., 2004) and suicide (Gurevich et
al., 2002b; Iwamoto and Kato, 2003; Niswender et al., 2001; Schmauss, 2003).
Using post-mortem samples from schizophrenic patients Sodhi et al. found
an overall reduction in RNA editing of the 5-HT2C receptor with higher levels
of the basally more active unedited INI isoform (Sodhi et al., 2001). This
however, was contradicted by 3 other groups who found no such changes
(Dracheva et al., 2003; Iwamoto and Kato, 2003; Niswender et al., 2001).
These different outcomes may partly be explained by the sample sizes of
each study with Sodhi et al. using a sample size thought to be too small to
produce any statistically significant results in such a complex editing
substrate. In addition, the mix of male and female subjects and the presence
or absence of drug treatment may also play a role in the differing results seen
between all the studies. Due to the complexity of schizophrenia and the
wide range and severity of symptoms seen by clinicians it is difficult to
ascertain the exact role RNA editing of the serotonin 5-HT2C receptor plays in
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Figure 1.7 RNA Editing of 5-HT2cR transcripts.
A. A schematic representation of the predicted topology for the 5-HT2C
receptor is presented.
B. Nucleotide and predicted amino acid sequence alignments between 5-
HT2cR genomic, mRNA and cDNA sequences. (Taken from RNA Editing,
2000 Ed. B.L. Bass)
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One factor highlighted by the Niswender et al. study was the elevated levels
of editing at the A-site seen in patients who had committed suicide
regardless of their underlying psychiatric disorder (Niswender et alv 2001).
This result was replicated in a later study (Iwamoto and Kato, 2003)
suggesting a link between the change in serotonin-mediated signalling due
to altered editing efficiencies at the A-site and the particular mental state
associated with suicide.
In contrast with the studies mentioned previously, Gurevich et al. found an
increase in editing at the E-site, a decrease at the D-site with the C-site
showing a trend towards an increase in suicide victims with a history of
major depression. The treatment of mice with Prozac (fluoxetine), a
serotonin-selective reuptake inhibitor, resulted in the complete opposite
changes in editing patterns than those seen in suicide victims, suggesting a
serotonin-dependent site-specific regulation of 5-HT2C RNA editing
(Gurevich et al., 2002b). In fact, further studies indicate that serotonin-
depleted animals show a decrease in editing at sites C and E resulting in
increased expression of more serotonin-sensitive 5-HT2C receptor isoforms
(Gurevich et al., 2002a). When treated with a partial agonist an increase in
RNA editing at the E-site is observed and hence the expression of 5-HT2C
isoforms less responsive to serotonin activation. This suggests a role for
RNA editing in maintaining 5-HT2C receptor activation within an optimal
range in response to changes in serotonin levels (Gurevich et al., 2002a).
These complex and conflicting data indicate that RNA editing may play a
role in regulating fundamental properties of neuronal cells including
polarity, migration and transformation via its A-to-I editing activity on the
serotonin 5-HT2C receptor with these changes potentially resulting directly or
as seems more likely, indirectly, in the pathology and prognosis of a number
of major psychiatric disorders.
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1.4.4 Transcripts edited in Drosophila
1.4.4.1 The 4f-rnp gene
The first transcript to be edited in Drosophila was encoded by the 4f-rnp gene.
Comparisons of genomic DNA and cDNA revealed multiple A-to-G
conversions in transcripts isolated from Drosophila adult head (Petschek et
al., 1996). The biological function of the 4f-rnp gene is unknown but
transcripts are particularly abundant in the central nervous system and
deletions of the gene result in lethality during the larval period indicating an
essential role for 4f-rnp (Petschek et al., 1996). Sequence analysis indicate it is
a novel gene with the non-edited transcript encoding a 943 amino acid
protein containing a C-terminal RNA binding domain (Petschek et al., 1997).
Editing events at some of the 263 sites identified result in altered splicing
patterns and the translation of a number of isoforms (Petschek et al., 1997).
Peters et al. identified the sas-10 gene as the source of the antisense RNA
transcript that complements 4f-rnp forming the dsRNA substrate required for
A-to-G modification (Peters et al., 2003). The 4f-rnp and sas-10 genes are
adjacent, located on opposite DNA strands and convergent transcription
results in long readthrough transcripts of sas-10 complementary to 4f-rnp
transcripts. The expression of this sas-10 transcript is developmentally
regulated appearing at the late embryo stage of Drosophila development and
accompanied by an increase in editing and decline in 4f-rnp transcript levels.
This suggests degradation or nuclear retention of the 4f-rnp transcripts but
like other transcripts regulated by a similar antisense/RNA editing
mechanism (Section 1.5.8.3) the role this system plays in gene regulation is
yet to be fully explained.
1.4.4.2 The Calcium channel al subunit, DmcalA
The al subunit of the Drosophila voltage-sensitive calcium channel (DmcalA)
was found to map to the locus identified in the cacophony (cac) courtship and
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night-blind-A visual (nbA) mutations on the X chromosome (Smith et al.,
1996). The DmcalA protein consists of four homologous repeats each
composed of six putative a-helical transmembrane domains and forms the
calcium conductance pore of the voltage-gated calcium channel. The fourth
transmembrane domain of each repeat has positively charged residues every
3 or 4 amino acids and is thought to be the voltage sensor whilst the link
between the fifth and sixth transmembrane regions forms part of the pore
(Peixoto et al., 1997).
11 putative editing sites were identified in DmcalA transcripts resulting in 10
amino acid changes (Peixoto et al., 1997; Smith et al., 1996). Putative ECS's
have been identified for six of the DmcalA editing sites and all contain a 9-
nucleotide region of complementarity perfectly centred on the edited
adenosine (Smith et al., 1998). Palladino et al. generated a dADAR null
mutant in which no A-to-G changes were detected in the DmcalA transcripts
demonstrating that the dADAR protein is responsible.
Along with the various alternatively spliced regions, editing at these 11 sites
provides another level of variability to the properties of the translated
protein and resulting in potentially 125,000 different isoforms.
1.4.4.3 The para voltage-gated Na+ channel
The Drosophila para locus was found to encode a voltage-sensitive sodium
channel in Drosophila neurons similar in structure to the a subunit of
vertebrate sodium channels (Loughney et al., 1989). Like the DmcalA
channel, the para channel consists of four hydrophobic homology domains.
Each of these repeats comprises six transmembrane a-helical structures with
the fourth segment having a positively charged residue every three amino
acids and representing the voltage sensor.
Analysis of para cDNA initially identified six editing sites, five of which
result in an amino acid change (Hanrahan et al., 1998). An A-to-G change at
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the FSP and SSP editing sites eradicate Fspl and Sspl restriction enzyme sites
and result in Q/R and K/R amino acid changes, respectively whilst editing
at the SFC site generates a S/cI restriction enzyme site and a N/S amino acid
change. These sites undergo editing independent of each other and
alternative splicing with levels varying throughout development and an
obvious increase apparent between embryo and adult (Hanrahan et al.,
1998). Complementary regions were identified in downstream introns for
the SSP and SFC sites with editing at both appearing to be evolutionarily
maintained (Hanrahan et al., 1998; Hanrahan et al., 2000). Unsurprisingly
the exonic sequences of the para gene are conserved between both D.
melanogaster and D. virilis however, the intronic sequences incorporating the
ECS for the SSP and SFC editing sites were also highly conserved (Hanrahan
et al., 2000).
Editing at the FSP site was not evident in D. virilis (Hanrahan et al., 1998;
Hanrahan et al., 2000) and a search for the ECS indicated that it may lie
within exonic sequences upstream of the editing site. A transgene containing
the intron upstream of the edited exon and part of the upstream exon was
efficiently edited when injected into flies indicating that the structure
necessary for A-to-I editing is constructed from these sequences (Hanrahan
et al., 2000).
The 12-nucleotide T/M editing region contains three A-to-G changes
introducing Taql and Mnll restriction enzyme sites and resulting in a Q/R
and N/D amino acid changes (Hanrahan et al., 1998). Sequence analysis
indicates that each of these three events occur independently of each other
and are evolutionarily conserved between D. melanogaster and D. virilis
(Hanrahan et al., 1998).
Phenotype similarities between the paralytic-temperature sensitive, para'5, and
the maleless-no action potential temperature sensitive mlenar'5 null mutants
suggested a link between the wild-type functions of both genes. Further
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analysis demonstrated that the lack of RNA helicase function in the mle"a,"s
null mutants prevent the resolution of the secondary structure around the
para T/M editing site resulting in appropriate splicing causing exon-skipping
of the T/M containing exon (Reenan et al., 2000). The resulting phenotype
demonstrates the importance of the editing events at the T/M sites for
normal function of the para voltage-gated Na+ channel.
Another four editing sites have since been identified in the para transcript,
three of which incorporate amino acid changes (Palladino et al., 2000b). This
brings the total number of editing sites within this transcript to ten and
alongside the ten alternative splicing locations; the potential to generate a
vast number of isoforms.
1.4.4.4 Other Drosophila neuronal targets
Two other classes of ion channel have also been identified as targets of A-to-I
RNA editing. The DrosGluCl-a subunit of the inhibitory glutamate-gated
chloride channel has 5 known editing sites (Semenov and Pak, 1999) and the
Da6 nicotinic acetylcholine receptor (nAChR) subunit transcript has seven
editing sites resulting in amino acid changes in the ligand-binding domain of
the receptor (Grauso et al., 2002). Sequence analysis indicated that four of
the sites seen in Drosophila Da6 nAChR were also edited in the moth Heliothis
virescens suggesting an evolutionary conserved function for these editing
events (Grauso et al., 2002). A-to-I changes were not detected in DrosGluCl-a
nor Da6 transcripts isolated from dAdar null mutant flies indicating they are
substrates of the wild-type dADAR enzyme (Palladino et al., 2000b).
Comparative sequence analysis of a selection of genes associated with
nervous system function in Drosophila melanogaster and pseudoobscura
identified 16 new neuronal targets (Hoopengardner et al., 2003).
Recently Bhalla et al. identified a new target, the Shab gene a member of the
Kv2 gene subfamily of voltage-gated K+ channel a subunits (Bhalla et al.,
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2004). The comparative genetics study between the melanogaster and
pseudoobscura genomes failed to identify Shab because it had not been cloned
in pseudoobscura. Two adjacent adenosines are edited with the 5' adenosine
in the degenerate position of a valine codon and silent and the 3' adenosine
analogous to the editing site in human Kvl.l K+ channel introducing an I/V
site to the Shab K+channel. Editing at this site is attributed to the dADAR
enzyme, as this modification is not seen in dAdar null mutant flies (Bhalla et
al., 2004).
That all the known targets, apart from 4f-rnp and dAdar itself, are involved in
the fly nervous system is not surprising when considering the behavioural
and locomotion defects seen in the null mutant flies. Interestingly, all the
neuronal substrates identified are involved in rapid chemical or electrical
neurotransmission suggesting that one of the main roles of the ADAR
enzyme in Drosophila is the regulation of ion channel function.
1.4.5 C. elegans edited transcripts
ADAR activity in C. elegans was first identified using a differential display
screen looking for A to G changes between genomic DNA and mRNA.
Initially 5 new substrates were identified, three mRNAs of unknown
function with editing sites in the 3' or 5' UTRs, a non-coding RNA, and the
pop-1 transcription factor with the deamination sites in its 3' UTR (Morse and
Bass, 1999). A further 5 substrates were identified in a repeat of the screen
with all the editing sites again located in non-coding regions. Interestingly,
three of these substrates were identified as mRNAs important for nervous
system function (Morse et al., 2002).
Structural analysis of the 10 substrates showed they all had the potential to
form stable stem-loop structures with the base-pairing involving inverted
repeats found within the mRNA molecules. Multiple A to G changes were
found in each substrate with those substrates predicted to be almost
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completely double-stranded have many more sites than the substrates
containing mismatches, loops and bulges (Morse et al., 2002).
1.4.6 Viral transcripts
1.4.6.1 Hepatitis Delta Virus
Hepatitis Delta Virus (HDV) is a subviral pathogen that requires the hepatitis
B virus in order to propagate. HDV particles consist of the HDV genomic
RNA, the hepatitis delta antigen (HDAg) and a viral envelope made from the
hepatitis B surface antigen. The ~1680 nucleotide closed circular RNA
genome has a single open reading frame coding for the HDV antigen protein
(Lai, 1995). A-to-I RNA editing by ADAR1 (Jayan and Casey, 2002b; Poison
et al., 1996) at position 1012 of the antigenomic RNA, the amber/W site,
converts the UAG amber termination codon to a UGG tryptophan codon
allowing a long (HDAg-L) and a short form (HDAg-S) of the HDAg protein
to be translated (Casey and Gerin, 1995) (Figure 1.5). The HDAg-S protein is
essential for RNA replication whilst the HDAg-L protein has been shown to
inhibit RNA replication and is essential for viral packaging into the hepatitis
B surface antigen envelope (Lai, 1995).
During viral replication, editing at the amber/W site takes place in the
nucleus by the constitutively expressed short form of ADAR1 (Wong and
Lazinski, 2002). When overexpressed in cultured cells both ADAR1 and
ADAR2 have been shown to edit the HDV antigenome (Jayan and Casey,
2002a; Sato et al., 2001; Wong et al., 2001). Increased expression of ADAR
proteins results in a strong inhibition of HDV RNA replication, likely due to
increased editing at the amber/W site resulting in higher levels of HDAg-L
that in turn inhibits viral replication. However, editing at other non-
amber/W sites is also seen resulting in other HDAg variants that have been
shown to have a dominant negative effect on RNA replication (Jayan and
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Casey, 2002a). Therefore levels of ADAR expression play a role in the
regulation of HDV antigenome editing.
It is clear that A-to-I editing of the HDV antigenome must be regulated and
highly specific for the amber/W site to ensure successful viral replication. If
RNA editing is non-specific and occurs at sites on the antigenome other than
the amber/W site then these mutations would be carried into the viral RNA
genome. Furthermore if editing of the amber/W site is unregulated then
only HDAg-L protein would be produced resulting in the inhibition of RNA
replication and no propagation of HDV.
Studies have indicated that editing of the HDV antigenome can occur at
other positions but around 90% of the time it is only the amber/W site that is
edited. This editing can occur independently of viral replication and the
HDAg protein however the presence of the HDAg protein has been shown to
inhibit editing of the amber/W site in a concentration dependent manner
(Poison et al., 1998). The ability of HDAg to bind to the HDV RNA genome
and the requirement of a 75 amino acid segment encompassing an RNA
binding domain for this inhibitory activity indicates that HDAg may inhibit
editing by binding to or near to the amber/W site.
1.4.6.2 A-to-G hypermutation in RNA viruses
A number of RNA viruses have been reported to accumulate A-to-G
hypermutations during their life cycle (Cattaneo et al., 1988b; Hajjar and
Linial, 1995; Martinez and Melero, 2002; O'Hara et al., 1984). Measles virus
(MV), a negative strand RNA virus is one of the best studied. Normally
causing an acute infection in children, on rare occasions measles virus can
result in a persistent infection leading to subacute sclerosing panencephalitis
(SSPE) or measles inclusion body encephalitis (MIBE). This persistence is
thought to be due to defective matrix protein (M protein) expression, whose
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main function is viral assembly, resulting in lack of viral protein budding
(Hall et al., 1979).
The defective expression of MV genes has been correlated to a number of
mutations detected throughout the genome in MV genes isolated from SSPE
and MIBE cases (Cattaneo et al., 1988a; Cattaneo et al., 1988b; Wong et al.,
1989). Many of these mutations result in amino acid changes altering protein
sequence and reading frames. Interestingly, a biased hypermutation was
identified in the matrix gene where around 50% of the U bases were changed
to C (Cattaneo et al., 1988b). These mutations in particular have been
identified in a number of measles virus strains resulting in SSPE and are
believed to disrupt M protein conformation likely abolishing protein
function, altering epitopes and resulting in non-productive infection (Wong
et al., 1991). Hypermutation in the viral genome of human respiratory
syncytial virus (HRSV) has also been shown to alter protein epitopes and
contribute to viral genetic variation (Martinez et al., 1997; Martinez and
Melero, 2002).
After the discovery of a dsRNA unwinding activity with the ability to
convert adenosine residues to inosine (Bass and Weintraub, 1988) it was
postulated that the multiple U-to-C changes seen in the MV matrix gene
could be due to A-to-I mutations (Bass et al., 1989). During viral
transcription and replication the formation of double stranded regions of
RNA involving the plus and minus strands is possible. These regions could
be modified by this editing activity. A-to-I changes on the minus strand
would result in U-to-C changes in the plus strand and if this plus strand acts
as a template for replication, the subsequent negative-stranded genome
would contain A-to-G mutations. In cases of persistent infection these
mutations could be positively selected in order to inactivate matrix protein
function. It should be noted however, that even though ADAR activity has
been identified as the enzyme responsible for A-to-G transitions in other
RNA viruses (Hajjar and Linial, 1995; Martinez and Melero, 2002) its
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involvement in MV hypermutation has yet to be shown (Horikami and
Moyer, 1995).
1.4.6.3 Nuclear retention of hyperedited viral transcripts
Throughout the life cycle of polyoma virus, like many other viruses, there is
a strict temporal regulation of early- and late-strand transcript levels. Late in
polyoma virus infection nuclear antisense RNA from the late strand reduces
the levels of early strand transcripts available for translation. Many of these
early strands contain adenosine to inosine base modifications and are
retained in the nucleus (Kumar and Carmichael, 1997) suggesting that the
subsequent dsRNA structures formed when the antisense RNA binds to the
early strands are acting as substrates for the dsRNA editing activity by
ADAR. This nuclear retention of the modified polyoma early transcripts has
since been attributed to a specific inosine-induced retaining complex that
anchors hyperedited mRNAs to the nuclear matrix preventing their export to
the cytoplasm and subsequent translation (Zhang and Carmichael, 2001).
The bi-directional transcription of the Xenopus laevis basic fibroblast growth
factor (bFGF) produces complimentary sense and antisense transcripts a
small fraction of which undergo multiple A-to-I modifications during
maturation of the oocyte (Kimelman and Kirschner, 1989). This
hypermutation has been attributed to cellular ADAR activity (Saccomanno
and Bass, 1999) and is similar to the extensive A-to-G changes observed in
the Drosophila gene 4f-rnp (Section 1.5.4.1) (Peters et al., 2003; Petschek et al.,
1996; Petschek et al., 1997). The biological role of this hypermutation was
initially thought to trigger an inosine-induced degradation of transcript and
studies identified a mammalian ribouclease specific for inosine-containing
double-strand RNA (I-RNase) (Scadden and Smith, 1997). This RNase has
recently been identified as Tudor-SN, a component of the RISC complex
(Scadden, 2005). However, the bFGF transcript was shown to be stable and
persist after maturation indicating another possible purpose for this activity.
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1.4.7 Other ADAR targets
1.4.7.1 Disease-related Targets
A number of transcripts have been identified that are edited by the ADAR
enzymes in the context of particular diseases. It is unlikely that these editing
events cause the disease but they may contribute to the overall pathology.
One such example has been uncovered in the cells of patients with acute
myeloid leukaemia (AML). A novel mRNA species of the PTPN6 gene found
to be derived from aberrant splicing within the N-SH2 domain has been
discovered (Beghini et al., 2000). PTPN6 is a SH2 domain-containing
tyrosine phosphatase mainly expressed in haematopoietic cell development,
proliferation and receptor mediated mitogenic signalling pathways.
Sequence analysis of PTPN6 transcripts isolated from the cells of AML
patients revealed a number of A-to-G conversions mainly occurring at
A7866, a putative branch site (Beghini et al., 2000). Editing at this site has
been shown to abrogate splicing resulting in the retention of intron 3 leading
to nonsense translation and a predicted inactive truncated protein. Levels of
the aberrantly spliced mRNA were lower in samples from patients in
remission than at the point of diagnosis suggesting the involvement of post-
transcriptional PTPN6 processing in leukaemogenesis (Beghini et al., 2000).
A similar aberrant editing event has been identified in the human endothelin
B (ETB) receptor gene known to be involved in Hirschsprung disease
(HSCR), a congenital intestinal disorder characterised by the absence of
ganglionic cells in the distal portion of the intestine (Tanoue et al., 2002).
Mutant ETB transcripts lacking a 134 bp nucleotide sequence corresponding
to exon 5 were obtained from lymphoblastoid cells from HSCR patients.
Some of these splice variants also contained an A-to-G change at position 950
in exon 4 resulting in a glutamine to arginine amino acid change. ADAR1
and ADAR2 were both shown to edit position 950 with ADAR2 being more
efficient. Interestingly, this editing event was only seen in the splice variants
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lacking exon 5 suggesting that in this instance, the omission of exon 5
suitably alters the structure of the mRNA creating a viable editing site.
Western blot analysis also revealed no protein present corresponding to the
predicted translated product of this splice variant indicating that the mRNA
or protein may be degraded (Tanoue et al., 2002).
Systemic lupus erythematosus (SLE) is an autoimmne disorder characterised
by abnormal functions of T-lymphocyte immune effector cells. Changes in
signal transduction pathways are thought to contribute to the SLE
phenotype. An abnormal cAMP/protein kinase A pathway has been
identified in a large number of SLE patients. This defect is due to the
deficient activity of the type 1 protein kinase A caused by reduced amounts
of both its a and p regulatory subunits (RIa and RIP). A large number of
mutations have been discovered in the RIa transcripts of SLE patients, many
of which are T-to-C or A-to-G changes clustered in GAGAG motif and CT
repeat "hotspots" (Laxminarayana et al., 2002). ADAR1 expression in SLE T
cells was increased 3.5 times when compared to wild-type suggesting that A-
to-I RNA editing may play a role in the mutagenesis seen in SLE
(Laxminarayana et al., 2002). This overexpression of ADAR1 is thought to be
due to the high circulating concentrations of interferon a in SLE patients
(Hooks et al., 1979). High levels of ADAR1 protein could explain the
aberrant editing of the RIa transcript however, it is unclear whether this
editing is responsible for the lower levels of RIa transcript. It is also possible
that other transcripts may be edited and so could contribute to the pathology
of SLE.
1.4.7.2 A-to-I Editing within Repetitive Elements
By screening poly(A+) mRNA from human brain for inosine-containing
transcripts, 19 new targets for ADAR editing were discovered (Morse et al.,
2002). Of the 9 transcripts that were identified from databases, the editing
site was located within repetitive elements such as Alu repeats embedded
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within non-coding regions of the mRNA including introns and 3' UTRs
(Morse et al., 2002).
More recently many groups have utilised the powerful tool of bioinformatics
to identify other ADAR targets within the human transcriptome. Levanon et
al. aligned human ESTs and cDNAs to genomic sequence lowering possible
mismatches by discarding all single-nucleotide repeats longer than 4 bp and
removing 150 bps from both ends of the sequence. SNPs of genomic origin
were removed and 50-nucleotide windows containing 5 or more mismatches
were discarded. Those with 4 or more identical sequential mismatches were
retained reflecting the many sequential editing sites that have been
previously documented (Morse et al., 2002). The application of these strict
criteria to the data resulted in mainly A-to-G mismatches being identified.
The same approach looking for G-to-A mismatches yielded only 242 sites
indicating there are a low number of false positives attributable to sequence
error, SNPs and mutations. Using this method they identified 12,723
putative editing sites belonging to 1,637 different genes, 26 of which were
verified by sequences analysis of DNA and RNA samples from up to five
tissues (Levanon et al., 2004). Reflecting the results of Morse et al. the
majority of the sites identified in this screen are located in noncoding regions
such as 5' UTRs, 3'UTRs and introns with 92% of these sites embedded in Alu
repeat elements (Levanon et al., 2004). This obvious preference for sites
within Alu repeats may be due to the long paired RNA structures that are
likely formed between repetitive elements. However, Kim et al. have further
documented high levels of A-to-I editing in Alu repeats when compared to
other repeat elements such as LINE-1, LTR and DNA transposon families
(Kim et al., 2004). This suggests a distinct preference for Alu repeats and




1.4.7.3 RNA editing of miRNA precursor molecules
Micro RNAs (miRNAs) are small functional RNA molecules involved in gene
regulation (Bartel, 2004). Luciano et al. have recently identified a miRNA
precursor, pri-miRNA22 that is edited at a number of sites in both humans
and mice (Luciano et al., 2004). The ribonuclease Ill-like enzyme Drosha
processes these long pri-miRNA transcripts in the nucleus into -60-70
nucleotide pre-miRNAs which are then further cleaved by Dicer into mature
20-22 nucleotide miRNAs (Bartel, 2004). ADAR1 and ADAR2 have both
been shown to edit pri-miRNA22 transcripts and display overlapping yet
distinct site specificities. It has been shown that edited dsRNA is not a good
substrate for Dicer (Scadden and Smith, 2001) however, the physiological
consequences of this editing are unknown as is the normal function of
miRNA22.
1.5 RNA Binding
RNA binding proteins have been found to be involved in many diverse
cellular functions, influencing and regulating RNA molecules. The dsRNA
binding motif (dsRBM) was first identified in the Xenopus laevis RNA-
binding protein A (XlrbpA) and the Drosophila maternal effect protein
Staufen (St Johnston et al., 1992). Since then a number of other proteins have
been identified as containing one or more dsRBMs often in tandemly
arranged copies. These include the mammalian dsRNA-dependent protein
kinase (PKR), the TAR RNA-binding protein (TRBP), RNase III, Dicer and
the members of the ADAR family.
1.5.1 The structure of dsRNA binding motifs
The dsRNA binding motif is approximately 70 amino acids in length and a
number of motifs have been analysed by NMR revealing a common
a-p-p-p-oc structure in which the two a-helices lie on one face of a three-
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stranded anti-parallel p-sheet (Bycroft et al., 1995; Kharrat et al., 1995;
Nanduri et al., 1998). In vitro studies have shown that dsRBDs bind any
dsRNA of at least 16bp regardless of its base composition but do not bind to
single-stranded RNA or DNA or dsDNA (Bevilacqua and Cech, 1996; St
Johnston et ah, 1992). A-form dsRNA has its sequence information buried
within the major groove (Steitz, 1993) therefore dsRBMs instead rely mainly
on non-electrostatic minor groove 2'-OH interactions with only one ionic
contact between the protein and dsRNA phosphate backbone (Bevilacqua
and Cech, 1996).
A 1.9A resolution crystal structure of the second dsRBM of XlrbpA
complexed with dsRNA confirms the biochemical analysis and shows the
motif spanning 16bp of mainly A-form RNA helix and interacting with two
successive minor grooves and the intervening major groove of the sugar-
phosphate backbone without any direct base contact (Ryter and Schultz,
1998). dsRBD specificity has been well documented. In the case of the
ADARs, site-specific editing has been observed in vitro indicating no other
co-factors are involved. Indeed, ADAR1 and ADAR2 are both capable of
binding to the glutamate receptor B subunit transcript yet deaminate
different adenosines within it (Melcher et al., 1995). This suggests that any
discrimination between specific editing sites by dsRBDs is not mediated by a
specific sequence but rather influenced by the secondary and tertiary
structural characteristics of the region around the editing site.
The proposal that dsRBMs recognise secondary and tertiary elements of
dsRNA was demonstrated by Ramos et al. in their NMR study of the third
dsRBM of Drosophila Staufen. The protein was complexed with an RNA stem
loop containing 12 uninterrupted base pairs and protein-RNA interactions
were detected along the sugar-phosphate backbone of the nucleic acid.
However, additional contacts were observed between the first a-helix of the
dsRBM and the single-stranded tetraloop capping the RNA helix (Ramos et
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al., 2000). More recently, the specific recognition of a physiologically
relevant RNA transcript by the dsRBD of Rntlp RNase III was found to
involve a specific interaction between the fold of a tetraloop structure within
the RNA and the two helical turns of the N-terminal helix al (Wu et al.,
2004).
Due to the highly constrained nature of the tetraloop structure, the
recognition of these elements demonstrates how dsRBMs convey specificity
for particular RNA targets in a sequence independent manner.
The residues identified in Staufen's third dsRBM that mediate the tetraloop
interaction are not conserved across all dsRBMs suggesting that individual
dsRBMs, even those within a single protein, are capable of discriminating
amongst different RNA molecules. Doyle et al. demonstrated that the
individual dsRBMs from the X. laevis ADAR1 enzyme each recognise
different chromosomal sites on transcriptionally active lampbrush
chromosomes in a specific manner indicating that each individual dsRBM
may recognise distinct and different elements with an RNA molecule (Doyle
and Jantsch, 2003).
More recently the structure of the human GluR-B R/G stem loop pre-mRNA
has been resolved by NMR (Stefl and Allain, 2005). A stable GCU(A/C)A
pentaloop fold was revealed and owing to its similarity to the tetraloop
structure described by Wu et al. this suggests that the pentaloop may play a
role in R/G site recognition (Stefl and Allain, 2005)
1.5.2 dsRNA binding domains can mediate protein dimerisation
As studies progress it has become increasingly apparent that dsRBDs do not
solely exist to facilitate the binding of proteins to dsRNA molecules. Instead,
as many of these dsRBD-containing proteins have more than one motif, some
of which display no dsRNA binding activity, other functions have been
identified by biochemical and deletion analysis and assigned to these
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domains. One of these alternative functions is the ability of a number of
dsRBDs to mediate the dimerisation of their proteins.
A number of dsRBD containing proteins have been found to function as
dimers including PKR (Patel et al., 1995), TRBP (Cosentino et al., 1995),
RNase III (Lamontagne et al., 2000), and XlrbpA (Hitti et al., 2004).
The most studied of this group is the mammalian dsRNA-dependent protein
kinase, PKR. The PKR-PKR interaction was found to be mediated by the
dsRNA binding domain and is dsRNA dependent (Cosentino et al., 1995). A
K60A point mutation within the dsRBD was found to abolish dsRNA
binding activity but have no effect on protein dimerisation indicating that the
dsRNA binding and dimerisation activities of the domain are distinct and
can be disassociated (Patel et al., 1995). Further studies demonstrate that the
converse is also true and dimerisation is not required for dsRNA binding.
Instead, dimerisation is mediated by hydrophobic residues located on one
side of the amphipathic a-helix of the dsRBD (Patel and Sen, 1998). Indeed,
the in vivo activation of the kinase domain in PKR is dependent on the
binding of dsRNA which in turn mediates dimerisation leading to
autophosphorylation and biochemical activation (Patel and Sen, 1998; Ung et
al., 2001; Wu and Kaufman, 1997; Zhang et al., 2001).
More recently a member of the ADAR family, the Drosophila ADAR protein,
has been shown to function as a dimer, mediating this interaction via its N-
terminus and first dsRBD (Gallo et al., 2003). Abolition of RNA binding
activity in dADAR by point mutations within the first dsRBD also disrupted
dimerisation indicating the requirement of dsRNA for dimer formation.
However, binding and dimerisation activities can be disassociated by
deletion of the N-terminus resulting in a monomer capable of interacting
with dsRNA but unable to catalyse the A-to-I editing reaction (Gallo et al.,
2003). The dADAR protein exists in a number of different isoforms
generated by alternative splicing and self-editing (Palladino et al., 2000a).
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These various isoforms have differing editing activities (Palladino et al.,
2000a) and can interact with each other via the N-terminus and first dsRBM
forming heterodimers (Gallo et al., 2003). This provides another mechanism
for the regulation of ADAR editing activity in vivo.
1.5.3 Other roles for the dsRNA binding motifs
Eckmann et al. identified the third dsRBM of human ADAR1 as a nuclear
localisation signal. Deletion analysis indicated that only the entire motif
could exhibit NLS activity and that this activity is independent of dsRNA
binding suggesting a dual function for this region of the protein (Eckmann et
al., 2001).
Studies looking at the different roles of each of the five Staufen dsRBMs
demonstrated that neither dsRBM2 nor dsRBM5 were capable of binding
dsRNA in vitro but played important roles in the microtubule-dependent
localisation of oskar mRNA and its translational control (Micklem et al.,
2000). This suggests that other dsRBMs not able to bind dsRNA may fulfil
other unique roles.
1.6 Substrate specificty of ADARS
1.6.1 Selection via dsRNA Binding domains
dsRNA binding domains are found in a number of proteins with a variety of
functions. It is obvious that the role of the dsRBD in each protein differs
however, it is unclear how much influence these binding domains have over
the catalytic activity.
To ascertain the role of dsRBDs in specific enzymatic function Liu et al.
constructed a chimeric protein in which the dsRBMs of ADAR1 were
substituted for the dsRBMs of PKR (Liu et al., 2000). In chimeras containing
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the two PKR dsRBMs and retaining the third dsRBM and catalytic domain of
ADAR1, editing activity on GluR-B sites was reduced when compared to
wild-type ADAR1 and editing at site A of the 5-HT2C serotonin receptor was
abolished. The chimera containing the two PKR dsRBMs plus the ADAR1
catalytic domain was only able to edit a synthetic dsRNA substrate and had
no activity on any physiological substrates (Liu and Samuel, 1996). These
results suggest an important role for the dsRBD of ADAR1 in the site-specific
selection and recognition of target substrates. Especially important is the
role and position of the third dsRNA binding motif of ADAR1. Previous
studies have found it to be essential for ADAR1 function (Lai et al., 1995)
(Liu and Samuel, 1996) and the results from the chimera analysis provide
further evidence of its importance.
It should be noted that the activity of the PKR-ADAR1 chimeras was
inhibited by known RNA antagonists of PKR indicating that the reduction in
ADAR catalytic activity was perhaps not solely due to a loss of function
within the dsRBD but rather a gain of function in the chimera in which the
PKR motifs have retained their ability to recognise and interact with
particular RNA molecules (Liu et al., 2000).
Since the initial identification of a conserved dsRNA binding domain (St
Johnston et al., 1992), many dsRBD-containing proteins have been found to
have multiple dsRNA binding motifs tandemly arranged. Mutation and
deletion analyses have demonstrated that the motifs within a dsRNA
binding domain are not functionally equivalent (Lai et al., 1995; McMillan et
al., 1995) displaying varying affinities for dsRNA (Bass et al., 1994; Krovat
and Jantsch, 1996; Tian and Mathews, 2001) with some possessing no dsRNA
binding capabilities at all (Krovat and Jantsch, 1996; Micklem et al., 2000).
Indeed, it has been demonstrated that dsRBMs have distinct properties, not
necessarily involving dsRNA binding (Micklem et al., 2000), but that some




It has been shown that the dsRBMs of Xenopus ADAR1 are responsible for
chromosomal targeting and that the individual motifs are capable of binding
to different sites in a distinct and specific manner (Doyle and Jantsch, 2003).
This indicates that each motif may play a role in the selection of specific
editing sites.
More recently, Stephens et al. demonstrated that the dsRBMs of ADAR2 bind
selectively on their own to particular contact points adjacent to the GluR-B
editing site on a model RNA duplex (Stephens et al., 2004). The dsRBMs of
PKR were also able to bind to this model RNA duplex but displayed
different binding preferences. Benzyl modification of guanosine 2-amino
groups blocks the ADAR2 dsRBM recognition surfaces resulting in a
decrease in deamination rate thus demonstrating a correlation between
ADAR2 deamination activity and dsRBM binding selectivity (Stephens et al.,
2004).
Due to the structural characteristics of an A-form dsRNA helix it is apparent
that dsRBDs do not bind in a sequence-specific manner instead it appears
they rely on the recognition of secondary and tertiary characteristics of the
dsRNA molecule. A number of dsRNA binding proteins have been shown
to specifically interact with stem-loop structures within an RNA molecule
(Ramos et al., 2000; Spanggord and Beal, 2001; Wu et al., 2004). This ability
to recognise a particular structural element of RNA allows for the
identification of target molecules.
Internal loops, mismatches and bulges within dsRNA substrates edited by
ADARs have been shown to increase selectivity (Bass et al., 1994; Nishikura
et al., 1991). It has been shown that these internal loops convert long
promiscuously edited dsRNA duplexes into a series of short, more
selectively edited substrates (Lehmann and Bass, 1999). This is an example
of how RNA structure and therefore its interaction with the dsRBD can
influence the efficiency and activity of the ADARs.
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As well as the binding capability and functional characteristics of the
individual dsRBMs it has been suggested that the linker region between
these motifs can influence the activity of the enzyme. NMR studies have
shown the dsRNA binding domain of PKR to consist of two dsRBMs
flanking a 22 residue highly flexible linker (Nanduri et al., 1998). This linker
region may enable the dsRBMs to wrap around the dsRNA duplex and bind
co-operatively.
ADAR1 and dADAR have both been shown to have alternative splice sites
located in linker regions between dsRBMs (Liu et al., 1997) (Palladino et al.,
2000a). The presence or absence of these alternative exons alters the spacing
between the dsRBMs potentially altering the binding characteristics of the
entire domain. Palladino et al. demonstrated that the absence of the
alternatively spliced exon 3a in Drosophila ADAR creates a shorter linker
region between the two dsRBMs and results in a more active isoform of the
ADAR enzyme (Palladino et al., 2000a).
1.6.2 Selection via the deaminase domain
Though they are able to recognise specific pre-mRNA that undergo editing,
the dsRBMs do not appear to have the capacity to select the specific
adenosine to be deaminated. This specificity is mediated via the catalytic
domain. When the deaminase domains of ADAR1 and ADAR2 are
exchanged, the resulting chimeras editing site preferences reflect the origin
of the deaminase domain indicating that it is this region of the ADAR
enzymes that plays a defining role in substrate specificity (Wong et al., 2001).
A subset of the ADAR family of enzymes, the ADATs, have no known
nucleic acid binding domain yet target specific adenosines on target tRNAs
effectively (Gerber and Keller, 2001). This begs the question, are the dsRBDs
essential for ADAR function? Herbert et al. constructed a deletion mutant of
ADAR1 consisting of only the deaminase domain and in a transfection assay
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this mutant successfully edited a 15bp dsRNA stem-loop structure (Herbert
and Rich, 2001). More recently, Macbeth et al. demonstrated that the
deaminase domain of hADAR2 alone was able to edit a non-specific dsRNA
substrate in vitro (Macbeth et al., 2005). In addition, studies on the hepatitis
delta virus amber/W site have shown that ADAR1 is able to edit a hairpin
consisting of the amber/W site with 4bps upstream and 4bps downstream of
the editing site (Sato et al., 2001). This is the smallest substrate described and
is likely too small a target for the dsRBD to bind. Taken together these
results suggest that the dsRBD is not essential for editing but instead may
play a role in increasing the efficiency of the editing reaction on more
complex substrates.
Sequence analyses around editing sites have shown that the editing
efficiency of ADAR1 and ADAR2 varies depending on the nucleotide
opposite the editing site. ADARs are more efficient when there is an A:C
mismatch at the editing site than an A:U base pair or A:G/A:A mismatch
(Stephens et al., 2000; Wong et al., 2001). ADAR1 has also been shown to
have a 5' neighbour preference, favouring adenosines with a 5' neighbour A
= U > C > G (Bass et al., 1994). ADAR2 also exhibits a 5' neighbour
preference ofA~U>C = G however, sequence analysis has also identified a
3' neighbour preference for ADAR2 ofU = G>C = A (Lehmann and Bass,
2000).
These data suggest that as well as the secondary and tertiary structural
characteristics of the dsRNA substrate recognised by the dsRNA binding




1.7 Catalyticmechanism of adenosine
DEAMINATION
1.7.1 The role of the Deaminase domain
The catalytic domains of the ADAR enzymes contain the conserved residues,
HAE(x)4158PCG(x)44.154SCSDK, analogous to sequences in the active sites of the
cytidine deaminase family of enzymes. Based on studies of two nucleoside
deaminase members of this family, adenosine deaminase (ADA) and cytidine
deaminase (CDA) (Carter, 1998), the cysteine and histidine residues are the
ligands to the active site zinc, while the glutamate residue is necessary for
proton transfer function. Site-directed mutagenesis studies of ADAR1
demonstrated that each of these residues was required for enzyme function
(Lai et al., 1995).
The cytidine deaminases are metalloenzymes that use a zinc-activated water
molecule for the hydrolytic deamination of their nucleoside substrates.
Poison et al. demonstrated that in ADAR reactions the source of the oxygen
atom incorporated at C6 of the inosine product is water suggesting a
nucleophilic attack at C6 of the adenosine nucleotide (Poison et al., 1991).
More recently, the 1.7A resolution crystal structure of the catalytic domain of
hADAR2 revealed a zinc ion within the active site and confirmed the role of
the histidine and cysteine residues in co-ordinating zinc and the hydrogen
bonding of a water molecule by the glutamate (Macbeth et al., 2005). Taken
together, this data would suggest a common evolutionary origin for the
catalytic domain of ADARs and members of the cytidine deaminase family.
Whilst the reaction mechanism of the ADARs may be similar to that of the
nucleoside deaminases, the target substrates vary greatly. ADARs
deaminate adenosine nucleotides within a dsRNA duplex by a nucleophilic
attack at C6 of the adenosine nucleotide. This C6 atom is buried deep within
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the major groove of the A-form helix therefore the ADAR enzyme may be
required to flip its target nucleotide out of the RNA helix core. By studying
enzyme-induced changes in the fluorescence of 2-AP-modified substrates,
Stephens et al. demonstrated that, like the adenosine methyltransferases,
ADAR2 appears to flip out the reactive adenosine into a binding pocket
(Stephens et al., 2000) and that this mechanism is dependent on the presence
of the catalytic domain of ADAR2 (Yi-Brunozzi et al., 2001).
Interestingly, a molecule of inositol hexakisphosphate (IP6) was also found
within the core of the catalytic domain and shown to interact with many
arginine and lysine residues (Macbeth et al., 2005). The S. cerevisiae mutant
ipklA is unable to synthesis IP6 and expression of hADAR2 and ADATI in
these mutants resulted in inactive proteins indicating that IP6 is required for
ADAR activity (Macbeth et al., 2005).
1.7.2 The role of the dsRNA binding domain
On binding a dsRNA substrate, ADAR2 has been shown to induce a number
of conformational changes. The footprint of the dsRNA binding domain
protects a region of duplex surrounding the editing site and on binding,
nucleotides on the non-edited strand become hypersensitive to hydrolytic
cleavage indicating an increase in the conformational flexibility of this region
(Yi-Brunozzi et al., 2001). For many base-flipping enzymes, the separation of
the phosphodiester backbone is proposed to lower the activation energy
barrier required for base flipping. This increase in flexibility initiated by
dsRBD binding may act to lower the energy barriers to base flipping during
the ADAR reaction. It should be noted that binding of the dsRBD of PKR to
the same dsRNA molecule did not induce this conformational change in
dsRNA structure indicating that this is a function particular to the ADAR
dsRNA binding domains (Yi-Brunozzi et al., 2001).
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1.8 Regulation of ADARs
1.8.1 The co-ordination of RNA editing and splicing
The A-to-I editing of a number of physiological substrates must occur before
or simultaneously to splicing as the dsRNA structure required for editing is
formed between exonic and downstream complementary intronic sequences
(Burns et al., 1997; Herb et al., 1996; Higuchi et al., 1993; Lomeli et al., 1994).
This suggests a possible regulatory role for splicing in the dsRNA editing
process. Indeed, the association of enzymatically active ADAR1 and ADAR2
proteins with spliceosomal Sm and SR proteins within the large nuclear
ribonucleoprotein (InRNP) would suggest a link between splicing and RNA
editing (Raitskin et al., 2001).
Bratt et al. demonstrated that in vitro editing and splicing of the glutamate
receptor pre-mRNA inhibit each other (Bratt and Ohman, 2003). Exposing
the transcript to splicing factors prior to ADAR2 abolished editing whilst the
presence of ADAR2 appears to sequester the 5' splice site required for
splicing to occur. This inhibition of splicing was overcome by the addition of
RNA helicase A suggesting it out competes ADAR2 in binding to this
transcript (Bratt and Ohman, 2003). Further studies in vivo indicate that
editing and splicing appear to happen sequentially during RNA pol II
transcription suggesting a regulatory role for the transcription machinery in
co-ordinating these RNA processing events (Bratt and Ohman, 2003).
1.8.2 Other factors potentially involved in ADAR regulation
As the ADAR3 enzyme currently has no known physiological substrates and
demonstrates no in vitro editing activity, it has been suggested that it plays a
role in regulating the activity of the other members of the ADAR family. It
has been shown to inhibit the in vitro editing activities of both ADAR1 and
ADAR2 though the mechanism for this is not understood (Chen et al., 2000).
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Likely, it is the result of competitive binding to the dsRNA substrate as
ADAR3 is capable of binding to dsRNA (Chen et al., 2000) and further
studies have suggested that ADAR3 is unable to form heterodimers with
ADAR1 and 2 (Cho et al., 2003).
Liu et al. demonstrated that the Vaccinia Virus E3L interferon resistance
protein is a potent inhibitor of ADAR1 enzymatic activity on synthetic
dsRNA substrates (Liu et al., 2001). E3L also weakly inhibited the site-
selective editing activity by ADAR1 at the R/G site of the glutamate receptor
B subunit pre-mRNA and the A site of serotonin 2C receptor pre-mRNA.
Deletion analysis of E3L protein indicated that the carboxy-proximal dsRBM
was essential for this antagonistic function (Liu et al., 2001). The precise
physiological function of this anti-ADARl activity is unclear but E3L is
known to antagonise other interferon-inducible proteins (Romano et al.,
1998) and so it is likely a part of the overall antagonism of interferon
mediated by the E3L viral protein.
Small nucleolar (sno) RNAs have been shown to modify nucleotides within
rRNAs and spliceosomal snRNAs. There are 2 classes of guide snoRNAs; the
fibrillarin-associated box C/D snoRNAs responsible for the methylation of
the ribose moiety at the 2'-hydroxyl group and the box H/ACA snoRNAs
responsible for the conversion of uridines to pseudouridine (Kiss, 2001).
With the identification of a number of novel snoRNAs in the brain tissue of
humans and mice, the possibility that these molecules may also modify
mRNAs has been hypothesised (Cavaille et al., 2000; de los Santos et al.,
2000). In particular, the identification of a novel box C/D snoRNA, EIBII-52,
which carries an 18 nucleotide region perfectly complementary to the 5-HT2C
mRNA suggests that modification of mRNAs may be possible (Cavaille et al.,
2000). Furthermore, the target nucleotide for 2'-0-methylation is the
adenosine at editing site C of the serotonin receptor (Cavaille et al., 2000). As
methylation at the 2'-OH group results in a decrease in deamination
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efficiency (Yi-Brunozzi et al., 1999), the possibility that this C/D snoRNA
may inhibit editing exists. More recently it has been demonstrated that
MBII-52 is indeed a C/D snoRNA and specifically decreases ADAR2-
mediated nucleolar editing at site C of the serotonin 5-HTzc receptor mRNA
(Vitali et alv 2005).
1.9 Aims
The aims of this work are to investigate the properties of the individual
dADAR functional domains.
Many studies have indicated that dsRNA binding motifs often have
distinctive roles that do not always involve binding to dsRNA (Cosentino et
alv 1995; Eckmann et al., 2001; Gallo et al., 2003; Micklem et alv 2000). The
Drosophila ADAR protein has 2 dsRNA binding motifs separated by a linker
region containing an alternatively spliced exon, 3a, whose presence or
absence can alter the editing activity of full length dADAR (Palladino et al.,
2000a). Structural analysis of these motifs will determine whether they are
bona fide members of the dsRBM family and by assaying their binding
capacity on dsRNA we may gain an insight into the relative functions of
these motifs. Indeed, it has already been shown that dsRBMl plays a role in
dADAR protein dimerisation (Gallo et al., 2003).
The Drosophila ADAR protein is a member of the cytidine deaminase (CDA)
family (Palladino et al., 2000a). Other CDA family members, such as the
ADATs, do not contain any known RNA binding motifs yet are capable of
editing highly structured RNA molecules, such as tRNA, accurately and
efficiently. This begs the question; can the deaminase domain of an ADAR
protein function without the dsRNA binding motifs? Expression of the
dADAR deaminase domain and assay of its editing function will determine
whether the dsRNA binding motifs are required for editing activity and
perhaps further elucidate their role also.
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A number of studies have attempted to clarify how the ADARs specify
which adenosine within a dsRNA molecule will be edited. Much of this
specificity in the human proteins has been assigned to the deaminase domain
(Wong et al., 2001) though more recently the dsRNA binding domain has
also been shown to play a role (Stefl et al., 2006). By comparing the editing
patterns of the dADAR deaminase domain and the full length protein on
dsRNA it will be possible to determine whether editing site specificity is also
conferred by the deaminase domain of dADAR.
The binding of RBMs to dsRNA has been shown to induce a conformational
change in a dsRNA substrate (Yi-Brunozzi et al., 2001) and therefore may
facilitate the editing activity of the deaminase domain. The possibility of an
interaction between these individually expressed domains maybe directly,
but more likely via a substrate dsRNA, may demonstrate how these domains




All reagents were obtained from Sigma or Roche unless otherwise stated.
2.1 Molecular Biology
2.1.1 Bacterial Strains
Competent XLl-blue or commercially produced DH5-a (subcloning
efficiency/ Invitrogen) cells were used for all cloning procedures. BL21 (DE3)
cells were used for protein expression. Cultures were grown in Luria-Bertani
(L-broth) medium (1% (w/v) tryptone, 0.5% yeast extract, 1% NaCl) or on L-
agar plates (1% tryptone, 0.5% yeast extract, 1% NaCl, 1.5% agar) at 37 °C.
2.1.2 Generating competent bacteria
1 ml of an overnight culture of XLl-blue or BL21 was grown to an absorbance
at 600 nm of 0.5 - 0.6 (using the sample equipment as described in section
2.1.6.5). Cells were pelleted at 4500 x g for 5 min at 4°C and resuspended in
0.4 original volume of ice cold TFB1 (30 mM C2H3K02, 10 mM CaCl2, 50 mM
MnCl2, 100 mM RbCl, 15% glycerol). The resuspended cells were incubated
on ice for 5 min at 4°C before being centrifuged again as before. The pelleted
cells were then resuspended in 1/25 original volume of ice cold TFB2 (100
mM MOPS or PIPES, pH 6.5, 75 mM CaCl2,10 mM RbCl, 15% (v/v) glycerol)
and incubated on ice for 15 - 60 min. Aliquots were snap frozen on dry ice
and stored at -70 °C until required.
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Electro-competent cells for high efficiency transformation were also
prepared. 1 ml of an overnight culture of XLl-blue or BL21 was grown at 37
°C to an absorbance at 600 nm of 0.5 -1.0. The flask was chilled on ice for 30
min and the cells harvested by centrifuge at 4,000 x g for 15 min at 4 °C. The
pellets were resuspended in 1 litre of cold water and centrifuged as before.
The pellets were then washed in 0.5 litres cold water and centrifuged once
more. Finally the pellets were washed in 20 ml of 10% glycerol, centrifuged
and the pellet was resuspended in a final volume of 2 to 3 ml of 10% glycerol.
The suspension was snap frozen in dry ice in 40 /xl aliquots and stored at -70
°C.
2.1.3 Bacterial Transformation
Competent cells were incubated on ice with plasmid DNA or ligation
product (Section 2.1.6.7) for at least 15 min. Transformations were then heat
shocked at 42 °C for lVi min. After addition of 1 ml of L-Broth, reactions
were incubated for at least 45 min at 37 °C before being plated on L-agar
plates containing the appropriate antibiotic selection (Ampicillin at 50
/xg/ml, Kanamycin at 50 /xg/ml ). Transformation plates were then grown
overnight at 37 °C.
Alternatively for higher efficiency the plasmid DNA or ligation product
could be electro-transformed. 1-2 /d of plasmid DNA was mixed with 40 /d
of competent E. coli cells in an ice-cold 0.2 cm electroporation cuvette and
electroporated at 2.5 kV, 25 /xF, 200 Q (Bio-Rad Gene Pulser). Immediately 1
ml of ice-cold SOC medium (2% Bacto trypyone, 0.5% Bacto yeast extract, 10
mM NaCl, 2.5 mM KC1, 10 mM MgCl2, 10 mM MgS04, 20 mM glucose) was
added to the cuvette and the cells quickly resuspended. The cell suspension
was transferred to a 15 ml sterile tube and incubated at 37 °C for 1 h before
being plated on L-agar plates containing the appropriate antibiotic selection
(Ampicillin at 50 pig/ml, Kanamycin at 50 /xg/ml). Transformation plates
were then grown overnight at 37 °C.
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2.1.4 Isolation of plasmid DNA
5 or 50 ml cultures of single bacterial colonies were grown overnight in L-
Broth at 37 °C. Plasmid preparations were then harvested from these
cultures using commercial mini- or midiprep kits (Qiagen). Briefly, bacteria
are lysed under alkaline conditions. The lysate is then neutralised and
passed through a silica-gel membrane that selectively absorbs DNA. The
membrane is then washed before the plasmid DNA eluted.
2.1.5 Purification of DNA
2.1.5.1 Phenol/Chloroform extraction
An equal volume of buffered phenol/chloroform (50% phenol/48%
chloroform, 2% isoamylalcohol, pH 8.0) was added to the DNA preparation
and agitated. This was centrifuged at ~12,000 x g for 1 minute. The top
(aqueous) phase was transferred to a fresh tube, avoiding any white
precipitate that may be present at the boundary between the two phases and
an equal volume of chloroform added. Agitation and centrifugation was
repeated. Again the top layer was removed. Ethanol precipitation was then
performed to concentrate the DNA (section 2.1.5.2).
2.1.5.2 Ethanol precipitation
l/10m volume 5 M NaCl and 3 volumes of ice cold 100% ethanol were added
to the DNA sample, the tube was vortexed and then centrifuged at -12,000 x
g for 30 min at 4 °C. The supernatant was discarded and the pellet washed in
ice cold 70 % (v/v) ethanol with dHzO. Centrifugation was repeated for 10
min and the supernatant discarded. The pellet was dried at room
temperature and resuspended in an appropriate volume of dHzO.
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2.1.6 Analysis and generation of recombinant DNA
2.1.6.1 Plasmid DNA digestion
Plasmid DNA was digested with restriction enzymes (New England Biolabs)
in reaction buffer in accordance with the manufacturers' instructions.
Digestion products were then analysed and/or purified by gel
electrophoresis (section 2.1.6.3) and used for further cloning steps (section
2.1.6.7).
2.1.6.2 PCR amplification of DNA fragments
Standard conditions for a 50 pi reaction were : 50 ng template DNA, 5 pi 1Ox
PCR buffer containing 15 mM MgCl2 (Roche), 0.2 mM Ultrapure dNTPs
(Amersham), 1 pM each forward and reverse primers, 2.5 Units Taq
Polymerase (Roche).
The standard PCR program used was a 94 °C hot start before 35 cycles of
melting at 94 °C for 30 seconds, annealing at 55 °C for 30 seconds and
elongation at 72 °C for 30 seconds. A final elongation step at 72 °C was
carried out for 8 min.
DNA fragments for cloning were generated by P/wTurbo DNA Polymerase
(Stratagene) amplification. This proofreading enzyme was chosen for its
increased yield and lower error rate when amplifying products. The reaction
mix was as follows: 100 ng DNA template, 100 ng of forward and reverse
primers, dNTP, polymerase and buffer diluted to manufacturer's
recommendations in dH20. The amplification conditions were as follows: a
95 °C hot start, 30 cycles of 95 °C for 30 seconds, 68 °C for 30 seconds, 72 °C
for 60 seconds and a final extension of 10 min at 72 °C. Primers are listed in
Table 2.1.
Table 2.1 PCR Primers
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RBM FW AAT AGC GCT AGC AAG AAC ACG GTG GCC ATG CTG
RBM REV CTA CTG GGA TCC TTA AAT ATT GCA TAA CGA AGC AAG
RBM1 REV CTA CTG GGA TCC TTA CTT AAA CTG TAT AAA GCT GCG
RBM2 FW CAG TCA GCT AGC GAT AAG GGT CCT GTC ATG CTC
DA REV TGA CTG GGT ACC TTC GGC AAG ACC GAA CTC GTC
DA FW CAG TCA GAA TTC GAC GAC AAG TCG TCA TCG
SP6
Promoter
ATT TAG GTG ACA CTA TAG AA
11
Promoter
TAA TAC GAC TCA CTA TAG GG
KP 5' 11
antisense
GAG ACC GGA ATT CGG ATC
KP 3' SP6
sense
GAT CCT CYA GAG YCG AYC
KP 5' SP6
sense
GAA TAC AAG CTT GTC GRG
2.1.6.3 Site-directed mutagenesis
Point mutations were generated by oligonucleotide-directed mutagenesis
using the QuikChange™ site-directed mutagenesis kit (Stratagene). The
reaction mix was as follows: 50 ng DNA template, 100 ng of forward and
reverse primers, dNTP, polymerase and buffer diluted to manufacturer's
recommendations in dH,0. The amplification conditions were as follows: a
30 seconds 95 °C hot start, 12 cycles of 95 °C for 30 seconds, 55 °C for 1 min,
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and extension at 68 °C for 1 min / kb of template plasmid. In the case of
human adarl in pPICZa the extension time was 6 min. The primers used in
this reaction are listed in table 2.2.
Table 2.2 Primers for oligonucleotide-directed mutagenesis
adar2 S/G FW GCC AGA ATC TTC GGA CCA CAT GAG CCA ATC
adar2 S/G REV GAT TGG CTC ATG TGG TCC GAA GAT TCT GGC
1 pi Dpnl was added to each PCR reaction and incubated for 1 h to digest the
parental methylated DNA. The PCR reaction was then cleaned and 1 pi
transformed into electo-competent XLl-blue cells.
2.1.6.4 Agarose Gel electrophoresis
1% horizontal agarose gels in 0.5x TBE (45 mM Tris-HCl, 45 mM boric acid,
0.05 mM EDTA pH 8.0) were used with 0.5x TBE electrophoresis buffer to
resolve DNA samples, PCR products and plasmid digestion products. All
samples had 1 volume of 6x loading buffer (15% Ficoll 400, 0.25%
Bromophenol Blue, 0.25% xylene cyanol) added to 5 volumes of sample.
Commercially available DNA size markers (100 bp and 1 Kb ladder Promega
and Invitrogen, respectively) were diluted to 50 ng/pl and 500 ng loaded per
well to enable size determination and quantification of DNA fragments.
Ethidium bromide (2,7-diamino-10-ethyl-9-phenyl-phenathridium bromide),
a DNA intercalating stain, was added to molten agarose before pouring a gel.
Stained DNA was then visualised with ultraviolet light from a
transilluminator.
2.1.6.5 Gel purification of DNA fragments
For purification, agarose slices containing the appropriate DNA fragments
were dissected from gels using clean razor blades. The DNA was extracted
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from the agarose using a commercial kit (Qiagen). Briefly, gel slices are
melted in equilibration buffer. The solution is then passed over a silica-gel
membrane that selectively binds DNA. Washing this membrane removes
ethidium bromide and residual agarose. The DNA was then eluted in the
required volume of dH20.
2.1.6.6 Measuring quality and quantity of DNA
DNA concentration was measured spectrophotometrically and/or by gel
electrophoresis alongside DNA of known concentration. DNA was diluted
1:100 in TE and transferred to a quartz cuvette. The absorbance 260 nm (A260)
was measured for DNA. An A260 of 1 corresponds to -50 pg/ml of DNA. To
determine the purity of nucleic acid, the A280 was also measured. Pure DNA
has an A260 /A280 of >1.8 and values lower than these indicate contamination
by proteins, RNA or phenol.
2.1.6.7 Dephosphorylation of DNA fragments
Linear plasmid DNA digested with the appropriate enzymes for a cloning
step was treated with alkaline phosphatase in accordance with the
manufacturers' instructions. This removes 5' phosphates from the ends of
the DNA backbone preventing reformation of empty circular plasmid DNA.
This subsequently increases the yield of positive ligation products as
successful ligation should only be achieved when phosphates are donated to
the backbone ends by untreated insert.
2.1.6.8 Ligation of DNA fragments
50 ng of digested vector was incubated with 3 times the molar ratio of
cloning insert. 400 U (1 pi) T4 DNA ligase enzyme (New England BioLabs)
and the appropriate volume of lOx reaction buffer were used per ligation
reaction, typically in a total volume of 10 pi. The reactions were incubated at
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room temperature for one hour or overnight at 16 °C. Subsequently, 5 pi of a
reaction were then used for bacterial transformation (section 2.1.3).
2.1.6.9 Sequencing of DNA fragments
All cloning products were sequenced to monitor the integrity of recombinant
plasmids and inserts. In a protocol similar to Sanger di-deoxy sequencing,
BigDye Terminator v2.0 (ABI Prism) chemistry was used as follows: 200 ng
of linear plasmid DNA, 0.8 pM sequencing primer and BigDye were diluted
in dH20 in accordance with the manufacturers' instructions.
Cycle conditions used for sequencing reactions were 25 cycles of; melting at
96 °C for 30 seconds, annealing at 50 °C for 15 seconds followed by
elongation at 60 °C for 4 min. Sequencing reactions were precipitated with 2
pi of 3 M Sodium Acetate (pH 4.6) and 50 pi of 100% ethanol at room
temperature and out of bright light for 20 min. Samples were then
centrifuged at -12,000 x g for 20 min at 18 °C and the supernatant was
removed. Pellets (not always visible) were washed with 150 pi of 70%
ethanol and air dried.
2.1.7 Isolation of Genomic DNA from Pichia pastoris
5 ml of BMGY was inoculated with a single yeast colony. At stationary
phase the culture was pelleted at 4000 x g for 5 min. The pellet was
resuspended in 250 pi of SP1 buffer (1.2 M sorbitol, 50 mM sodium citrate, 50
mM Na3P04, 40 mM EDTA, pH 5.6) containing 0.4 mg/ml zymolase and
incubated for 45 min at 37 °C. The cells were pelleted at 6000 x g for 15
seconds and resuspended in 0.5 ml TE and 50 pi 10% SDS before being
vortexed. 165 pi of 5 M potassium acetate was added and the pellets were
stored on ice for 30 min before being centrifuged for 10 min at 4 °C. The
supernatant was added to 750 pi of isopropanol, placed on dry ice for 5 min
and then centrifuged for 10 min. The pellet was resuspended in 300 pi of TE
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and RNase added to a final concentration of 10 fig/ml. The sample was
incubated for 30 min at 37 °C before phenol /chloroform extraction (section
2.1.5.1) and ethanol precipitation (section 2.1.5.2). The genomic DNA was
then resuspended in 20 /d of TE.
2.1.8 Isolation of total RNA from Pichia pastoris
A 50 ml culture inoculated with a single yeast colony was grown up and
protein expression induced as described in section 2.2.1.5. 10 ml of culture
was pelleted and resuspended in 500 /d of TE. This was transferred to a
microfuge tube and pelleted again before being resuspended in 300 /d of
extraction buffer (50 mM Tris-HCl, pH 7.5, 10 mM EDTA, 100 mM NaCl, 1%
SDS). Approximately 300 /d of glass beads and 300 /d of phenol were added
to the tube and the cells vortexed for 15 min at high speed at +4 °C. The
samples were centrifuged for 5 min at 12,000 x g and the supernatant
transferred to a fresh tube. The sample was phenol/chloroform extracted,
ethanol precipitated and the pellet air dryed before being resuspended in 25
/d of dH20. The sample was stored at -20 °C.
2.1.9 RT-PCR of yeast mRNA
The yeast RNA was treated with DNase to remove any contamination. 2.5 /d
of a 1 \jlg//d RNA stock was incubated with 1 /d of lOx DNase buffer, 1 /d of
DNase and 5.5 /d dHzO for 1 hour at 37 °C. 1 /d of 25 mM EDTA was added
and the reaction mix incubated for a further 10 min at 65 °C. 12 yu,l of dHzO
and 2 /d of 0.5 /xg/ytxl oligo dT was added to each RNA sample and incubated
at 70 °C for 10 min to allow annealing of the oligo dT to the poly(A) tails of
the mRNA molecules. The samples were placed on ice and spun briefly at 4
°C. 4 /d of lOx PCR buffer, 4 /d 25 mM MgCl2,2 /d of 2.5 mM dNTPs and 4 /d
of DTT were added and the samples mixed well and split into two 19 fil
aliquots. Each aliquot was incubated at 42 °C for 5 min and then 1 jul of
Superscript reverse transcriptase (Gibco BRL) added to one of each pair of
83
2 Materials and Methods
tubes. The sample was incubated for a further 50 min at 42 °C and then 70 °C
for 15 min. The sample was placed on ice and 1 /d of each used as template
for a 20 pi PCR reaction (section 2.1.6.2).
2.1.10 pGEM®- T Easy cloning
Prior to sequencing PCR products were cloned into the pGEM®-T Easy vector
(Promega). The single 3'-T overhangs at the vector insertion site allow for
high efficiency cloning of PCR products. 1 p\ of PCR product was added to a
ligation mix containing buffer, ligase and vector in accordance with the
manufacturer's instructions. 5 /d of each ligation reaction was transformed
into DH5a cells and plated on L-agar plates containing 50 yg/ml ampicillin,
0.5 mM IPTG and 80 yg/ml X-gal. Plates were incubated overnight at 37 °C
and screened the following day for white insert-containing colonies.
2.2 Synthesis and Analysis of ADAR Proteins
2.2.1 Expression and purification of recombinant ADAR
proteins in Pichia pastoris
2.2.1.1 pPICZ A expression constructs
Drosophila ADAR domains and hADAR2 were amplified (section 2.1.6.2)
from full length cDNA and ligated (section 2.1.6.7) into pPICZ A
(Invitrogen). The myc and 6 X HIS epitope tag sequences of pPICZ A are
expressed in the resulting fusion protein. pPICZ A was also used to
construct a derivative called pPICZ A-FLIS6 that contains a short open
reading frame encoding a FLAG epitope tag at the N-terminus and a 6 X HIS
epitope tag at the carboxy terminus inserted at the EcoRI site in the pPICZ A
multiple cloning site. A SpeI site between the two epitope tags was used to
clone ADAR coding sequences in frame to the epitope tags. The myc and 6 X
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HIS epitope tag sequences present in the original pPICZ A vector are not
expressed in these constructs. For dual expression of 2 domains of the
Drosophila ADAR protein, the pHIL D2 (Invitrogen) cloning vector was also
used.
The ligation reactions were transformed into E. coli DH5a cells, plated on low
salt LB agar (1% tryptone, 0.5% yeast extract, 0.5% NaCl, 1.5% agar)
containing 25 pg/ml Zeocin™ (Invitrogen) and incubated overnight at 37 °C.
Single colonies were selected and grown overnight in low salt LB media (1%
tryptone, 0.5% yeast extract, 0.5% NaCl) with 50 pg/ml Zeocin™. Plasmid
DNA was isolated and checked for inserts by restriction enzyme digestion.
Positive clones were sequenced to confirm the presence of the correct open
reading frame.
2.2.1.2 Generating competent Pichia pastoris
5 ml of YPD (1% Yeast extract, 2% peptone, 2% dextrose) was inoculated
with the strains KM71 or KM71H and grown overnight in a 50 ml conical
flask at 30 °C. The following day 500 ml of fresh YPD was inoculated with 1
ml of the overnight culture and grown in a 2 litre flask to an OD^ of 1.3 - 1.5.
The cells are harvested by centrifugation at 1500 x g for 5 min at 4°C then
washed twice with 500 ml ice-cold sterile water and once with 20 ml ice-cold
1 M sorbitol. Finally, the pellet was resuspended in 1 ml 1 M sorbitol to give
a final volume of approximately 1.5 ml. The cells were stored on ice until
required.
2.2.1.3 Pichia pastoris transformation
5-10 pg of the pPICZ A or pHIL D2 expression constructs was digested with
Sacl and linearisation checked by electrophoresing a small aliquot on a 1%
agarose gel. The linearised DNA was extracted with phenol/chloroform
(section 2.1.5.1) and ethanol precipitated (section 2.1.5.2). The pellet was
resuspended in 10 pi dH20. The linearised DNA was mixed with 80 pi of
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competent Pichia cells in an ice-cold 0.2 cm electroporation cuvette and
electroporated at 1.5 kV, 25 pF, 200 Q (Bio-Rad Gene Pulser). Immediately 1
ml of ice-cold 1 M sorbitol was added to the cuvette, transferred to a 15 ml
sterile tube and incubated without shaking at 30 °C for 1-2 hours. 25 and 100
pil was plated on separate YPDS (1% yeast extract, 2% peptone, 2% dextrose,
1 M sorbitol, 2% Agar) plates containing 100 /xg/ml Zeocin™and incubated
for 2-5 days at 30 °C until colonies formed.
2.2.1.4 Analysis of Pichia transformants
10-20 colonies from transformation plates were picked and streaked for
single colonies on fresh YPDS agar plates with 100, 200, 500 and 1000 /xg/ml
Zeocin™. Plates were incubated for 2-3 days at 30 °C. The transformant lines
showing the highest resistance to Zeocin™have the highest copy number of
the expression construct.
2.2.1.5 Expression of recombinant ADAR in Pichia pastoris
5 ml of buffered glycerol-complex medium (BMGY: 1% yeast extract, 2%
peptone, 100 mM potassium phosphate, pH 6.0, 1.34% YNB, 4 x 10~5% biotin,
1% glycerol) was inoculated with a Pichia colony and grown overnight at 30
°C in a loosely capped 50 ml falcon tube. 500 ml of fresh BMGY was
inoculated with the 5 ml starter culture and grown overnight at 30 °C to an
OD^ of 2-6. The cells were pelleted by centrifugation at 1500 x g for 5 min at
+4 °C and resuspended in buffered methanol-complex medium (BMMY: 1%
yeast extract, 2% peptone, 100 mM potassium phosphate, pH 6.0,1.34% YNB,
4 x 10"5% biotin, 0.5% methanol) to induce expression. The culture was
returned to the original flask and grown overnight at 30 °C. The following
day methanol was added to a final concentration of 1% to counter any losses
due to evaporation and grown overnight as before.
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2.2.1.6 Harvest of Pichia pastoris
The cells were pelleted by centrifugation at 1500 x g for 5 min at +4 °C and
the BMMY supernatant removed. The pellets were washed with 250 ml of
autoclaved ice-cold water to remove any remaining BMMY and spun as
before. Each pellet was resuspended in 40 ml of Buffer Q/200 (200 mM KC1,
50 mM Tris-HCl, pH 7.9, 20% glycerol, 0.5 mM PMSF, 0.7 mg/ml Pepstatin,
and 0.4 mg/ml Leupeptin), divided into 2 x 50 ml falcon tubes and spun as
before. At this point the cells were either broken and protein extracted or the
pellets were frozen in liquid nitrogen and stored at -70 °C for up to 1 year.
2.2.1.7 Protein extraction
Cells were resuspended in 1 ml buffer Q/200 per gram of cell pellet. The
suspension was lysed with 2-3 passes using a French press (Thermo
Electron).
2.2.1.8 Ni2+-NTA affinity chromatography of Drosophila ADAR and
hADAR2
Lysed Pichia cells were centrifuged for 15 min, at 20,000 x g at +4°C to
separate cell debris. The supernatant was removed and combined with Ni2+-
NTA resin (Qiagen) previously equilibrated with load buffer (buffer Q/200 +
10 mM imidazole, 0.5% Triton X-100) and rotated gently for 1-2 hours at 4 °C.
The resin mix was loaded onto a 20 ml Econo-column (Bio Rad) 3 times at 4
°C and the flow through collected. The column was washed with 2 x 10 ml
of wash buffer (Buffer Q/200 + 20 mM Imidazole, 0.5% Triton X-100) and
fractions collected. The protein was eluted with elution buffer (Buffer Q/200
+ 250 mM imidazole, 0.5% Triton X-100) in 10 x 500 pi fractions. At each
stage all fractions are collected and stored in -70 °C. 30 pi aliquots of crude
extract, flow through, wash and each eluate were collected for analysis by
SDS-PAGE (section 2.2.3.1).
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2.2.1.9 Anti-FLAG affinity column purification of recombinant ADARs
It is possible to further purify the Ni2+-NTA eluates using the N-terminal
FLAG epitope tag. The eluates are loaded on to an anti-FLAG M2 affinity gel
in which a purified murine monoclonal antibody is coupled to agarose. The
protein is eluted with a FLAG peptide. A mini-column (0.7 cm diameter)
was poured containing a 150 fil bed volume of anti-FLAG M2 matrix and
was equilibrated with buffer Q/200. The column was washed by loading
three sequential 5 ml aliquots of 0.1 M glycine HC1, pH 3.5 followed by three
sequential 5 ml aliquots of buffer Q/200 to activate the resin. The fractions
containing dADAR from the Ni2+-NTA column were pooled and loaded on to
the anti-FLAG M2 affinity column. The flow through was collected and
passed over a further 2 times to maximise binding. The column was washed
three times with 12 ml of buffer Q/200 and the protein was eluted from the
column with 5 X 500 /x1 fractions of elution buffer (buffer Q/200 plus FLAG
peptide 100 /xg/ml). At each stage all fractions are collected and stored in -
70 °C. Small aliquots of crude extract flow through, wash and each eluate
were collected for analysis by SDS-PAGE (section 2.2.3.1).
2.2.2 Expression and Purification of recombinant Drosophila
ADAR dsRNA binding domains in E. coli
2.2.2.1 pET28a expression vector
PCR products encoding the dsRNA binding domain were digested with Nhel
and Sacl and ligated into the corresponding restriction enzyme sites of the
digested pET28a vector. The ligated DNA was transformed in E. coli DH5a
cells and spread on an LB agar plate containing 50 /xg/ml kanamycin. Plates
were incubated overnight at 37 °C. Single colonies are selected and grown
overnight in 2 ml LB medium containing 50 pg/ml kanamycin. Plasmid
DNA was purified and an aliquot digested with EcoRI and Kpnl to check for
inserts. Positive clones were sequenced to confirm that the construct was
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correct and that the correct open reading frame fusing ADAR to the carboxy-
terminal 6 X HIS epitope tag is present. Positive clones were transformed
using standard methods into E. coli BL21 (DE3) prior to protein expression.
2.2.2.2 Expression and harvest of the dADAR dsRNA binding domains in
E. coli
The pET28a plasmid containing the insert was transformed into electro
competent BL21 (DE3) E.coli cells (section 2.1.3), plated on LB agar containing
50 /xg/ml kanamycin and incubated overnight at 37 °C. A single bacterial
colony was picked and 10 ml of M9 medium (200 ml 5x M9 salts, 2 ml 1 M
MgS04, 100 ml 1 M CaCl2, 10 ml 40% glucose, up to 1 litre with dH20)
containing 50 /xg/ml kanamycin was inoculated and grown overnight at 37
°C. 500 ml of fresh M9 medium containing 50 /xg/ml kanamycin was
inoculated with the 10 ml starter culture and grown at 37 °C to an ODffl0 of
0.6. At this point expression was induced with 500 /xl of 1 M IPTG and the
cultures grown for a further 4 hours. The cells were harvested by
centrifugation. At this point the cells can be broken immediately or stored in
-70 °C.
2.2.2.3 Extraction and purification of the dADAR dsRNA binding domains
The cells pellets were resuspended in 1 mL/g of sonication buffer with fresh
protease inhibitors (50 mM KH2P04, 500 mM NaCl, 20 mM imidazole, 0.5
mM PMSF, 0.7 mg/ml pepstatin, 0.4 mg/ml leupeptin) and sonicated in
three 10 second bursts. Between sonication bursts the cells were incubated
on ice for 20 seconds. The samples were centrifuged and the supernatant
transferred to a fresh tube. At this point it is recommended to continue with
purification rather than freezing the lysate, to avoid proteolysis. The dsRNA
binding domains were purified over a Ni2+-NTA column as described in
section 2.2.1.8.
89
2 Materials and Methods
2.2.3 Analysis of recombinant proteins
2.2.3.1 Resolution of proteins on denaturing gels
Protein samples were mixed with 4x Laemmli Buffer (40% glycerol, 0.02%
bromophenol blue, 4% (3-mercaptoethanol, 8% SDS, 250 mM Tris-HCl, pH
6.8) and heated for 5 min at 95 °C before loading. Denaturing acrylamide
minigels (10-12% acrylamide, 0.375 M Tris-HCl, pH 8.8, 0.1% SDS, 0.1%
Ammonium persulphate, 0.2% TEMED) with stacking gels (4% acrylamide,
0.125 M Tris-HCl, pH 6.8, 0.1% SDS, 0.1% Ammonium persulphate, 0.2%
TEMED) were poured using 30% acrylamide (29:1 acrylamide:bis-
acrylamide, Severn Biotech). Gels were resolved in electrophoresis tanks
(Pharmacia) in Tris-Glycine running buffer (25 mM Tris, 200 mM Glycine,
pH 8.3, 0.1% SDS w/v) at 110 V for 2 hours. Broad range protein markers
(Bio-Rad) were loaded to aid with analysis
2.2.3.2 Staining denaturing protein gels
Resolved protein gels had stacking gels removed and were then submerged
in Coomassie stain (50% methanol, 10% acetic acid, 0.05% Coomassie blue
R250, 40% dH20) for 1 hour with gentle agitation. The stain was discarded
and gels were incubated for 1 hour in destain (20% isopropanol and 7.5%
acetic acid) with gentle agitation.
2.2.3.3 Western Blotting
After resolution on denaturing gels protein samples were transferred to
nitrocellulose for further analysis by semi-dry Western Blotting. Briefly, gels
had the stacking gel removed and transfer apparatus (Bio-Rad) was
assembled in accordance with the manufacturers' instructions with the gel
and nitrocellulose membrane sandwiched on each side by 3 pieces of 3MM
paper equilibrated in transfer buffer (50 mM Tris, 40 mM glycine, 0.05% SDS,
20% methanol). The apparatus was run at 120mA for 1 hour. Successful
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transfer of protein was assessed by Ponceau S staining of the membrane -
membranes were incubated with Ponceau S stain for 2 min. After two rinses
with dH20 membranes were visualised.
Specific proteins were detected on western blot membranes using antibody
detection. Membranes were blocked for 1 hour with agitation in lx PBS
(phosphate buffered saline) with 5% milk protein (Marvel) or alternatively
with a 1:10 dilution ofWestern Blocking Reagent (Roche) in PBS.
Primary antibodies were diluted in 5% milk, lx PBS and incubated with
membranes overnight at 4 C or in a 1:20 dilution of Western Blocking
Reagent (Roche) in PBS (antibody dilutions are shown in table 2.3).
Membranes were washed 3 times in lx PBS plus 0.05% Tween and incubated
with secondary antibodies for at least 1 hour. After a further 3 washes
membranes were detected with ECL (Amersham) and signals were exposed
on Kodak Biomax film.
Table 2.3 Primary antibody dilutions for Western Blotting
Antibody Species Source Dilution Factor
Anti-flag M2 Mouse Sigma 1:3000
Anti-tetra HIS Mouse Qiagen 1:1000
2.2.3.4 Bradford Assay
Standard 100 /zl BSA solutions were prepared of 1 /xg/ml, 2 /xg/ml, 5 /xg/ml,
10 jU.g/ml, 15 jug/ml and 20 /xg/ml from a stock solution of 0.5 mg/ml BSA.
The protein sample to be measured was diluted in 100 fi 1 dHzO as
appropriate, making sure a note of the dilution was taken. One part Protein
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assay solution (Biorad) was mixed with four parts dHzO and 900 p1 of this
mix was added to each of the standards and left at room temperature for 15
min. Each sample was measured on the spectrophotometer at 595 nm and a
note taken of the reading. A standard graph is drawn using the values for




2.3.1.1 In vitro transcription of dsRNA
The dsRNA substrate used was AKP, which comprises exons 2 and 3 of the
rat a-tropomyosin gene with no intron between. The sense RNA strand was
synthesised using SP6 RNA polymerse (Stratagene) following linearisation of
AKP with BamHI to give a 296 nt transcript. The antisense RNA was
synthesised using T7 RNA polymerase (Stratagene) from a template
generated by PCR using the SP6 and T7 promoter sequences as primers (See
section 2.1.6.2). The reaction mix was as follows: 1 pg DNA template, 1U T7
or SP6 RNA polymerase (Stratagene) 5x transcription buffer, 10 mM DTT, 2
mM nCGU, 0.1 mM nATP, 150 pg/ml BSA, 1U RNA guard (Pharmacia), and
if required, 10 pCi [a-32P] ATP (3000 Ci/mmol; Amersham). The reaction was
brought up to 25 pi with dEEO and incubated at 37 °C for 1-2 h.
The sense and antisense strands were mixed at a molar ratio of 1:2
(sense:antisense) in buffer Q (50 mM Tris-HCl, pH 7.9, 100 mM KC1, 5 mM
EDTA, 10% glycerol) and then heated to 75 °C for 10 min. The RNAs were
allowed to cool slowly to 30 °C.
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2.3.1.2 In vitro transcription of dADAR exon 7
The dADAR exon 7 sense strand was synthesised using SP6 polymerase
(Stratagene) from a template generated by linearisation of pGEM®-T Easy
with Ncol. The reaction mix was as follows: 1 jag DNA template, 1U SP6
RNA polymerase (Stratagene) 5x transcription buffer, 10 mM DTT, 2 mM
nCGUA, 150 pg/ml BSA, and 1U RNA guard (Pharmacia). The RNA was
trace labelled with [a-32P] ATP (3000 Ci/mmol; Amersham). The reaction was
brought up to 25 pi with dThO and incubated at 37 °C for 1-2 h.
2.3.1.3 5' End-labelling of primers
The Adar exon 7 RT primer CAG TGT CGT TTT CGT GAG was 5' end-
labelled prior to poison primer extension. 5 pmol of primer was incubated
with lx PNK buffer, 10U polynuleotide kinase, 30 pCi [y-32P] dATP at 37 °C
for 40 min. The reaction was stopped with 15 mM EDTA and 0.1% SDS and
the RNA purified using a Sephadex G-25 spin column.
2.3.2 Editing Assays
2.3.2.1 Non-specific editing assay
Using 200 femto moles per reaction, the amount of radiolabelled dsRNA to
set up the required number of reactions, including one reaction with no
ADAR protein, was calculated. The dsRNA was ethanol precipitated,
centrifuged, and the pellet washed with cold 70% ethanol. After drying in a
spee vac, the pellet was then resuspended in 12.5 pi per reaction of 5 mM
EDTA, 0.75 pi 5 mg/ml tRNA per reaction and 0.5 pi RNAguard (Pharmacia)
per reaction.
Protein samples containing 1-12.5 pi of ADAR-containing protein fraction
were set up on ice; buffer Q/200 was used to make up the remaining volume
to 12.5 pi. 12.5 pi of the resuspended dsRNA substrate was added to each
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EDTA, 0.75 pi5 mg/ml tRNA per reaction and 0.5 pi RNAguard (Pharmacia)
per reaction.
Protein samples containing 1-12.5 pi of ADAR-containing protein fraction
were set up on ice; buffer Q/200 was used to make up the remaining volume
to 12.5 pi. 12.5 pi of the resuspended dsRNA substrate was added to each
protein sample and incubated for 1 hour at 37 °C. 8.3 pi of 7.5 M ammonium
acetate and 120 pi of ice cold ethanol were added and the samples
centrifuged at 12,000 x g for 30 min at 0 °C. The pellets were washed with
70% ethanol and centrifuged for a further 15 min at 0 °C before being
vacuum dried. The dried pellets were resuspended in 10 pi of PI buffer [30
mM potassium acetate pH 5.3, 10 mM zinc sulphate] containing 1.5 pg of 20
mg/ml nuclease PI and incubated for 1 hour at 50 °C.
A 20 cm X 20 cm TLC plate was prepared by marking an origin line lightly
with a pencil 1.5 cm from the bottom of the plate. Vertical lanes were created
(15 lanes 1.3 cm wide or thirteen lanes 1.5 cm wide) by using the edge of a
spatula to remove the cellulose layer between the lanes and unlabelled
inosine was spotted at the origin of each lane and allowed to dry.
5 pi of the PI nuclease digest was loaded at the origin of each lane on the
TLC plate, allowed to dry before the second 5 pi was loaded. IMP was also
spotted as a standard for inosine in each lane. The nucleotide mixture was
resolved using 100 ml of chromatography solvent (saturated ammonium
sulphate, 100 mM sodium acetate pH 6, and isopropanol (79:19:2)).
The plate was air-dried and exposed overnight to a Phosphorlmager screen.
5' a-32P inosine migrates faster in this system than 5' a-32P adenosine. The
radioactivity in the inosine and adenosine spots in each lane can be
quantitated using ImageQuant™ software (Amersham Biosciences).
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2.3.2.2 Poisoned primer extension
Based on using 10 femto moles per reaction, the amount of radiolabelled
dsRNA to set up the required number of reations was calculated. As in
section 2.3.1.1, the radiolabelled RNA substrate was ethanol precipitated,
washed and dried and the pellet was resuspended in 12.5 pi of reaction mix
(5 mM EDTA, 0.125 pi of poly(A) RNA, 0.5 pi RNAguard (Pharmacia), 20
mM DTT, 5 pg BSA).
As before, protein samples containing 1-12.5 pi of ADAR-containing protein
fraction were set up on ice and buffer Q/200 was used to make up the
remaining volume to 12.5 pi. 12.5 pi of the resuspended RNA substrate was
added to each protein sample and incubated for 1 hour at 37 °C. 25 pi of
proteinase K mixture consisting of 1 pi of 10 mg/ml proteinase K and 25 pi of
2x PK Buffer (20 mM Tris-HCl, pH 7.6, 20 mM NaCl, 2 mM MgCl2, 1% SDS)
was added to each sample and incubated for 30 min at 50 °C. Each sample
was made up to 100 pi with dHzO and the RNA phenol/chloroform
extracted, ethanol precipitated and the pellet air-dried.
2 pico moles of the reverse transcription primer were y -32P and resuspended
in 100 pi dH20. The RNA pellet from the editing reaction was resuspended
in annealing mix (0.5 pi of the end-labelled primer, 2 pi of 5x RT buffer, 0.5 pi
of 0.5 pM ddTTP, 0.5 pi each of 2 mM dCTP, dGTP and dATP, made up to
8.3 pi with dH20) and incubated overnight at 55 °C to allow efficient
annealing of the primer. The following day 1.3 pi of MMLV reverse
transcriptase (Stratagene) was added to each sample and incubated for 1
hour at 42 °C.
Each sample was then ethanol precipitated and the dried pellets resuspended
in 3 pi of formamide loading buffer boiled for 5 min at 95 °C and placed on
ice. The samples were resolved on a 15% TBE/Urea gel, 0.5 mm spacer and
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the gel dried before exposure to a Phosphorlmager screen. The radioactivity
in each lane was quantitated using ImageQuant™ (Amersham Biosciences).
2.3.3 Filter Binding assays
Increasing concentrations of pure recombinant ADAR dsRBMs were mixed
with dsRNA containing 200 fmoles of 32P-labelled adenosine in 50 pi of buffer
C (50 mM Tris-HCl, pH 7.9, 150 mM KC1, 5 mM EDTA, 20% glycerol, 1 mM
DTT, 0.5 mM PMSF, 0.7 pg/ml pepstatin, 0.4 pg/ml leupeptin, 0.15 mg/ml
tRNA, 0.2 mg/ml BSA) for 10 min at 37 °C. The samples were then
immediately filtered on a 0.45 pm nitrocellulose membrane filter (Schleicher
& Schuell) that had been pre-soaked in the same buffer. The filters were then
washed twice with 500 pi of buffer C, dried and the radioactivity was




The Drosophila ADAR Deaminase
Domain
3.1 Introduction
The ADAR family of enzymes are a member of the larger family of cytidine
deaminases (CDA). A C-terminal catalytic domain is found in all ADARs
and contains conserved residues, HAE(x)41.58PCG(x)44.154SCSDK/ analogous to
sequences in the active sites of the cytidine deaminase family of enzymes.
The cysteine and histidine residues are the ligands to the active site zinc,
while the glutamate residue is necessary for proton transfer function. These
motifs are also found in the ADAT (adenosine deaminase acting on tRNA)
family of enzymes responsible for converting adenosine to inosine in tRNA.
This homology between the ADARs and ADATs has prompted suggestions
that the ADARs have evolved from the ADATs by the addition of dsRNA
binding motifs.
Studies have shown that the deaminase domain of the ADAR enzymes is
responsible for substrate specificity. I have cloned and purified the
Drosophila deaminase domain and assayed its editing activity in vivo and in
vitro on the dADAR self edit site, and on a dsRNA. The results suggest that
the dADAR deaminase domain can edit dsRNA by itself. The editing pattern
on the dsRNA is a subset of sites that are edited with the full length wild-
type ADAR enzyme suggesting that site specificity is indeed conferred by the
deaminase domain.
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Figure 3.1 Sequence alignment of the Drosophila ADAR deaminase
domain with the catalytic domains of other CDA family members.
The Drosophila ADAR deaminase domain is shown aligned by the Clustal W
multiple sequence alignment program (http://www.ebi.ac.uk/clustalw/)
with the catalytic domains of hADARl, hADAR2, hADAR3, hADATl,
dADATl, APOBEC-l and AID. Conserved residues are highlighted in black
with similar residues highlighted in gray. The three motifs, I, II and III,
involved in the chelation of zinc and proton transfer are shown in red with
the editing site of Drosophila ADAR indicated by an * and highlighted in
green. Gaps are shown by dashed lines.
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3.2 Alignment of ADAR catalytic domains
Amino acid sequence analysis of the Drosophila deaminase domain alongside
the catalytic domains of other ADAR proteins has highlighted the presence
of the three conserved CDA catalytic motifs and shown that dADAR is more
similar to hADAR2 and hADAR3 than hADARl. dADAR also shares good
homology with both the human and Drosophila ADAT1 proteins. Figure 3.1
presents an alignment of the deaminase domains of a number of ADAR
family and related proteins.
The ADATs are able to convert adenosine to inosine in tRNA with no
identifiable RNA binding motif present. I decided to investigate whether the
catalytic domain of dADAR was also capable of editing dsRNA with no
identifiable RNA binding motifs present.
3.3 Expression and purification of dADAR
deaminase domains
A number of constructs were designed based on previous studies of the
dADAR full length enzyme. Wild-type dADAR is capable of editing its own
transcript when expressed in Pichia pastoris resulting in a mix of edited and
unedited isoforms. To allow the expression of a single isoform rather than a
mixed population the edited serine codon AGT can be mutated to another
codon for serine, the ineditable form TCT or alternatively, the AGT serine
codon can be mutated to glycine GGT allowing the expression of the edited
Figure 3.2A Schematic of the Drosophila ADAR Deaminase Domain
Constructs were designed to begin translation at aspartate residue 283 of the
full length dADAR protein and a C-terminal tail containing the 6 X histidine
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3 The Drosophila ADAR Deaminase Domain
isoform alone. A point mutation in motif I changing the glutamate residue to
alanine has been shown to result in an inactive isoform (Lai et al., 1995; Liu
and Samuel, 1996). As all these modifications occur within the catalytic
region I was therefore able to amplify and clone four different isoforms of the
dADAR deaminase domain; wild-type, ineditable (S430S), edited (S430G)and
inactive (E367A) (Figure 3.2a); into the pPICZa vector in frame with the 6x
HIS tag. Once transformed into Pichia colonies the expression of these 6x HIS
tagged proteins was efficient giving approximately 8 mg protein per 1 litre of
culture after purification over Ni2+-NTA agarose. SDS-PAGE and western
blot analysis using an anti-tetra HIS antibody detected a 45 kDa band
corresponding to the predicted molecular weight of the deaminase domain
constructs (Figure 3.2b).
3.4 The Drosophila ADAR wild-type
deaminase domain displays no activity in
vivo
As discussed before, the full length dADAR enzyme is able to edit its own
transcript at the exon 7 site when expressed in the yeast Pichia pastoris.
Because editing at the Adar exon 7 site does not require any intronic
sequences to form a permissible structure the expression of a recombinant
dADAR protein from a cDNA clone results in active protein and a high
affinity site being produced within the yeast cell. As there is no endogenous
Figure 3.2B Purification of recombinant dADAR deaminase domain (DA)
proteins. His-tagged DA proteins were purified from Pichia pastoris over
Ni2+NTA agarose. Samples were taken from the crude (CR), flow through
(FT), wash (W) and elutions (E1-E17) and the level of purification was
determined by SDS-PAGE and Coomassie staining. Protein markers (kDa)
are indicated on the left.
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ADAR activity in Pichia any A-to-I editing of mRNA must be due to the
recombinant ADAR proteins expressed.
To assess the activity of the deaminase domain, RT-PCR and sequence
analysis was performed on total RNA isolated from Pichia pastoris expressing
either full length dADAR 3/4 WT (full length dADAR minus exon 3a), full
length dADAR 3/4 E367A or the wild-type deaminase domain. As
demonstrated by Palladino et al the 3/4 wild-type enzyme showed high
levels of self editing (Palladino et al., 2000a) whilst the inactive E367A
isoform displayed no activity (Figure 3.3). Unfortunately, the wild-type
deaminase domain also showed no activity suggesting that the dsRNA
binding domains may be required for activity (Figure 3.3).
Western blot analysis of the recombinant wild-type deaminase domain using
an anti-tetra F1IS antibody showed two bands of approximately 45 kDa and
96 kDa (Figure 3.4). To further confirm the purification of the deaminase
domain the upper and lower bands from elution fraction 7 were separated by
SDS-PAGE and the bands analysed using peptide mass fingerprinting. As a
control a sample of active full length dADAR 3/4 S430S was also analysed.
The two bands from the deaminase domain purification produced good
spectra and the peptides detected post tryptic digest suggested they were the
same protein however, theoretical digest on the Drosophila ADAR sequence
did not match. Database searches with the peptide sequences did not
produce any hits suggesting that rather than purifying the dADAR
Fig 3.3 Editing at the dADAR exon 7 self editing site RNA was isolated
from individual Pichia clones expressing dADAR 3/4 wild-type (3/4 WT),
dADAR 3/4 E367A (3/4 E367A) and wild-type deaminase domain were
sequenced and multiple sequence chromatograms show the level of editing
at the Adar exon 7 self editing site for each enzyme. 3/4 WT shows 62%
editing at exon 7 (n=13). For 3/4 E367A (n=7) and for deaminase domain
WT (n=25) no editing activity was detected.
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3 The Drosophila ADAR Deaminase Domain
Figure 3.4 Purification of wild-type dADAR deaminase domain The elution
fractions from the purification of wild-type deaminase domain over Ni2+
NTA agarose was analysed by Western blot using an anti-tetra HIS antibody
(Qiagen). Two bands were apparent, a 45 kDa band matching the predicted
size of the recombinant dADAR deaminase domain protein and an unknown
band of approximately 96 kDa. The upper and lower bands from elution
fraction 7 were analysed by peptide mass fingerprinting. Protein size
markers (kDa) are indicated on the left.
deaminase domain I was instead purifying a Pichia contaminant of a similar
size that cross reacted with the anti-tetra His antibody. It should be noted
that the control sample of dADAR 3/4 S430S did map to the full length
protein.
The peptide fingerprinting results explain the lack of editing seen in the RT-
PCR sequence analysis with the deaminase sample. One explanation is that
the deaminase domain construct was too short and the protein that was
generated was unstable and was degraded. If this occurred then the
contaminant Pichia protein would bind to and be purified from the Ni2+-NTA
column.
3.5 An alternative deaminase domain
construct
To further confirm whether it is possible to produce recombinant dADAR
deaminase domain, an alternative construct was cloned into pPICZ A and
transformed in Pichia. This construct, termed DM WT, instead begins at P270
and has an N-terminal FLAG tag and a C-terminal histidine tag immediately
downstream of the last glutamate residue (Gallo et al., 2003). SDS-PAGE and
Western blot analysis using an anti-tetra HIS antibody detected a 45 kDa























3 The Drosophila ADAR Deaminase Domain
Figure 3.5A Purification of recombinant wild-type Drosophila ADAR
deaminase domain (DM WT) protein. N-terminal FLAG-tagged and C-
terminal His-tagged DM proteins were purified from Pichia pastoris over
Ni2+NTA and FLAG agarose. Samples were taken from the crude (CR),
Ni2+NTA flow through (Ni-NTA FT), Ni2+NTA wash (Ni-NTA W), Ni2+"NTA
eluate (Ni2+-NTA E), FLAG flow through (FLAG FT), FLAG wash (FLAG W)
and FLAG elutions (FLAG El, FLAG E2, FLAG E3) and the level of
purification was determined by SDS-PAGE and Coomassie staining. Protein
markers (kDa) are indicated on the left.
Figure 3.5B Peptide Mass fingerprinting of dADAR 3/4 S430S and DMWT
proteins Samples from dADAR 3/4 S430S and DM WT purifications were
separated by SDS-PAGE and the bands excised and analysed by peptide
mass fingerprinting.
construct (Figure 3.5A). Once again a sample was run on SDS-PAGE and the
band excised for peptide mass fingerprinting alongside the full length
dADAR 3/4 S430S protein (Figure 3.5B). The peptides for the full length
protein mapped the entire protein whilst the peptides from the DM WT
digest mapped to the C-terminal portion of the protein (Figures 3.5C and
3.5D).
3.6 The dADAR DM WT can editAdar exon 7 in
vivo in Pichia pastoris
Now that peptide mass fingerprinting had confirmed the expression and
purification of DM WT I decided to assess its ability to deaminate its own
transcript. As before, RT-PCR and sequence analysis was performed on total
RNA isolated from Pichia pastoris expressing DM WT and of the 25 sequences
examined, 3 showed editing at the exon 7 S/G editing site (Figure 3.6A).
On analysing the exon 7 sequences it became apparent that a number of other





















































































































































































































































































































































































































































































































































































































































































































































































































3 The Drosophila ADAR Deaminase Domain
Figure 3.6A Editing at the dADAR exon 7 self editing site by DM WT
RNA was isolated from individual Pichia clones expressing dADAR DM WT
were sequenced and multiple sequence chromatograms show the level of
editing at the Adar exon 7 self editing site. DM WT shows 12% editing at
exon 7 (n=25).
Figure 3.6Bi Mapping of dADAR 3/4 S430S editing on the exon 7 substrate.
RNA structure prediction for all 187 bases of exon 7 of the Adar transcript
using the mfold program (Zuker, 1989). 13 Adar transcripts isolated from
individual Pichia clones were analysed and all A-to-G changes mapped. Full
length dADAR 3/4 S430S can edit exon 7 of the Adar transcript at 4 different
sites.
Figure 3.6Bii Mapping of dADAR DM WT editing in the exon 7 substrate.
RNA structure prediction for all 187 bases of exon 7 of the Adar transcript
using the mfold program (Zuker, 1989). 33 Adar transcripts isolated from
individual Pichia clones were analysed and all A-to-G changes mapped. DM



















































































































3 The Drosophila ADAR Deaminase Domain
deaminase domain did indeed confer a level of site specificity I decided to
map the editing events within Adar exon 7 and compare the sites targeted by
full length dADAR 3/4 WT and the DM WT. DM WT and 3/4 WT were
expressed in Pichia pastoris, the total RNA extracted and RT-PCR performed.
The resulting PCR products were TA cloned into pGEM®-T Easy vector and
transformed into E. coli. Colonies were screened and plasmid preps made
before sequencing using the SP6 and T7 promoter sequences within the
pGEM®-T Easy multiple cloning site.
Four editing sites were identified, including the well-documented S/G site.
With reference to the RNA fold illustrated in Figure 3.6Bi, of the 13
transcripts analysed full length dADAR targeted four adenosines within
exon 7 including the S/G site at 54%, two sites situated within loops at either
end of the structure (A87 and A165) at 23% and another adenosine (A59)
immediately opposite the S/G site at 8%. A far greater number of transcripts
were sequenced to map the editing of DM WT indicating it edits much less
efficiently than full length dADAR. Of the 33 sequences analysed (Figure
3.6Bii) DM WT was shown to target three adenosines within exon 7; the S/G
site at 11%, A165 at 3% and A59 immediately opposite the S/G site at 6%.
Figure 3.7 Poisoned primer extension assay comparing editing in vitro on
Adar exon 7 by DM WT and dADAR 3/4 S430S. DM WT and dADAR 3/4
S430S were incubated with 10 femto moles Adar exon 7 transcript for 1 and 2
hours. The first lane contains no ADAR protein. Lanes 4 and 5 are duplicate
lanes containing 125 pico moles 3/4 S430S that edits Adar exon 7 transcript to
20% after one hour incubation rising to 25% after 2 hours. 22 n moles DM
WT showed no editing activity on Adar exon 7 in vitro. Editing activity was
quantified using a phosphoimager and ImageQuant™ software.
Radiolabeled primer; P, the unedited; U and edited; E primer extensions
products.
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3 The Drosophila ADAR Deaminase Domain
This overlap of specificity between full length ADAR and the deaminase
domain indicates that the catalytic domain does indeed confer a level of
specificity though without the dsRNA binding domain it edits far less
efficiently than the full length protein.
3.7 The dADAR DM WT can not editAdar
EXON 7 IN VITRO
Now DM WT has shown it is capable of editing dsRNA I performed a
poisoned primer extension assay to measure the DM WT editing activity on
the S/G site in exon 7 transcripts in vitro. Full length 3/4 S430S edited exon 7
at about 20% but no DM WT editing activity was detected (Figure 3.7).
Macbeth et al. recently reported the crystal structure of the hADAR2
deaminase domain. The construct analysed was similar to DM WT (See
appendix 2) and able to edit dsRNA substrates in vitro but was less efficient
than full length hADAR2 (Macbeth et alv 2005). In the case of dADAR full
length 3/4 S430S will normally edit exon 7 in vitro to approximately 70%
therefore in this case the control was working at a much lower efficiency than
normally seen. If DM WT is able to edit this transcript in vitro levels may be
below the threshold of the experiment.
Figure 3.8 Poisoned primer extension assay on Adar exon 7 editing in vitro
by DM WT and increasing amounts of dADAR 3/4 E367A 2.2 nano moles
DM WT and increasing amounts (18.75 pico moles to 1875 pico moles) of
dADAR 3/4 E367A were incubated with 10 fernto moles Adar exon 7
transcript. The first lane contains no ADAR protein. Lane 2 contains
dADAR 3/4 E367A and lane 3 contains DM WT; neither demonstrated
editing activity on Adar exon 7. Lane 4 shows editing of Adar exon 7 transcript
to 5% by dADAR 3/4 S430S. Lanes 5 to 14 contain constant amounts of DM
WT with increasing amounts of dADAR 3/4 E367A added. No editing was
seen. Editing activity was quantified using a phosphoimager and
ImageQuant™ software. Radiolabeled primer; P, the unedited; U and



























































3 The Drosophila ADAR Deaminase Domain
To test whether another dsRNA binding protein might facilitate the catalytic
function of the deaminase domain, DM WT was incubated with Adar exon 7.
and increasing amounts of full length 3/4 E367A. Previous studies have
shown that the deaminase domain does not interact with or form dimers
with full length dADAR protein (Gallo et alv 2003).
However, the conformational changes induced by the binding of a full length
ADAR protein (Yi-Brunozzi et al., 2001) may facilitate editing by the
deaminase domain. Therefore any editing that occurred would be the
function of the DM WT protein as the E367A mutation in the full length
dADAR protein renders it unable to deaminate dsRNA yet it retains its
ability to bind to dsRNA. No editing by DM WT was seen (Figure 3.8)
suggesting it did not interact with the 3/4 E367A protein.
If the activity of DM WT can not be supplemented by the presence of a full
length dADAR protein then perhaps it may inhibit the activity of an active
full length ADAR isoform. 3/4 S430S was incubated with Adar exon 7
transcript and decreasing amounts of DM WT. The level of editing by 3/4 by
3/4 S430S alone was first determined to be 36%. The addition of DM WT did
not alter this significantly and levels remained steady at approximately 40%.
Figure 3.9 Poisoned primer extension assay on Adar exon 7 editing in vitro
by dADAR 3/4 S430S and decreasing amounts of DM WT. 187.5 pico moles
dADAR 3/4 S430S and decreasing amounts (8.67 nano moles to 222 pico
moles) of DM WT were incubated with 10 femto moles Adar exon 7 transcript.
The first lane contains no ADAR protein. Lanes 2 and 3 are duplicate lanes
containing 3/4 S430S that edits Adar exon 7 transcript to 36%. Lanes 4 to 11
contain constant amounts of 3/4 S430S with decreasing amounts of DM WT
added. Editing of Adar exon 7 transcript in these lanes remains constant at
approximately 40%. Editing activity was quantified using a phosphoimager
and ImageQuant™ software. Radiolabeled primer; P, the unedited; U and
















































3 The Drosophila ADAR Deaminase Domain
The presence of full length dADAR proteins with which the possibility of an
interaction via the deaminase domain may exist, have no effect on DM WT
activity with the reciprocal being true in that DM WT has no effect on their
enzymatic activity.
3.8 The dADAR DM WT can edit non-specific
dsRNA IN VITRO
If DM WT is unable to edit a specific dsRNA substrate in vitro perhaps a
dsRNA duplex would provide a more accessible substrate. I assayed DM
WT activity on the dsRNA substrate AKP, comprising exons 2 and 3 of the rat
oc-tropomyosin gene with no intron between, and analysed the results by thin
layered chromatography. Under conditions where editing of between 28%
and 48% were obtained for increasing amounts of 3/4 S430S, DM WT
showed no editing activity. This method of analysis is not very sensitive
therefore very low levels of editing would remain undetected.
I decided to analyse the AKP substrate by RT-PCR and sequencing each
strand. The sense strand was reverse transcribed using the KP 3' Sp6 oligo
and the anti sense strand using the Sp6 promoter oligo. The sense strand
was then amplified using KP 3' Sp6 and KP 5' Sp6, with the anti sense strand
amplified by the Sp6 promoter oligo and KP 5' T7 (see Table 2.1 for oligo
sequences). The PCR products were TA cloned into the pGEM®-T Easy
vector as before and positive clones sequenced.
Analysis of the sequences demonstrated that DM WT did indeed edit the
AKP dsRNA substrate at a number of sites. As before the levels of editing
were much lower than that seen for the full length 3/4 S430S protein
however, again reiterating the earlier results on Adar exon 7, there was a
definite specificity in the adenosines targeted with DM WT targeting fewer
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3 The Drosophila ADAR Deaminase Domain
Figure 3.10A Editing assay comparing editing in vitro on a non-specific
dsRNA substrate by dADAR 3/4 S430S and DMWT
3/4 S430S and DM WT were incubated with dsRNA labelled with a-P32-ATP,
the RNA digested, the products separated by thin layer chromatography and
editing activity was quantified using a phosphoimager and ImageQuant™
software. The fastest migrating spots were IMP; inosine monophosphate,
AMP; adenosine monophosphate, and the origin; Ori is at the bottom. The
first lane contains no ADAR protein. Lanes 2 to 11 contain increasing
amounts (125 pico moles to 625 pico moles) of 3/4 S430S and corresponds to
editing of the dsRNA substrate to 28% (10 ng/125 pico moles), 37% (20
ng/250 pico moles), 42% (30 ng/375 pico moles), 44% (40 ng/500 pico moles)
and 48% (50 ng/625 pico moles). Lanes 12 and 13 contain 13.75 nano moles
DM WT and show no editing activity on the dsRNA substrate.
Figure 3.10Bi Mapping of dADAR 3/4 S430S editing on the AKP substrate
The sequence of the AKP substrate is shown at the top of the page.
Adenosines highlighted in red indicate sites where 3/4 S430S has
deaminated an adenosine and resulted in an A-to-G change on the sense
strand. Uridines highlighted in blue indicate U-to-C changes on the anti-
sense strand. Each editing site is listed and the percentage editing by 3/4
S430S calculated.
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1 11 21 31 41 51
GAAUACAAGC UUGUCGAGG§ GGAC|UCUC| GCHH|gaga lGClGClGCG GGCG|CGG|G
61 71 81 91 101 111
g|cg|gcggg |ccggg|gc| ggagg|gc|g c|c||ggc|g |ggac|gcc| gc|ggc0gcc
121 131 141 151 161 171
G|CG|G|ccg ccGccHGcg GGHGA|G|G c|GG|G|C1c 0GC^HgaI |c|CHGGGC
181 191 201 211 221 231
|cdgBg|ug «ctoggacaa iftjuftcuccGjftG Gcu: :uc|aa^; :• |ogccc|gg| gaaacugg|g
241 251 261 271 281 291
c!Sggcgg|g| BBggg&g cifccluGcc gGc|GqgcG| ||cgac|c|ag aggauc
RED: Sense strand (A > G) BLUE: Anti-sense strand (T > C)
u C/total no. seq U C/total no. seq U C/total no. seq
11 4/33 (12%) 140 34/41 (83%) 215 34/41 (84%)
12 4/33 (12%) 147 21/41 (51%) 222 4/41 (9.75%)
26 3/33 (9%) 152 39/41 (95%) 236 35/41 (85%)
28 27/33 (81%) 155 14/41 (34%) 242 26/40 (65%)
44 37/38 (97%) 157 6/41 (15%) 262 31/41 (76%)
47 37/38 (97%) 161 32/40 (80%) 263 11/41 (27%)
55 28/39 (72%) 173 4/40 (10%) 267 31/41 (76%)
77 36/41 (88%) 183 37/40 (92.5%) 271 35/41 (85%)
80 35/41 (85%) 189 3/40 (7.5%) 277 17/41 (41%)
89 38/40 (95%) 194 32/40 (80%) 281 8/41 (19.5%)
110 32/40 (80%) 202 39/40 (97.5%) 286 2/41 (4.8%)
113 34/40 (85%) 205 1/40 (2.5%) 288 37/41 (90%)


























3 The Drosophila ADAR Deaminase Domain
G/total no. seq G/total no. seq G/total no. seq
1/16 (6.25%) 137 21/21 (100%) 209 9/23 (39%)
3/16 (18.75%) 143 5/21 (24%) 217 18/23 (78%)
7/16 (43.75%) 144 21/21 (100%) 218 21/23 (91%)
4/16 (25%) 149 12/21 (57%) 219 20/23 (87%)
12/16 (75%) 159 6/20 (30%) 221 4/23 (17%)
12/16 (75%) 164 16/21 (76%) 227 22/24 (92%)
13/17 (76%) 165 19/21 (90%) 230 8/24 (33%)
13/17 (76%) 166 19/21 (90%) 232 3/24 (12.5%)
1/18 (5.5%) 167 21/21 (100%) 233 23/24 (96%)
6/20 (30%) 170 19/22 (86%) 234 23/24 (96%)
13/20 (65%) 171 14/22 (63%) 239 4/24 (17%)
6/21 (28%) 175 5/22 (22%) 248 1/24 (4%)
15/21 (71%) 176 20/22 (91%) 250 1/24 (4%)
10/18 (55%) 181 18/22 (81%) 251 20/24 (83%)
3/18 (16.5%) 185 6/22 (27%) 252 20/24 (83%)
18/18 (100%) 186 20/22 (91%) 253 23/24 (96%)
14/19 (74%) 188 1/22 (4.5%) 254 22/24 (92%)
2/19 (10.5%) 191 2/23 (8.7%) 258 9/24 (37.5%)
14/19 (74%) 192 12/23 (52%) 259 23/24 (96%)
7/20 (35%) 199 4/23 (17%) 266 16/24 (67%)
16/20 (80%) 200 20/23 (87%) 274 20/24 (83%)
3/20 (15%) 201 20/23 (87%) 280 11/24 (46%)
17/21 (81%) 203 21/23 (91%)
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Figure 3.10Bii Mapping of dADAR DMWT editing on the AKP substrate
The sequence of the AKP substrate is shown at the top of the page.
Adenosines highlighted in red indicate sites where DM WT has deaminated
an adenosine and resulted in an A-to-G change on the sense strand. Uridines
highlighted in blue indicate U-to-C changes on the anti-sense strand. Each
editing site is listed and the percentage editing by DM WT calculated.
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1 11 21 31 41 51
gaauacaagc uug'jcg|gga ggaca§cuc| gcaaaagaga agcugc|gcg ggcgucgg|g
61 71 81 91 101 111
GACGAGCGGG ACCGGGUGCU GGAGGAGCjjG CAC|AGGCAG |GG|CAGCC| GCUGGC|gCC
121 131 141 151 161 171
GACGAGACCG CCGCCAAGC| GGA§GAgjGAG CUGG|gUCAC UGCAAA|GAA ACUCAAGGGC
181 191 201 211 221 231
ACjgGAAGjUG |acuggaca§ |uacuccgag gcucucaaag augcccagga gaaacuggag
241 251 261 271 281 291
cuggcggaga aaa|ggga|g cuugcaugcc ugcagg|cg| ucg|cucu(g aggauc
RED: Sense strand (A > G) BLUE: Anti-sense strand (T > C)
A G/total no. seq T C/total no. seq
17 8/48 (16%) 11 2/46 (4.3%)
30 1/49 (2%) 12 1/46 (2.2%)
59 2/49 (4%) 26 1/45 (2.22%)
94 1/47 (2.1%) 47 1/47 (2.1%)
101 1/47 (2.1%) 89 1/47 (2.1%)
104 1/47 (2.1%) 110 1/47 (2.1%)
144 2/47 (4.25%) 117 3/47 (6.4%)
167 1/47 (2.1%) 140 1/47 (2.1%)
188 1/47 (2.1%) 147 1/47 (2.1%)
191 1/47 (2.1%) 155 2/47 (4.25%)
200 1/47 (2.1%) 183 1/46 (2.2%)
201 1/47 (2.1%) 189 1/46 (2.2%)
254 1/47 (2.1%) 202 2/46 (4.35%)
259 1/47 (2.1%) 277 2/46 (4.35%)
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sites than 3/4 S430S but those it did deaminate were also edited by the full
length protein.
3.9 A Serine to Glycinemutation reduces
hadar2 editing activity IN VITRO
Having demonstrated that the deaminase domain has activity and can edit
its own transcript, I decided to further investigate the role of this editing
event. It has been shown that the serine to glycine change within the
deaminase domain of full length dADAR lowers editing activity (Keegan et
al., 2005; Palladino et al., 2000a). However, does this editing event occur in
other adar transcripts and does it have the same effect?
Sequence analysis of this region in other adar enzymes shows Drosophila
pseudoobscura, Anopheles and Culicoides also have an AGT serine codon in this
position therefore the possibility of editing at this site exists (see Figure 3.11).
The human adar2 gene also codes for serine at this position though in the
form of an uneditable TCA codon. To assess whether the reduction in ADAR
activity seen in the edited form of dADAR is conserved I decided to mutate
the serine codon in adarl to glycine and compare its activity to the wild-type
hADAR2 protein.
Point mutations in adarl were generated by oligonucleotide-directed
mutagenesis (See section 2.1.6.3) to change the TCA serine codon to the GGA
glycine codon. Mutagenesis was performed on adarl cloned in pPICZa, a
Pichia pastoris vector, using the QuikChange™ site-directed mutagenesis kit
(Stratagene) and the sequences analysed.
Wild-type hADAR2 and hADAR2 S/G were expressed and purified as
described in section 2.2.1 and their ability to edit a non-specific dsRNA
substrate assayed and the results analysed by thin layer chromatography.
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TGTGAAAAGAAACAAGGT - TTCAGAC 2 5
GACCACCAGAAGTCAATATTTGTCCACTGTGAGAAGGGAGGC - TACAGGT 4 9
TAACAAAGATGATCAAAAAGAATCCATCTTTCAGAAATCAGAGCGAGGGGGG-TTTAGGC 5 9

























* * * * * ★ * * * ★
Ser
CCTCACGAGGCTGGAGTGGAAGATCAGGGAGACAGGCACCCTAAC- - 13 8




CCGCATGAAGCTGACACAATTAAC GGTGATAAGCATCCAAAT - - 165
CCGCACGAAAACGACAGCATGGAC GTGGACAAGCATCCGAAT-16 8
Figure 3.11 Alignment of adar gene sequences corresponding to the RNA
editing substrate exon 7 in the Drosophila melanogaster deaminase
domain.
The ADAR sequences are shown aligned by the Clustal W multiple sequence
alignment program (http://www.ebi.ac.uk/clustalw/) with the
corresponding regions of Takifugu rubripes ADAR2a and ADAR2b, human
ADAR2 (exon 5), Drosophila melanogaster ADAR (exon 7), Drosophila
pseudoobscura ADAR (exon 7), Culicoides sonorensis ADAR2 and Anopheles
gambiae. Conserved residues are highlighted by an *. The serine codon of
dADAR modified by RNA editing to glycine is highlighted in red. Gaps are
shown by dashed lines.
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Figure 3.12 Editing assay comparing editing in vitro on a
non-specific dsRNA substrate by hADAR2 and hADAR2 S/G.
hADAR2 and hADAR2 S/G were incubated with dsRNA labelled with
a-32P-ATP, the RNA digested and the products separated by thin layer
chromatography. Editing activity was quantified using a phosphoimager
and ImageQuant™ software. The fastest migrating spots were IMP;
inosine monophosphate, AMP; adenosine monophosphate, and the
origin; Ori is at the bottom. The first lane contains no ADAR protein.
Lanes 2 to 7 contain increasing amounts of hADAR2 and corresponds to
editing of the dsRNA substrate to 5.8% (5 ng/72.5 pico moles), 11% (10
ng/125 pico moles), 20% (20 ng/250 pico moles). Lanes 8 to 13 contain
hADAR2 S/G and corresponds to editing of the dsRNA substrate to
0.6%% (5 ng/72.5 pico moles), 1.4% (10 ng/125 pico moles), 4.6% (20
ng/250 pico moles).
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The editing activity of the mutated hADAR2 S/G protein on this substrate
was around 5 - fold less that of the wild-type protein (Figure 3.12).
I now decided to assay the activity of the wild-type and mutant hADAR2
proteins on the mini B13 GluR-B Q/R transcript. As with the non-specific
dsRNA substrates, hADAR2 S/G was less active when compared to the
wild-type hADAR2. This time however, the reduction in activity was
around 8 - fold (Figure 3.13A and 3.13B).
These results indicate that this serine residue influences ADAR activity
however, the role it plays is unclear. A number of residues were identified
that co-ordinate with IP6but serine 458 does not appear to be involved. One
hypothesis suggests that the serine residue is phosphorylated and its change
to glycine prevents this phosphorylation and thus affects enzyme activity
however, this has yet to be shown.
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Figure 3.13A Poisoned primer extension assay comparing editing
in vitro on mini B13 GluR-B Q/R site by hADAR2 and hADAR2 S/G.
hADAR2 and hADAR2 S/G were incubated with 10 femtomoles mini
B13 GlnR-B Q/R transcript for 1 hour. The first lane contains no
ADAR protein. Lanes 2 to 9 contain increasing amounts of hADAR2
and corresponds to editing of the mini B13 substrate to 17% (4 ng/50
pico moles), 28% (8 ng/100 pico moles), 34.5% (12 ng/150 pico moles)
and 36% (16 ng/200 pico moles). Lanes 10 to 17 contain increasing
amounts of hADAR2 S/G and corresponds to editing of the mini B13
transcript to 2% (4 ng/50 pico moles), 4% (8 ng/100 pico moles), 6% (12
ng/150 pico moles) and 6.4% (16 ng/200 pico moles). Editing activity
was quantified using a phosphoimager and ImageQuant™software.
Radiolabeled primer; P, the unedited; U and edited; E primer
extensions products.
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Figure 3.13B Poisoned primer extension assay comparing editing
in vitro on mini B13 GluR-B Q/R site by hADAR2 and hADAR2 S/G.
hADAR2 and hADAR2 S/G were incubated with 10 femto moles mini B13
GluR-B Q/R transcript for 1 hour. The first lane contains no ADAR
protein. Lanes 2 to 9 contain increasing amounts of hADAR2 and
corresponds to editing of the mini B13 substrate to 31% (20 ng/250 pico
moles), 32.5% (40 ng/500 pico moles), 35% (60 ng/750 pico moles) and 35%
(200 ng/2.5 nano moles). Lanes 10 to 17 contain increasing amounts of
hADAR2 S/G and corresponds to editing of the mini B13 transcript to 8.6%
(20 ng/250 pico moles), 13% (40 ng/500 pico moles), 14% (60 ng/750 pico
moles) and 17% (200 ng/2.5 nano moles). Editing activity was quantified
using a phosphoimager and ImageQuant™software. Radiolabeled
primer; P, the unedited; U and edited; E primer extensions products.
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3.10 Discussion
The catalytic domain of the Drosophila ADAR enzyme is highly conserved
sharing active site motifs with the family of cytidine deaminases. The
function of these motifs has been well studied and the recent resolution of
the crystal structure of the deaminase domain of hADAR2 has documented
the individual roles assigned to these conserved residues (Macbeth et al.,
2005). Initially a series of deaminase constructs were designed including an
edited isoform, an unedited isoform, an inactive isoform and the wild-type
domain. However, these appeared to be unstable on expression resulting in
the purification of a Pichia contaminant. A new construct was designed
extending the amino terminus to the 3' end of the second dsRBM and this
was expressed successfully. This construct is very similar to the hADAR2-D
construct crystallized by Macbeth et al., with only 4 residues different at the
amino terminus (Macbeth et al., 2005) (see appendix 1).
Both dADAR and hADAR2 are very similar proteins functionally as human
adarl is able to rescue null mutant Adar flies (Keegan, unpublished).
Structurally they share the same tertiary pattern with both proteins
consisting of two dsRNA binding domains and a catalytic domain unlike
human ADAR1 which consists of three dsRBDs and has an extended amino
terminus containing Z-DNA binding domains. However, a number of post
transcriptional modifications occur in dADAR that influence the proteins
activity which are not seen in either human ADAR1 or ADAR2.
In particular, the serine to glycine change that occurs in the deaminase
domain of dADAR has been shown to reduce enzymatic activity (Keegan et
al., 2005). This self editing is believed to be a method of negative auto
regulation and has so far only been detected in the D. melanogaster protein.
Sequence analysis of other ADAR proteins show the ADAR2-like proteins
have serine in this position and as my results demonstrated, the mutation of
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this serine to glycine in another ADAR protein, in this case human ADAR2,
has the same effect and decreases editing activity.
The functional cause of this decrease in activity is unclear as a specific role
has not yet been assigned to this residue, though as discussed it has been
hypothesised that it may be phosphorylated. Analysis of the dADAR full
length protein did highlight a number of phosphorylated residues across the
protein however this serine was not one of them (M. O'Connell,
unpublished).
Interestingly ADARl-like proteins have a negatively charged aspartic acid
residue in this position (See figure 3.1). When the serine residue of dADAR
is mutated to aspartic acid the protein is inactive (M. O'Connell,
unpublished) indicating that not only do they have different numbers of
dsRBDs, the deaminase domains of dADAR and hADAR2 differ from that of
hADARl.
One common characterisitic they share though is the ability of their catalytic
domains to function without the dsRBDs. I have demonstrated that the
deaminase domain of dADAR is able to edit exon 7 transcripts in vivo and
non-specific dsRNA in vitro though at much lower levels than the full length
protein. This corresponds to results from Herbert et al. and Macbeth et al.
who demonstrated in vivo ADAR1 and in vitro ADAR2 deaminase domain
activity, respectively (Herbert and Rich, 2001; Macbeth et al., 2005).
Macbeth was able to demonstrate hADAR2 deaminase domain activity on
non-specific dsRNA using thin layer chromatography unlike my own results
on the Drosophila ADAR deaminase domain which required the more
sensitive RT-PCR to detect any editing activity. As discussed earlier, the
constructs were very similar therefore it would seem unlikely that a
structural difference between the two construct designs could account for the
different editing activity.
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As I discussed in section 3.7, the editing activity of the full length dADAR
control is much lower than normally seen so perhaps some DM WT activity
could be detected on a more efficiently edited sample of exon 7. However,
the difference in activity on the non-specific dsRNA substrate is less easily
explained and may simply be due to inherent differences between the human
and Drosophila proteins.
The fact that the human and Drosophila deaminase domains are able to edit
transcripts at all is surprising. A number of studies have demonstrated that
both proteins function as a homodimer and that dimerisation is required for
activity (Gallo et al., 2003; Jaikaran et alv 2002). A distinct region of
interaction for hADAR2 has yet to be identified however; Gallo et al. clearly
showed that the amino terminus and first dsRBM were required for the
dimerisation of dADAR and hence protein activity. My results would
suggest that this is not the the whole story. The recruitment of dADAR
monomers onto the dsRNA substrate and the mechanism by which the
deamination reaction occurs is unclear but the possibility of even weak
interactions between points in the deaminase domain would make sense.
Mapping the editing sites of both full length and DM WT on exon 7 and the
non-specific dsRNA AKP illustrated two things. Firstly, regarding the non¬
specific dsRNA, the full length protein will repeatedly edit the same
adenosine bases indicating that not all adenosines along a dsRNA substrate
are suitably positioned for editing and that even within a duplex there is a
basal level of specificity. Secondly, the pattern of editing seen with the full
length protein is repeated at a number of sites for the deaminase domain
even though efficiency is greatly reduced. This specificity is more clearly
seen when analysing the exon 7 substrate as the main difference here is not in
site selection but in editing efficiency. The suggestion that the deaminase
domain plays a role in site selection is supported by Wong et al. who clearly
demonstrated that the deaminase domain of hADARl and hADAR2 retained
editing site specificity (Wong et al., 2001).
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More recently, the editing patterns of hADARl, hADAR2 and dADAR on a
non-specific substrate have been analysed. As expected, all three proteins
exhibited distinct but overlapping specifities with the Drosophila protein
editing many sites more efficiently than the human proteins (Scadden and
O'Connell, 2005).
Overall the structural and functional differences between each of these
proteins may influence the obvious difference in specificity they have for




The Drosophila ADAR dsRNA
Binding Domain
4.1 Introduction
The dsRNA binding motif (dsRBM) was first identified in the Xenopus laevis
RNA-binding protein A (XlrbpA) and the Drosophila maternal effect protein
Staufen (St Johnston et al., 1992). It has since been identified in a number of
diverse proteins involved in the regulation and modification of RNA
molecules. The ADAR family of proteins contain two or more dsRNA
binding motifs tandemly arranged at the amino terminus. Studies have
shown that not all of the dsRBMs are neccessary for enzyme activity but one
is normally essential (Lai et al., 1995; Liu and Samuel, 1996).
I have cloned and purified the Drosophila dsRNA binding domains and
analysed their structural and binding characteristics. The results suggest that
they are bona fide members of the dsRBM family. The co-expression of these
domains alongside the catalytic domain in vivo alters the editing activity of
the deaminase domain indicating that the dsRBMs can indeed interact with
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4.2 Sequence and Structural analysis of the
dsRBMs
Analysis of the D. melanogaster ADAR dsRNA binding motifs dsRBMl and
dsRBM2 demonstrates that they are 63 and 60 amino acids in length,
respectively and are share a similar sequence. They show strong homology
with the dsRBM consensus sequence (Doyle and Jantsch, 2002) across their
full length indicating they are type A dsRBMs and will bind dsRNA strongly
(See figure 4.1). Indeed, targeted point mutations changing alanine 106 and
110 to glutamate in the first dsRNA binding motif have been shown to
abolish dsRNA binding activity of the full length protein (Gallo et al., 2003).
Secondary structure prediction programmes suggest a typical
aPPPa structure. The HSQC spectrum of dsRBMl indicated the protein was
well folded (See figure 4.2). Data from two-dimensional and three-
dimensional NOESY provided information on interproton distances whilst
two dimensional TOCSY and COSY allowed the assignments of amino acid
side chains (Data provided by Jose Gallego, MRC LMB). Taken together
these data show that dsRBMl is indeed a typical dsRNA binding motif with
a ai-p-p-p-a2 structure.
4.3 Expression and purification of dADAR
dsRNA binding domain
An alternatively spliced exon, 3a, is located between the two dsRNA binding
motifs of dADAR and the presence or absence of this exon alters the spacing
between these two motifs (Palladino et al., 2000a). This has been shown to
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Figure 4.2 "N-'H HSQC spectrum of Drosophila ADAR dsRBMl. Each
signal in the HSQC spectrum represents a proton that is bound to a nitrogen
atom. Since there is only one backbone Hx per amino acid, each HSQC signal
represents one single amino acid. The HSQC also contains signals from the
NH2 groups of the side chains of Asn and Gin and of the aromatic HN protons
of Trp and His. Analysis of RBM1 with the 6x His tag cleaved results in a
good dispersion pattern and indicates a well folded protein. Data provided
by Jose Gallego.
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affect the activity of the dADAR protein with exon 3a containing transcripts
less active than 3/4 isoforms.
A number of constructs were designed to allow analysis of these dsRNA
binding domains together with and without the alternatively splice exon as
well as separately (See figure 4.3A). Constructs were cloned into the pET-28a
vector in frame with a 6x HIS tag and expression in E. coli was under the
control of the T7lac promoter. To assess the efficiency of induction culture
samples were taken prior to induction and at hourly intervals after the
addition of IPTG. Analysis by SDS-PAGE and Coomassie staining showed
all proteins were expressed except the full domain consisting of both
dsRBMs and exon 3a (See figure 4.3B). Further analysis indicated that this
protein was cleaved. The presence of exon 3a in full length dADAR
lengthens the relatively unstructured linker region between the two dsRBMs
probably increasing the overall flexibility of the domain. When expressing a
recombinant version of the domain alone this unstructured linker region will
probably be more susceptible to proteolytic cleavage.
The His-tagged RBM proteins were initially purified over Ni2+-NTA agarose
in 500 mM KC1. SDS-PAGE analysis detected bands corresponding to the
predicted molecular weight of the constructs however a number of
contaminant proteins were also present. Further elution over a second Ni2+-
NTA column at 500 mM KC1 followed by a 1 M KC1 column improved the
purification though an E. coli contaminant of approximately 45 kDa remained
present especially in the purification of RBM1 +RBM2 minus exon 3a. (See
figures 4.4A, 4.4B and 4.4C)
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Figure 4.3A Schematic of the dsRBM constructs expressed in £. coli.
Constructs containing RBM1 were designed to begin translation at proline
residue 55 of the full length dADAR protein and a C-terminal tail containing
the 6x histidine tag was added. The RBM2 construct begins at aspartate
residue 200.
144
4 The Drosophila dsRNA Binding Domain
RBM1+RBM2 RBM1+RBM2
+ exon 3a - exon 3a
kQ (26.7 kDa) (21.3 kDa)
M un +1 +2 +3 M un +1 +2 +3
200
RBM1 RBM2
(14.4 kDa) (7.3 kDa)
un M+1 +2 +3 un M+1 +2+3
Figure 4.3B The induction and expression of the dsRBM constructs in E.
coli. Expression of His-tagged RBM proteins in E. coli was induced by IPTG.
Culture samples were taken prior to induction (un) and at 1 hour, 2 hours
and 3 hours after IPTG induction. The samples were analysed by SDS-PAGE
and Coomassie staining. Arrows indicate the expressed proteins. No
expression was seen for the construct containing both dsRBMs and exon 3a.
Protein markers (kDa) are indicated on the left.
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Figure 4.4A The purification of RBM1
His-tagged RBM1 protein was purified from E. coli over a series of Ni2+NTA
columns initially at a stringency of 500 mM KC1. This was then repeated
with the pooled and dialysed elutates followed by a third column at 1 M KC1
for the final purification. Samples were taken from the crude (CR), flow
through (FT), wash (W) and elutions (E1-E7) and the level of purification at
each stage was determined by SDS-PAGE and Coomassie staining. Protein
markers (kDa) are indicated on the left.
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Figure 4.4B The purification of RBM2
His-tagged RBM2 protein was purified from E. coli over a series of Ni2+NTA
columns initially at a stringency of 500 mM KC1. This was then repeated
with the pooled and dialysed elutates followed by a third column at 1 M KC1
for the final purification. Samples were taken from the crude (CR), flow
through (FT), wash (W) and elutions (E1-E7) and the level of purification at
each stage was determined by SDS-PAGE and Coomassie staining. Protein
markers (kDa) are indicated on the left.
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Figure 4.4C The purification of RBM1 + RBM2 minus exon 3a
His-tagged RBM1 + RBM2 minus exon 3a protein was purified from E. coli
over a series of Ni2+NTA columns initially at a stringency of 500 mM KC1.
This was then repeated with the pooled and dialysed elutates followed by a
third column at 1 M KC1 for the final purification. Samples were taken from
the crude (CR), flow through (FT), wash (W) and elutions (E1-E7) and the
level of purification at each stage was determined by SDS-PAGE and
Coomassie staining. Protein markers (kDa) are indicated on the left.
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4.4 The dADAR dsRNA Bindingmotifs can
bind dsRNA and influence RNA editing
To assess the binding activity of the dsRBMs filter binding assays were
performed using radiolabeled AKP dsRNA as the ligand. A series of
dilutions ranging from 31.25 nM to 24 pM were incubated with 200 fmoles of
dsRNA for 10 min and filtered on a nitrocellulose membrane. The filters
were washed twice, dried and the radioactivity measured in a scintillation
counter in the presence of scintillation liquid. Two control samples of
unfiltered dsRNA and a sample of washed dsRNA were also measured to
assess the load and background values. The percentage of dsRNA bound
was calculated and plotted against the protein amounts (See figure 4.5A).
RBM1 saturated at around 4 pM. RBM2 failed to saturate even at levels of 24
pM however, circular dichroism and UV spectroscopy indicated nucleic acid
contamination of the RBM2 protein (See figure 4.5B). This was repeated a
further two times with no change in the result. Further purification steps
were attempted including ion exchange chromatography to remove the
nucleic acid contamination but these steps were unsuccessful. It therefore
appears that this contamination may be RNA from E. coli binding to RBM2
and therefore preventing it binding to the radiolabeled dsRNA hence the
reason saturation point was never reached.
4.5 The dsRBMs can be co-expressed with DM
WT in PlCHIA PASTORIS
A cloning strategy was devised to enable the dsRNA binding domain
constructs to be co-expressed with DM WT in Pichia pastoris. This would
allow me to assay whether the dsRBMs can influence the in vivo editing
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Figure 4.5A Filter binding of RBM1 and RBM2 to dsRNA. Filter binding
was performed with the two dsRNA binding motifs; the protein amounts are
indicated on the x-axis in pM.
Figure 4.5B Far UV CD spectroscopy of RBM1 and RBM2. Far UV circular
dichroism spectroscopy of RBM1 and RBM2 was performed. Nucleotide
contamination is evident in RBM2 indicated by the continued rise in signal
after 240 nM.
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activity of DM WT on the Adar exon 7 substrate. The DM WT construct
cloned into pPICZ A was integrated into the Pichia KM71 genome at the
aox::ARG4 loci and clones were screened for Zeocin resistance. Meanwhile,
the dsRBM constructs were cloned into pHIL-D2 and integrated into DM WT
containing KM71 strains at the his4 locus before being screened for the His+
phenotype (See figure 4.6A). His+ ZeocinR clones were selected and grown as
before in glycerol media before protein expression was induced by
transferring the cells into a methanol medium. Expression of each protein
was assayed by western blot analysis using an anti-tetra HIS antibody. DM
WT co-expressed well with RBM2, RBM1+2 plus exon 3a and RBM1+2 minus
exon 3a. RBM1 was expressed though a longer exposure was required to
view the band. As before, RT-PCR and sequence analysis was performed on
total RNA isolated from Pichia expressing DM WT and each of the RBM








DM WT + RBM1 20 3 15%
DM WT + RBM2 21 9 42.8%
DM WT + RBMs 1+2
minus exon 3a
18 0 0%
DM WT + RBMs 1+2
plus exon 3a
28 2 7%
DM WT 43 4 9.3%
dADAR 3/4 WT 20 13 65%
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Figure 4.6A Schematic of the cloning strategy used for co-expressing the
dsRBM constructs in Pichia pastoris with DMWT
The DM WT construct was cloned into pPICZ A and integrated into the
Pichia KM71 strain genome at the aox::ARG4 loci. Positive clones were
isolated by Zeocin resistance screening. The dsRBM constructs were cloned
into pHIL-D2 and integrated into the DM WT containing Zeocin resistant
KM71 strains at the his4 locus. Positive clones demonstrated a His+
phenotype.
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RBM1 + 2 plus exon 3a
RBM1 + 2 minus exon 3a
RBM2
Figure 4.6B Co-expression of dsRBMs and DM WT in Pichia pastoris
After screening His+ ZeocinR colonies were selected and grown as
described. After induction samples were analysed by Western blot using
an anti-tetra HIS antibody (Qiagen). Arrows indicate the expressed
proteins. Lane 1 contains the DMWT plus RBM1 sample. Expression
of RBM1 can be detected with longer exposures seen in the lower gel.
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According to the data it appears RBM2 has the greatest effect on DM WT
editing activity. It should be noted that it is impossible to control the relative
amounts of protein expressed in Pichia as it is very dependent on the
insertion locus and in the case of DM WT and integration in the AOX1
region, multiple insertion events are possible. However, in this case the
expression levels of DM WT should be constant as the same original DM WT
KM71 colony was used for the integration of the RBMs. The comparison of
the relative amounts of protein by western analysis is possible as the lanes
were equally loaded therefore it appears that RBM1 has little effect due to its
lower expression levels. Interestingly, the constructs consisting of both
dsRBMs also had little effect on DM WT editing activity even though
expression was detected. This could be due to construct design resulting in a
incorrectly folded domain which interacts less well with dsRNA than the
individual motifs.
4.6 Discussion
dsRNA binding domains consist of one or more dsRNA binding motifs
tandemly arranged. In the case of dADAR two dsRNA binding domains are
situated at the amino terminus. The hypothesis is that the two motifs and the
linker region between them form a dumbell-like shape that wraps itself
around a dsRNA substrate allowing the catalytic domain to deaminate an
adenosine base.
Interestingly the linker region in dADAR separating these motifs contains an
alternatively spliced exon, 3a, whose presence or absence changes the
spacing and has been found to affect the overall activity of the protein
(Palladino et al., 2000a). Isoforms with exon 3a are less active than those
without 3a. It is believed that the extra residues between the motifs increase
the flexibility of the whole domain and perhaps in the case of dADAR
prevent it from binding as efficiently to a dsRNA substrate. Structural
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analysis of this region should clarify the role of exon 3a and define the
characteristics of both dsRNA binding motifs.
An attempt was made to express RBM1, RBM2 as well as both motifs with
and without exon 3a in E.coli. As discussed earlier, I was unable to express
the construct consisting of both motifs with exon 3a and believe this to be
due to proteolytic cleavage within the unstructured linker region. However,
successful expression of RBM1 allowed us to perform NMR and resolve the
structure. As with other well documented dsRBD's (Bycroft et al., 1995;
Kharrat et al., 1995; Nanduri et al., 1998), RBM1 revealed the common
a-p-p-p-a structure in which the two a-helices lie on one face of a three-
stranded anti-parallel P-sheet. Sequence analysis also indicated that both
RBM1 and RBM2 were type A domains with the conserved residues at their
carboxy terminus and would likely display dsRNA binding activity (Doyle
and Jantsch, 2002).
The dsRBMs of a number of proteins have been found to perform different
functions with some displaying no dsRNA binding activity but instead
playing a role in nuclear localisation, protein dimerisation or activiation of
transgene expression. Gallo et al. have already demonstrated that RBM1 is
involved in protein dimerisation and that point mutations within this region
can disrupt dsRNA binding activity preventing protein-protein interaction
(Gallo et al., 2003). I performed filter binding analysis on recombinant RBM1
and RBM2 to compare the relative binding affinities of each motif. Both were
able to bind dsRNA with high affinity however, the recombinant RBM2
samples appeared to be contaminated with dsRNA preventing a clear and
accurate result. Further purification steps in up 1 M KC1 did not change the
result and RBM2 continued to bind unefficiently to dsRNA.
Having analysed both dsRBMs and the deaminase domain and found that all
are able to function in isolation, I opted to co-express these constructs in
Pichia and assay the editing activity of the deaminase domain on the exon7
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transcript. As mentioned previously, the hADARl and hADAR2 deaminase
domains have been shown to be active on their own and a number of
deletion analyses of both proteins have identified the important regions
essential for activity. However, no one has expressed the domains
individually and then assayed editing activity.
My results showed that when co-expressed with the deaminase domain
RBM2 can increase editing activity by around 4-fold. Many deletion analyses
have been done on the human ADARs and all have concluded that the
dsRNA binding motif immediately upstream of the deaminase domain is
critical for catalytic activity (Lai et al., 1995; Liu and Samuel, 1996; Macbeth et
al., 2004). My results would suggest the same as the editing activity of DM
WT was greatly increased in the presence of RBM2.
Recent work by Stefl et al. clearly demonstrates that both RBMs of hADAR2
interact with the R/G substrate at different sites and at distinctive motifs on
the dsRNA stem loop structure (Stefl et al., 2006). Each RBM contributes to
the editing reaction in either a substrate-specific manner, like RBM1, or is
essential for all editing, like dsRBM2 (R.B. Emeson, unpublished). Owing to
their homology, the possibility exists that the dADAR RBM2 plays a similar
role to that of the hADAR2 RBM2 and is essential for editing. This would
explain the increase in RNA editing activity of the DM WT protein when co-
expressed with RBM2.
More interesting though is that neither of the constructs containing both
dsRBMs was able to improve editing efficiency, in fact if anything they
appear to have a negative effect. As discussed by Gallo et al. the amino
terminus and RBM1 of dADAR are essential for protein dimerisation and
dADAR activity and removal of the amino terminus abolishes all activity
(Gallo et al., 2003). This differs from hADAR2 where the amino terminus is
not required for RNA editing (Macbeth et al., 2004) and is not involved in
dimerisation (Poulsen, 2006). None of the RBM constructs I expressed
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contained the amino terminus perhaps explaining the lack of co-operation
between the domain and the DM WT protein. It could be hypothesised that
the first dsRNA binding motif has an inhibitory effect on activity and
requires the amino terminus to activate the domain or quench this activity.
As RBM1 is capable of binding to dsRNA when expressed in isolation and
did show a moderate increase in editing activity when co-expressed with the
deaminase domain I would suggest that the latter is more likely.
One can only assume that the story of the dADAR dsRBD and its role has a
few more chapters yet to come.
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Summary and Future Work
5.1 Summary ofWork
Throughout this thesis I have been attempting to clarify the roles of the
functional domains of the Drosophila melanogaster ADAR enzyme. I have
demonstrated that the deaminase domain of dADAR is active and will edit
both double strand RNA and dAdar exon7 transcripts. The specificity of the
deaminase domain mirrors that of the full length protein with each targeting
the same adenosine bases.
The activity of the Drosophila ADAR protein is decreased by a serine to
glycine residue change and this decrease can be replicated in a human
ADAR2 mutant encoding serine at this position.
The dsRNA binding domains of dADAR share the same structural
characterisitics as the domains of other well studied dsRBD-containing
proteins with each being capable of binding to dsRNA on their own and
when co-expressed with the deaminase domain RBM2 can increase the
editing activity of the deaminase domain by around 4-fold.
5.2 Future Directions
As summarised above I have attempted to shed light on the characteristics of
the Drosophila ADAR enzyme but as with all science, it "...never solves a
5 Summary and Future Directions
problem without creating ten more" (George Bernard Shaw) therefore the
scope of possible future work is large and varied.
5.2.1 The formation of Drosophila ADAR dimers
The mechanism by which the Drosophila ADAR catalytic domain is able to
edit dsRNA transcripts without the dsRNA binding domain and the
dimerisation region could be investigated further. As discussed earlier,
previous work suggested the formation of a homodimer was a pre-requisite
for editing activity (Gallo et al., 2003). Editing activity was not detected with
deletion constructs lacking the amino terminus however Gallo et al. assayed
activity using poisoned primer extension and thin layered chromatography.
In order to detect any editing activity of the deaminase domain I have to use
the more sensitive method of RT-PCR. A re visit to this AN construct and
further sequence analysis may show that it possesses very weak editing
activity similar to that seen for the DM WT construct. However, the fact
remains that the role of the amino terminus in dADAR is an important one
and this differs from that of hADAR2 where the amino terminus appears
dispensible for activity (Macbeth et al., 2004; Poulsen, 2006).
The model of dimer formation for dADAR is unclear. Poulsen et al. have
formulated a hypothesis for the dimerisation of hADAR2 where dsRBMl
initially binds to the dsRNA and loses its auto-inhibitory effect on catalysis
and allows dimers to form (Poulsen, 2006). Upon dimerisation the second
dsRBM binds to the substrate resulting in a conformational change and an
active enzyme. This model could be applicable to dADAR with perhaps the
amino terminal playing a role in releasing a possible dsRBMl auto inhibition
in the presence of dsRNA. This hypothesis would explain the lack of editing
activity by DM WT when co-expressed with the RBM1 + RBM2 with or
without exon 3a as both these constructs did appear to inhibit the intrinsic
deaminase domain editing activity rather than increase it.
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The region of interaction between dADAR monomers has been identified but
the symmetry of the dimer is unknown. Analysis of editing patterns on
substrates such as the exon 7 transcript show that more than one site is
edited. Interestingly, my results show four editing sites on exon 7 including
the S/G site. If the mfold structural prediction of the secondary structure of
this substrate is accurate then an adenosine opposite the S/G site is edited
along with one within the tetraloop structures at either end of the duplex.
This suggests a number of possibilities with regards to the quaternary
structure of the homodimer but would suggest that both deaminase domains
within a dimer are able to edit an adenosine.
5.2.2 The role of the edited serine residue
As previously discussed, dADAR edits its own transcript resulting in a
serine to glycine change within the catalytic domain and a decrease in
editing activity. This effect can be replicated in other ADARs that are not
normally edited and can be mutated to code for serine at this site. So far, this
auto regulatory mechanism has only been identified in D. melanogaster
however, the idea that it may be a universal method of ADAR regulation is
quashed by the fact that not all ADAR enzymes have a serine at this position;
hADARl for example codes for aspartic acid at this position.
Considering the significant negative effect this serine to glycine change has
on dADAR activity it is surprising it has not been conserved. Further
investigation to identify the role of this residue would involve structural
studies to ascertain if it is involved in the catalytic mechanism or perhaps
interacts with the dsRNA transcript. Perhaps even more interesting would
be the comparison of the hADARl and dADAR structures in this region to
give a better understanding as to why both enzymes vary so much in what is




Clustal peptide alignment of full length human ADAR2 (Accession No.
NP_001103) and Drosophila ADAR (Accession No. AAF63702) proteins. All
peptides referred to in the text are numbered according to the sequences
below. The DM WT dADAR construct analysed is highlighted in red, the
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. * . * * . * * . * • * * * * * * * * * .
hADAR2
dADAR as ■ 652PNFGINWTIGDTPLEWNSLTGRTIGGOVSRXTKOAFFVKYGFDMANLPGILVR-KV 622
***** .***.**. •**.*. **. *. **. *.*.. .. . ..* *.*•*.
hADAR2
dADAR TTD--YGQTKANVKDYQIAKLELFSAFKREDLGSWLKKPIEQDEFGLAE 669
* * ..* *.** ** **.** . **.*..** ***.* *.
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